Proxy Statement (Form DEF 14A)
Filed by a party other than the Registrant
☐
|
Preliminary Proxy Statement | |
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☒
|
Definitive Proxy Statement | |
☐
|
Definitive Additional Materials | |
☐
|
Soliciting Material Under Rule
240.14a-12
|
☒
|
No fee required. | |||
☐
|
Fee paid previously with preliminary materials. | |||
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
Dear Fellow Shareholders: On behalf of Fiscal 2024 was another year of attaining milestone financial performance for Our unique focus and internal ownership drive our forever strategy to deploy capital that creates long-term shareholder value. In 2024, we acquired 32 high-quality businesses with annual revenues of approximately In Finally, we want to extend our deepest appreciation to Whether or not you attend the virtual meeting, we encourage you to vote online, by phone or by signing and returning your proxy card promptly in the enclosed envelope to ensure your shares will be represented at the meeting. If you decide to attend the virtual meeting and vote your shares electronically, you will, of course, have that opportunity. |
2024 Total Shareholder Return +44% |
|||||||
Proxy Statement Highlights |
||||||||
1 |
Proxy Summary |
|||||||
4 |
Board and Corporate |
|||||||
45 |
Executive Compensation Tables |
|||||||
On behalf of our Board of Directors, our leadership team and our teammates, thank you for your investment in and commitment to Sincerely, Lead Independent Director Chairman of the Board |
"In 2024 we grew our total revenues to over
by strong organic revenue growth companywide across all
three of our operating segments. Our net cash provided by
operating activities increased again to nearly
we further expanded our industry-leading operating margins."
The Annual Meeting of Shareholders of
1 |
To elect thirteen (13) nominees to the Company's Board of Directors; | |||
FOReach director nominee |
||||
2 |
To ratify the appointment of |
|||
FOR |
||||
3 |
To approve, on an advisory basis, the compensation of named executive officers; | |||
FOR |
||||
4 |
To approve an amendment to the Company's 2019 Stock Incentive Plan to increase the number of shares available for issuance under the plan and extend the term; and | |||
FOR |
||||
5 |
To transact such other business as may properly come before the meeting or any adjournment thereof. | |||
The Board of Directors has fixed the close of business on
By Order of the Board of Directors
Secretary
Your Vote is Important You will be able to attend the Annual Meeting online, vote your shares electronically and submit your questions during the Annual Meeting via a live audio webcast by registering at https://web.viewproxy.com/BBrown/2025 by A replay of the webcast will be available in the "Investor Relations" section of our website (www.bbrown.com) beginning the afternoon of How to Vote |
||
By Internet Prior to the Annual Meeting, you can vote your shares online via the website on your proxy card or voting instruction form. During the Annual Meeting, you can vote your shares online at www.AALvote.com/BRO. See "Attending the Virtual Annual Meeting" for more details. |
||
By Telephone In the |
||
By Mail Please vote, date, sign and promptly retuthe enclosed proxy in the envelope provided for that purpose, whether or not you intend to be present at the meeting. |
||
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON The Proxy Statement and Annual Report to Shareholders are available at: https://web.viewproxy.com/BBrown/2025. |
TABLE OF CONTENTS
II | BROWN &
|
This summary highlights information contained elsewhere in this Proxy Statement. This summary does not contain all of the information you should consider. You should read the entire Proxy Statement carefully before voting. |
Meeting Agenda |
Meeting Information TIME AND DATE LOCATION The Annual Meeting will be held virtually. Please register at https://web.viewproxy.com/BBrown/2025 RECORD DATE |
|||||||||||||
PROPOSAL |
Board Recommendation |
For More Information |
||||||||||||
1 |
Election of Directors | FOR each nominee |
page 4 | |||||||||||
2 |
Ratification of the Appointment of |
FOR |
page 19 |
|||||||||||
3 |
Advisory Vote to Approve Executive Compensation |
FOR |
page 23 |
|||||||||||
4 |
Approval of Amendment to the Company's 2019 Stock Incentive Plan to Increase Number of Shares Available for Issuance under the Plan and Extend the Term |
FOR | page 60 |
Director Nominees
Committee Chair Audit Committee Compensation Committee Acquisition Committee Nominating/Corporate Governance Committee 1 Ms. Jennings previously served on our Board of Directors from 1999 until 2 Lead Independent Director |
||||||||||||
BROWN, 87 Director since: 1993 |
BROWN, 57 Director since: 2007 |
Director since: 2018 |
Director since: 1994 |
JAMES S. HUNT, 69 Director since: 2013 |
||||||||
TONI JENNINGS,1 75 Director since: 2007 |
PAUL J. KRUMP, 65 Director since: 2023 |
TIMOTHY R.M. MAIN, 59 Director since: 2010 |
Director since: 2023 |
|||||||||
JAYMIN B. PATEL, 57 Director since: 2023 |
PROCTOR, JR.,2 56 Director since: 2012 |
WENDELL S. REILLY, 67 Director since: 2007 |
KATHLEEN A. SAVIO, 59 Director since: 2024 |
|||||||||
PROXY SUMMARY
Director Skills and Diversity Highlights |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
GENDER |
RACE/ |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Male | Female | White | Asian | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lawrence L. Gellerstedt III |
● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
● | ● | ● | ● | ● | ● | ● | ● |
Independent
Corporate Governance Highlights |
Director Nominees |
|||||||
SHAREHOLDER RIGHTS • Annual election of directors • Majority voting for directors, with director resignation policy BOARD INDEPENDENCE • Strong role for Lead Independent Director • Periodic rotation of committee members, committee chairs and Lead Independent Director • Executive sessions at every in-personBoard meeting and virtually, when necessary |
GOOD GOVERNANCE • Strong anti-hedging and anti-pledging provisions • Annual Board and committee self-evaluations • Strong executive and director stock ownership guidelines • Robust clawback policy • Committee meetings generally open to, and attended by, all directors |
85% of Our Directors Are Independent |
13 Average Tenure of Our Directors in Years |
|||||
8% of Our Directors Are Ethnically/ Racially Diverse |
15% of Our Directors Are Female |
2 | BROWN &
PROXY SUMMARY
Our Strategy and Performance
The Company's strategy is focused on growing our total and organic revenues while delivering strong, industry-leading operating margins and cash conversion. As part of our goal to manage capital in the long-term interests of our shareholders, we generally invest our earnings in the following ways: (1) internally by hiring new teammates and investing in innovation, thereby expanding our capabilities, (2) making high-quality acquisitions and (3) returns to shareholders through the payment of dividends and periodic share repurchases. As part of our overall capital allocation strategy, we remain focused on preserving a level of flexibility and a conservative leverage profile, which enables us to deploy our capital in ways we believe will optimize long-term shareholder value.
HOW WE INVEST OUR EARNINGS
1 |
Hiring new teammates and expanding our capabilities |
2 |
Making high-quality acquisitions |
3 |
Returns to shareholders through the payment of dividends and periodic share repurchases |
Performance Highlights
In fiscal 2024, we delivered strong results, as reflected in the following financial and operational highlights:
2024
PERFORMANCE |
2023
PERFORMANCE |
Strong total and ORGANIC REVENUE GROWTH companywide and in each of our three segments INCREASEDour industry-leading operating margins 31stconsecutive annual dividend increase, returning approximately ROBUST GROWTHin net cash provided by operating activities 32 |
||||||||||||
Total revenue |
||||||||||||||
Net income attributable to the Company |
||||||||||||||
Diluted earnings per share |
||||||||||||||
Company total commissions and fees growth |
12.1% | 17.9% | ||||||||||||
Retail segment total commissions and fees growth |
8.8% | 16.1%2 | ||||||||||||
Programs segment total commissions and fees growth |
18.5% | 21.2%2 | ||||||||||||
Wholesale Brokerage segment total commissions and fees growth |
13.2% | 19.0% | ||||||||||||
Company Organic Revenue3 growth |
10.4% | 10.3% | ||||||||||||
Retail segment4 Organic Revenue3 growth |
5.8% | 7.4%2 | ||||||||||||
Programs segment Organic Revenue3 growth |
22.4% | 16.1%2 | ||||||||||||
Wholesale Brokerage segment Organic Revenue3 growth |
9.1% | 12.1% | ||||||||||||
Income before income taxes margin5 |
27.1% | 26.9% | ||||||||||||
Adjusted EBITDAC Margin3 |
35.3% | 34.2% | ||||||||||||
Net cash provided by operating activities |
||||||||||||||
(1) Amount includes a pre-taxgain on disposal of (2) In the fourth quarter of 2023, the Company sold certain third-party claims administration and adjusting services businesses representing approximately 50% of the total revenues of the Services segment. As a result, beginning in fiscal year 2024, the Company operates three segments. Historical results have been recast to align with the three-segment structure. (3) See Annex Afor additional information regarding Organic Revenue, Organic Revenue growth and Adjusted EBITDAC Margin, which are non-GAAPfinancial measures, including a reconciliation to the most closely comparable GAAP financial measure. (4) The Retail segment includes commissions and fees reported in the "Other" column of the Segment Information table in Note 16 to our audited consolidated financial statements in our Annual Report on Form 10-Kfor the fiscal year ended (5) Income before income taxes margin is calculated as the Company's income before income taxes, as reported, divided by total revenues, as reported. |
||||||||||||||
Proposal 1: Election of Directors
At the Meeting, 13 directors will stand for reelection for a term expiring at the 2026 Annual Meeting of Shareholders. Information about each nominee's experience and qualifications appears below.
All nominees have consented to being named in the Proxy Statement and have agreed to serve if elected. If any director nominee becomes unable or unwilling to serve, proxies will be voted for any substitute nominee(s) as the Board of Directors (the "Board") may nominate on the recommendation of the Nominating/Corporate Governance Committee.
Vote Required; Majority Voting; Board Recommendation
Our By-Lawsprovide for a majority voting standard for the election of our directors in uncontested elections. If the director election were contested, the plurality standard would apply, which means the nominees receiving the greatest numbers of votes would be elected to serve as directors.
To be elected, a nominee must receive the affirmative vote of more than 50% of the votes cast, present either in person or by proxy, at the Meeting. If an incumbent director does not receive more than 50% of the votes cast with respect to his or her election, he or she must promptly tender a conditional resignation following certification of the vote. The Nominating/ Corporate Governance Committee will then consider the resignation and recommend to the Board whether to accept it, and the Board would be expected to act on the recommendation within 90 days. Thereafter, the Board will
promptly publicly disclose its decision concerning whether to accept the director's resignation offer (and, if applicable, the reasons for rejecting the offer). If the Board does not accept the resignation, the director will continue to serve until the next annual meeting and until a successor has been elected and qualified. If the Board accepts the resignation, then the Board may fill any resulting vacancy or may decrease the size of the Board.
The Board unanimously recommends a vote "FOR"each of the 13 director nominees |
|
4 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Director Nominees
Director Nominees and Qualifications
Set forth below is certain information concerning our current directors, all of whom are director nominees. All directors hold office for one-yearterms or until their successors are elected and qualified.
Age:87 Director Since:1993 |
Chairman of the Board Skills and Experience Nominee Attributes |
|||
Age:57 Director Since:2007 |
Director and Chief Executive Officer Skills and Experience Mr. Nominee Attributes Mr. |
BOARD AND CORPORATE GOVERNANCE MATTERS
Age:68 Director Since:2018 Committees Served: • Acquisition • Compensation (Chair) |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:83 Director Since:1994 Committees Served: • Nominating/Corporate Governance |
Independent Director Skills and Experience Nominee Attributes |
6 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Age:69 Director Since:2013 Committees Served: • Acquisition • Audit |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:75 Director Since:2007 Committees Served: • Compensation • Nominating/Corporate Governance |
Independent Director Skills and Experience Nominee Attributes |
BOARD AND CORPORATE GOVERNANCE MATTERS
Age:65 Director Since: 2023 Committees Served: • Acquisition (Chair) • Audit |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:59 Director Since:2010 Committees Served: • Acquisition |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:63 Director Since:2023 Committees Served: • Audit • Compensation |
Independent Director Skills and Experience Nominee Attributes |
8 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Age:57 Director Since:2023 Committees Served: • Audit (Chair) |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:57 Director Since:2012 Committees Served: • Nominating/Corporate Governance (Chair) |
Lead Independent Director Skills and Experience Nominee Attributes |
BOARD AND CORPORATE GOVERNANCE MATTERS
Age:67 Director Since:2007 Committees Served: • Acquisition • Nominating/Corporate Governance |
Independent Director Skills and Experience Nominee Attributes |
|||
Age:59 Director Since:2024 Committees Served: • Audit |
Independent Director Skills and Experience Nominee Attributes |
10 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Director Independence
The Board has considered the independence of our nominees in light of these NYSE standards and has affirmatively determined that the following 11 of the 13 director nominees have no material relationship with us other than service as a director, and are therefore independent: Lawrence L. Gellerstedt III; |
85% of Our Directors Are Independent |
• |
The Board considered the relationships described below in "Relationships and Transactions with Affiliated Parties." |
• |
In each case, the Board considered the fact that from time to time, in the ordinary course of business and on usual commercial terms, we and our subsidiaries may provide services in our capacities as insurance intermediaries to various directors of the Company, and to entities in which various directors of the Company have direct or indirect interests. |
• |
In the case of |
• |
In the case of |
• |
In the case of |
• |
In the case of Messrs. Proctor and Gellerstedt, the Board considered the fact that Messrs. Hyatt Brown, |
BOARD AND CORPORATE GOVERNANCE MATTERS
Director Nominee Selection Process
The Nominating/Corporate Governance Committee is responsible for identifying and evaluating director nominees and for recommending to the Board a slate of nominees for election at each Annual Meeting of Shareholders. The Committee has not established "minimum qualifications" for director nominees because it believes that rigid "minimum qualifications" might preclude the consideration of otherwise desirable candidates for election to the Board.
1 |
The Committee evaluates director candidates based on a number of factors, including: |
• the need or desirability of maintaining or expanding the size of the Board; • independence; • credentials, including, without limitation, business experience, technology acumen, experience within the insurance industry, educational background, professional training, designations and certifications; • interest in, and willingness to serve on, the Board; • ability to contribute by way of participation as a member of Board committees; • financial expertise and sophistication; • basic understanding of the Company's principal operational and financial objectives, plans and strategies, results of operations and financial condition, and relative standing in relation to the Company's competitors and • willingness to commit requisite time and attention to Board service, including preparation for and attendance at regular quarterly meetings, special meetings, committee meetings and periodic Board "retreats" and director education programs. |
||||
2 |
Board diversity | The Committee actively seeks diverse, highly qualified candidates for membership on the Board, including gender-diverse candidates and candidates that are racially or ethnically diverse, as well as candidates with diverse backgrounds, points of view, experience and credentials. | ||||
3 |
Sources for identifying potential Board members |
The Committee and the Board consider a variety of sources when identifying individuals as potential Board members, including other enterprises with which current Board members are or have previously been involved and through which they have become acquainted with qualified candidates. The Company does not pay any third party a fee to assist in the identification or evaluation of candidates. The Committee will consider director nominations that are submitted in writing by shareholders in accordance with our procedures for shareholder proposals. See "Proposals of Shareholders" below. Such proposals must contain all information with respect to a proposed candidate as required by the |
12 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
The Board's Role and Responsibilities
Overview
The role of the Board of Directors is to oversee the affairs of the Company for the benefit of our shareholders and other constituencies, including our teammates, customers, suppliers, carrier partners and the communities in which we do business. The Board strives to propel the success and continuity of the Company's business through the selection of qualified management and through ongoing monitoring designed to assure the Company's activities are conducted in a legal, responsible and ethical manner.
Risk Oversight
The Board and its committees actively oversee the management of the Company's risks. They receive regular reports from senior management on areas of material risk to the Company, including operational, financial, strategic, acquisition-related, technological, competitive, reputational, legal and regulatory risks.
The Board believes risk oversight is a responsibility of the entire Board and does not delegate its responsibility to any individual director or committee. However, our Board committees have specific oversight responsibilities relating to certain aspects of risk management:
Our Audit Committee Regularly reviews our financial statements, certain financial disclosures, our financial and other internal controls, and regularly receives reports from management, including the Company's Chief Security Officer, on the Company's cybersecurity risks. Additionally, our Internal Audit Team and independent registered public accountants regularly identify and discuss with the Committee risks and related mitigation measures that may arise during their regular reviews of the Company's financial statements and audit work, as applicable. |
Our Compensation Committee Regularly reviews our executive compensation policies and practices, and other related employee benefits, and the risks associated with each. We believe our compensation policies and principles, in conjunction with our internal oversight of those policies and principles, reduce the possibility of imprudent risk-taking. We do not believe our compensation policies and principles are reasonably likely to have a material adverse effect on the Company. |
Our Nominating/Corporate Governance Committee Considers issues associated with the independence of our Board, corporate governance and potential conflicts of interest. Additionally, the Committee oversees our environmental, social and governance (ESG) policies and initiatives. |
While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board of Directors is regularly informed through attendance at committee meetings or through committee reports about such risks.
We believe the Board's approach to risk oversight, as described above, helps assess various risks, make informed decisions and proactively evaluate emerging risks for the Company.
Further, our Financial Internal Audit Team is responsible for the performance of the internal audit function and for testing compliance with policies and procedures relating to our financial reporting and control environment. Our Information Technology Audit Team is responsible for testing our systems and data security, as well as information technology controls. Our Insurance Operations Audit Team is responsible for the testing of our operational internal controls. Our Team Resources Audit Team tests compliance with internal guidelines and applicable employment law requirements relating to compensation and human resources and regularly assesses risks and potential risks associated with our operations. These teams report, through our Chief Audit Officer, to our Audit Committee quarterly, unless more frequent reports are necessary. Our Chief Audit Officer reports directly to the Audit Committee and has oversight for the audits of our businesses and related control environment
Our Chief Legal Officer is primarily responsible for enterprise risk management for the Company. The Company's Enterprise Risk Management Committee ("ERMC"), which is composed of a multidisciplinary team of the Company's executive officer leaders, meets at least quarterly to (i) understand and report an enterprise view of the risks facing the Company, (ii) oversee the management of key
BOARD AND CORPORATE GOVERNANCE MATTERS
risks and (iii) ensure that a comprehensive enterprise risk management (ERM) program exists. The ERMC occasionally invites members of the Board to attend its meetings because we believe their diverse experience in a variety of industries helps us better identify, understand and manage the risks facing the Company.
On a quarterly basis, our Chief Legal Officer presents an enterprise risk management analysis to our Audit Committee, which includes an assessment of overall risk, risk mitigation and elimination priorities, anonymous ethics hotline reports and claims liabilities. Also, our Chief Executive Officer and Chief Legal Officer annually deliver a detailed presentation to our Board of Directors about risks associated with our business. This presentation includes extensive discussion, analysis and categorization of risks with respect to the likelihood of occurrence, severity and frequency, as well as consideration of mitigating factors that contribute to lessening the potential adverse consequences associated with such risks (which can never, in any business, be fully eliminated). The quarterly presentations to our Audit Committee and the annual presentation to our Board of Directors are prepared with input from the Company's senior leaders, as well as our Chief Security Officer, and are informed by the activities of our ERMC.
Talent Management and Succession Planning
The Chairman of the Board, as well as our Chief Executive Officer and our
Communication with Directors
Interested parties, including shareholders, may communicate with our Board of Directors, with specified members or committees of our Board, with non-managementdirectors as a group or with the Lead Independent Director,
Corporate Governance Principles; Code of Business Conduct and Ethics; Code of Ethics for Chief Executive Officer and Senior Financial Officers
The Board of Directors has adopted Corporate Governance Principles, a Code of Business Conduct and Ethics and a Code of Ethics for Chief Executive Officer and Senior Financial Officers, the full text of each of which can be found in the "Corporate Governance" section of the "Investor Relations" tab, under "Key Documents" on our website (www.bbrown.com), and each of which is available in print to any shareholder who requests a copy by writing to our Corporate Secretary at
Related Party Transactions Policy
Under our written Related Party Transactions Policy, our Chief Legal Officer (or our Chief Executive Officer if the related party is our Chief Legal Officer or an immediate family member of our Chief Legal Officer) will review any potential Related Party Transaction to determine if it is subject to the Policy. If so, the transaction will be referred to the Nominating/Corporate Governance Committee for approval or ratification. If, however, the Chief Legal Officer determines that it is not practical to wait until the next meeting of the Nominating/Corporate Governance Committee, the Chair of the Nominating/Corporate Governance Committee shall have the authority to act on behalf of the Nominating/Corporate Governance Committee on whether to approve or ratify a Related Party Transaction (unless the Chair of the Nominating/Corporate Governance Committee is a
For purposes of our Policy, "Related Party Transactions" are transactions in which the Company is a participant, the amount involved exceeds
14 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Relationships and Transactions with Affiliated Parties
During 2024, Mr.
The owners of
During 2024, THG, HFG and Mr.
Board Structure and Process
Board Leadership
Our Board has the flexibility to determine whether the roles of Chairman of the Board and Chief Executive Officer should be separated or combined. The Board makes this decision based on its evaluation of the circumstances and the specific needs of the Company.
We believe our leadership structure is desirable because it allows Mr.
The Board conducts executive sessions of non-managementdirectors in connection with each regularly scheduled meeting of the Board. Our Lead Independent Director,
BOARD AND CORPORATE GOVERNANCE MATTERS
Board and Board Committee Matters
Our Board of Directors has an
AUDIT COMMITTEE | ||
Members Bronislaw E. Masojada Meetings Held in 2024: 6 |
The Audit Committee is composed of independent directors as defined in the NYSE listed company manual and includes two audit committee financial experts, |
|
COMPENSATION COMMITTEE | ||
Members Lawrence L. Gellerstedt III Meetings Held in 2024: 6 |
Each member of the Compensation Committee is independent as defined in the NYSE listed company manual. The Compensation Committee sets the compensation for our Chief Executive Officer and reviews and approves the compensation for our other executive officers, including the Named Executive Officers. See "Executive Compensation - Compensation Committee Report" and "Compensation Discussion and Analysis." The Compensation Committee also reviews, makes recommendations with respect to, and approves our existing and proposed compensation plans and is responsible for administering our 1990 Employee Stock Purchase Plan ("ESPP"), our 2008 Sharesave Plan, our Performance Stock Plan ("PSP"), which was suspended in |
|
NOMINATING/CORPORATE GOVERNANCE COMMITTEE | ||
Members Meetings Held in 2024: 5 |
Each member of the Nominating/Corporate Governance Committee is independent as defined in the NYSE listed company manual. This Committee's duties include responsibilities associated with corporate governance, as well as the nomination of persons to stand for election to the Board at our Annual Meeting of Shareholders and recommendation of nominees to the Board of Directors to fill vacancies on, or as additions to, the Board. |
16 | BROWN &
BOARD AND CORPORATE GOVERNANCE MATTERS
Director Tenure and Board Refreshment
The Nominating/Corporate Governance Committee regularly considers the composition of the Board. However, we have not established a mandatory retirement age or other term limits because we believe longer-tenured directors can bring important experience and institutional knowledge that are critical to the success of our Board and the long-term interests of our shareholders. Consideration is given to rotating committee members, committee chairs and the Lead Independent Director position generally every three to five years because we believe we benefit from having a level of consistency in our committee compositions and committee chairs, but that fresh perspectives likewise facilitate enhanced Board and committee performance. Our Nominating/Corporate Governance Committee evaluates the performance of each incumbent director at least annually before recommending such director's nomination for an additional term. In addition, any director who has a job change must submit a letter of resignation resigning from the Board. The submission of a letter of resignation provides an opportunity for the Board to review the continued appropriateness of the director's membership on the Board under the circumstances.
Board Evaluations
The Nominating/Corporate Governance Committee conducts an annual evaluation of the Board and its committees, as well as the individual performance of each director. As part of this process, all directors complete detailed confidential questionnaires to provide feedback on the effectiveness of the Board, the committees and the performance of individual directors. These questionnaires solicit director feedback on a wide range of topics, including the Board's knowledge base, the effectiveness of information provided to the Board, the functioning of Board and committee meetings, the Board's relationship with the Company's chief executive officer and director independence. The results of the questionnaires are compiled by the Chair of the Nominating/Corporate Governance Committee in the form of summaries, and the anonymized feedback is reviewed and discussed by the Nominating/Corporate Governance Committee and subsequently reported to, and discussed among, the full Board. We believe these assessments allow us to continually improve the effectiveness of our Board and committee meetings throughout the year.
Director Orientation and Continuing Education
New directors participate in a director orientation program when they join the Company's Board that familiarize the directors with the Company and their role. The Company offers, at its own expense, continuing education programs to assist the directors in maintaining skills and knowledge necessary to perform their duties.
Meetings and Attendance
During 2024, our Board of Directors held seven meetings. Each incumbent director serving during 2024 attended at least 75% of the total number of Board meetings, and 75% of the total number of meetings of committees of which such director is or was a member. The Board expects, but does not require, directors, all of whom are director nominees, to attend the Annual Meeting of Shareholders. All then-current members of the Board attended the virtual 2024 Annual Meeting of Shareholders.
Shareholder Engagement
We regularly meet with investors, prospective investors and investment analysts on a broad range of topics, including our business and capital allocation strategy, operating model, financial performance and technology initiatives. We also routinely engage with shareholders after each quarterly earnings call and material news announcement, as well as in connection with conferences and other events and on an ad-hocbasis. We view these conversations, which typically include our Chief Financial Officer, and may also include our Chief Executive Officer and/or the leaders of our operating segments, as opportunities for us to receive and discuss valuable insights into our shareholders' priorities and perspectives throughout the year.
We also engage with shareholders on corporate governance matters and have implemented various enhancements to our corporate governance practices and disclosures based on feedback from investors.
Director Compensation
Our Board of Directors reviews the compensation of our non-employeedirectors at least every two years or as such other time as circumstances may warrant.
Our non-employeedirectors are paid an annual retainer of
BOARD AND CORPORATE GOVERNANCE MATTERS
Also, each director who is not an employee of the Company receives a grant of fully vested shares valued at
No director who is an employee receives separate compensation for services rendered as a director.
2024 Director Compensation
The following table sets forth cash and other compensation earned during 2024 by directors who are not Named Executive Officers.
2024 DIRECTOR COMPENSATION
|
Fees Earned or Paid in Cash ($) |
Stock Awards ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||
|
- | - | 241,648 | (1) | 241,648 | |||||||||||
Lawrence L. Gellerstedt III |
120,000 | 119,933 | - | 239,933 | ||||||||||||
|
- | - | 688,179 | (2) | 688,179 | |||||||||||
|
25,000 | - | - | 25,000 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
120,000 | 119,933 | - | 239,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
120,000 | 119,933 | - | 239,933 | ||||||||||||
|
130,000 | 119,933 | - | 249,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 | ||||||||||||
|
100,000 | 119,933 | - | 219,933 |
(1) |
|
(2) |
|
(3) |
Stephen P. Heawas appointed to the Board effective |
(4) |
|
18 | BROWN &
PROPOSAL 2: RATIFICATION OF THE APPOINTMENT
OF DELOITTE & TOUCHE LLP AS THE COMPANY'S
INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
The Audit Committee of the Board of Directors has selected
The Committee and the Board are requesting that shareholders ratify this appointment as a means of soliciting shareholders' opinions and as a matter of good corporate governance. If the shareholders do not ratify the selection, the appointment of the independent registered public accountants will be reconsidered by the Committee. Even if the selection is ratified, the Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such change would be in the best interests of the Company and its shareholders.
One or more representatives of
Vote Required; Board Recommendation
In order to be ratified, this Proposal 2 must receive the affirmative vote of a majority of the votes cast on the proposal. The Board of Directors believes that the ratification of Proposal 2 is in the best interests of the Company and its shareholders.
The Board unanimously recommends a vote "FOR"this proposal. |
|
AUDIT MATTERS
Report of the Audit Committee
The Audit Committee of the Board of Directors operates pursuant to an Audit Committee Charter, which was most recently reviewed by the Committee in
Each member of the Audit Committee qualifies as "independent" (as that term is defined in the NYSE listed company manual, as well as other statutory, regulatory and other requirements applicable to the Company's Audit Committee members).
With respect to the fiscal year ended
1. |
has reviewed and discussed the Company's audited financial statements with management and the independent registered public accountants; |
2. |
has discussed with the independent registered public accountants of the Company the matters required to be discussed by the standards of the |
3. |
has received and reviewed the written disclosures and the letter from the independent registered public accountants required by the applicable requirements of the |
4. |
based on the review and discussions with management and the independent registered public accountants referenced above, recommended to the Board of Directors that the audited financial statements be included in the Company's Annual Report on Form 10-Kfor the fiscal year ended |
It is not the duty or responsibility of the Audit Committee to conduct auditing or accounting reviews or procedures. In performing its oversight responsibility, members of the Audit Committee rely without independent verification on the information provided to them and on the representations made by management and the independent registered public accountants. Accordingly, the Audit Committee's considerations and discussions do not assure that the audit of the Company's financial statements has been carried out in accordance with the standards of the
AUDIT COMMITTEE
20 | BROWN &
Fees Paid to
We incurred the following fees for services performed by
2023 | 2024 | |||||||
Audit Fees(1) |
$ | 3,836,864 | $ | 4,239,530 | ||||
Audit-Related Fees(2) |
$ | 120,947 | (3) | $ | 0 | |||
Tax Fees(4) |
$ | 0 | $ | 0 | ||||
All Other Fees(5) |
$ | 0 | $ | 0 | ||||
Total |
$ | 3,957,811 | $ | 4,239,530 | ||||
(1) |
Audit Fees were the aggregate fees billed to us by |
(2) |
Audit-Related Fees are fees for assurance and related services reasonably related to the performance of the audit or review of our financial statements that are not reported above under the caption "Audit Fees" for the fiscal year ended |
(3) |
These fees were billed in connection with due diligence services performed in connection with the Company's acquisition of |
(4) |
Tax Fees are fees for tax compliance, tax advice and tax planning for the fiscal years ended |
(5) |
|
Audit Committee Policy for Pre-Approvalof Independent Registered Public Accountants Services
Our policy requires that the Audit Committee consider and approve in advance any proposed engagement of the independent registered public accountants to perform services in addition to those approved in connection with their annual engagement letter, except for certain limited non-auditservices. During fiscal years 2024 and 2023, all services were approved by the Audit Committee in accordance with this policy.
Negotiation of Fees Payable to the Independent Registered Public Accountants
Each year, the Company's management begins a robust, good-faith negotiation, overseen by the Audit Committee, with the independent registered public accountant regarding the independent registered public accountants' proposed fees for the engagement. This negotiation includes a review for reasonableness of fees incurred during the previous year, as well as a review for reasonableness of fees for the proposed engagement, with consideration of any enhancements to the Company's financial and other internal controls as a result of the Company's year-over-year growth and expansion into new international jurisdictions.
Audit Committee Audit Partner Selection
In conjunction with the required rotation, the Audit Committee is involved, together with the Company's management team, in the evaluation and selection of the new lead audit partner.
INFORMATION CONCERNING INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
Evaluation of Independent Registered Public Accountants
On at least an annual basis, the Audit Committee, together with the Company's management, evaluates the performance of the independent registered public accountants in connection with its decision to re-engagethe independent registered public accountants. As part of this evaluation, which is based, in part, upon the
22 | BROWN &
PROPOSAL 3: ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION
At the Meeting, we will ask our shareholders to approve, on a nonbinding, advisory basis, under Section 14A of the Exchange Act, the compensation of our Named Executive Officers as disclosed in this Proxy Statement. This proposal, commonly known as a "say-on-pay"proposal, gives our shareholders the opportunity to express their views on our executive compensation. We have held a similar shareholder vote every year since 2011 and expect to hold a similar vote at the 2025 Annual Meeting.
As described in detail below under "Compensation Discussion and Analysis," our executive compensation program is designed to attract, motivate and retain our Named Executive Officers, who are critical to our success. Accordingly, our Named Executive Officers are rewarded to the extent we achieve specific annual goals and deliver financial performance intended to increase long-term shareholder value.
Our Compensation Committee has adopted an approach to executive compensation that we believe enables the Company to retain its executive talent, while remaining committed to our core compensation philosophy of paying for performance and aligning executive compensation with shareholder interests. The Committee continually reviews the compensation programs for our Named Executive Officers with the goal of most effectively aligning our executive compensation structure with our shareholders' interests and current market practices. For example, (1) a significant portion of pay is performance-based, (2) compensation is incentive-driven with both a short- and long-term focus and (3) we believe the components of compensation are linked to increasing shareholder value.
We are again asking our shareholders to indicate their support for our executive officer compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the philosophy, program and practices described in this Proxy Statement in accordance with the
The say-on-payvote is advisory and therefore not binding on the Company, the Compensation Committee or our Board. However, our
Accordingly, we ask our shareholders to vote on the following resolution at the Meeting:
"RESOLVED, that the compensation paid to the Company's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K,including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED."
Vote Required; Board Recommendation
In order to be approved, this Proposal 3 must receive the affirmative vote of a majority of the votes cast on the proposal. The Board of Directors believes that the advisory approval of Proposal 3 is in the best interests of the Company and its shareholders.
The Board unanimously recommends a vote "FOR"this proposal. |
|
COMPENSATION MATTERS
Compensation Committee Report
Notwithstanding anything to the contrary set forth in any of our previous filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate future filings, including this Proxy Statement, in whole or in part, the following Board Compensation Committee Report shall not be incorporated by reference into any such filings.
The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management and based on this review and those discussions, has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.
COMPENSATION COMMITTEE
Lawrence L. Gellerstedt III(Chair)
24 | BROWN &
EXECUTIVE SUMMARY
Our Compensation Committee has responsibility for the design, implementation, review and approval of the compensation of our executive officers. We seek to provide an executive compensation package that supports our business strategy and is driven by our overall industry-leading financial performance, the success of the operating segments and corresponding financial performance that are directly impacted by the applicable executive's leadership and the performance of the individual executive. The Compensation Committee periodically reviews, with the support of an independent compensation consultant, the pay practices of other companies with the goal of confirming that the Company's executive compensation program remains competitive but does not generally target compensation decisions or levels to a specific percentile or other absolute measures related to comparison group data.
At last year's Annual Meeting of Shareholders, 94% of the votes cast were in favor of the advisory vote to approve executive compensation. In view of this favorable vote (as well as a similar favorable vote in 2023) and the success of our 2023 executive compensation policies in incentivizing results that were aligned with the long-term interests of our shareholders, as well as other factors (including regulatory requirements, market considerations and Company and individual performance), our executive compensation policies and practices for 2024 remained substantially unchanged from the prior year.
Named Executive Officers
For 2024, our Named Executive Officers were as follows:
Chief Executive Officer |
Chief Financial Officer, |
Executive Vice |
Executive Vice |
Executive Vice |
We believe our compensation system continues to effectively incentivize our executive officers to deliver results for the Company that are aligned with the long-term interests of our shareholders. As reflected in the table below, we delivered another year of strong performance in 2024, and as a result, the annual cash incentives for our Named Executive Officers were calculated and paid above the target amounts:
COMPENSATION DISCUSSION AND ANALYSIS
Performance Highlights
TOTAL SHAREHOLDER RETURN(1)
Source:
1 |
Calculated as change in share price plus total dividends paid |
2024
PERFORMANCE |
2023
PERFORMANCE |
Strong total and ORGANIC REVENUE GROWTHcompanywide and in each of our three segments INCREASEDour industry-leadingoperating margins 31stconsecutive annual dividend increase, returning approximately ROBUST GROWTHin net cash provided by operating activities 32 |
||||||||||||
Total revenue |
||||||||||||||
Net income attributable to the Company |
||||||||||||||
Diluted earnings per share |
||||||||||||||
Company total commissions and fees growth |
12.1% | 17.9% | ||||||||||||
Retail segment total commissions and fees growth |
8.8% | 16.1%2 | ||||||||||||
Programs segment total commissions and fees growth |
18.5% | 21.2%2 | ||||||||||||
Wholesale Brokerage segment total commissions and fees growth |
13.2% | 19.0% | ||||||||||||
Company Organic Revenue3 growth |
10.4% | 10.3% | ||||||||||||
Retail segment4 Organic Revenue3 growth |
5.8% | 7.4%2 | ||||||||||||
Programs segment Organic Revenue3 growth |
22.4% | 16.1%2 | ||||||||||||
Wholesale Brokerage segment Organic Revenue3 growth |
9.1% | 12.1% | ||||||||||||
Income before income taxes margin5 |
27.1% | 26.9% | ||||||||||||
Adjusted EBITDAC Margin3 |
35.3% | 34.2% | ||||||||||||
Net cash provided by operating activities |
||||||||||||||
(1) Amount includes a pre-taxgain on disposal of (2) In the fourth quarter of 2023, the Company sold certain third-party claims administration and adjusting services businesses representing approximately 50% of the total revenues of the Services segment. As a result, beginning in fiscal year 2024, the Company operates three segments. Historical results have been recast to align with the three-segment structure. (3) See Annex Afor additional information regarding Organic Revenue, Organic Revenue growth and Adjusted EBITDAC Margin, which are non-GAAPfinancial measures, including a reconciliation to the most closely comparable GAAP financial measure. (4) The Retail segment includes commissions and fees reported in the "Other" column of the Segment Information table in Note 16 to our audited consolidated financial statements in our Annual Report on Form 10-Kfor the fiscal year ended (5) Income before income taxes margin is calculated as the Company's income before income taxes, as reported, divided by total revenues, as reported. |
||||||||||||||
26 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
Our Compensation Philosophy
Our compensation system is intended to:
1 |
Attract and Retain High-quality people that are crucial to both the short-term and long-term success of the Company |
2 |
Compensate for Performance Linked to our strategic objectives through the use of incentive compensation programs |
3 |
Create a Common Interest Between our executive officers and shareholders through compensation structures that promote the sharing of the rewards and risks of strategic decision-making |
In support of these goals, our incentive compensation program for 2024 included both short- and long-term compensation components that were tied to increases in our adjusted diluted earnings per share, Organic Revenue growth, Adjusted EBITDAC Margin and predetermined personal objectives for each of our executive officers. We believe our compensation program rewarded our executives for delivering strong financial results that aligned with the interests of our shareholders.
Compensation Components
Our compensation philosophy is reflected in the following short-term and long-term compensation components:
1 |
Base Salary |
Rationale • Provide competitive levels of compensation to our executive officers based on scope of responsibilities and duties • Retain executive officers How Amounts Are Determined • Based on a wide range of factors, including total business and segment responsibilities, individual responsibilities and comparative market assessments |
||
2 |
Annual Cash Incentives and Bonuses |
Rationale • Align executive officers' performance with annual goals and objectives • Create a direct link between pay and current year financial and operational performance How Amounts Are Determined • Target payouts based upon comparative market assessments, recommendations by Chief Executive Officer, and input from the Compensation Committee's independent compensation consultant, subject to the approval of Compensation Committee or, in the case of the Chief Executive Officer, recommendations from the Compensation Committee's independent compensation consultant, subject to the approval of Compensation Committee based upon its annual Chief Executive Officer performance review • Actual payout based upon a combination • Additional discretionary bonus available as determined by Chief Executive Officer, subject to the approval of Compensation Committee, or, in the case of Chief Executive Officer, as determined by Compensation Committee |
||
3 |
Long-Term Equity Incentive Awards |
Rationale • Reward effective long-term capital management and decision-making • Focus attention on future returns to shareholders • Retain executive officers who have the potential to impact both our short-term and long-term value creation through a combination of time- and performance-based awards • Recognize and reward specific achievements and/or the previous year's performance • Generally granted annually during first quarter How Amounts Are Determined • Award amount determined based upon a blend of quantitative measures and consideration of personal performance, as well as comparative market assessments • For awards with a performance-based vesting condition, number of awarded shares may be higher or lower than target, subject to specified threshold and maximum amounts, based upon the Company's performance during the performance period • Actual value realized based upon the Company's stock price over the measurement and vesting periods |
COMPENSATION DISCUSSION AND ANALYSIS
The chart below shows the 2024 mix of compensation for our Chief Executive Officer and for the other Named Executive Officers as a group.
How We Set Compensation
Role of Management
The Compensation Committee considers input from our Chief Executive Officer in making determinations regarding the compensation of our executive officers, other than our Chief Executive Officer. As part of the annual planning process, our Chief Executive Officer recommends and presents to the Compensation Committee for consideration, base salary adjustments, framework and targets for our annual cash incentive program and long-term equity incentive award amounts, in each case based upon an individual's performance and responsibilities, as well as comparative market data, as described below, for our executive officers, other than our Chief Executive Officer. In addition, our Chief Executive Officer periodically presents to the Compensation Committee and the Board his evaluation of each executive officer's performance and reviews succession plans for each of our executive officers.
Role of the Compensation Consultant
Beginning in
Comparative Market Assessments
The Compensation Committee does not target compensation decisions or levels to a specific percentile or other absolute measures related to comparison group data but does periodically review the pay practices of other companies with the goal of seeing that the Company's executive compensation program remains competitive. Historically, these analyses have been completed approximately every two years, unless there has been a material change in our business or in one of our segments, as comparative market rates do not typically materially change over the short term.
28 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
2024 Compensation
In
PEER COMPARISON GROUP For the |
At the time of analysis, our total market capitalization was at the |
Business Focus | ||||||
Insurance Intermediary | ||||||
Property & Casualty Insurance Carrier | ||||||
Property & Casualty Insurance Carrier | ||||||
Insurance Intermediary | ||||||
Property & Casualty Insurance Carrier | ||||||
Research & Consulting Services | ||||||
Insurance Intermediary | ||||||
Property & Casualty Insurance Carrier | ||||||
Insurance Intermediary | ||||||
Investment Banking & Brokerage | ||||||
Property & Casualty Insurance Carrier | ||||||
Property & Casualty Insurance Carrier | ||||||
Insurance Intermediary | ||||||
Survey Comparison
As part of the
Results of the
Based upon the results of the
• |
The total 2023 direct compensation for Messrs. Powell |
• |
The total 2023 direct compensation for Messrs. |
• |
The total 2023 direct compensation for |
As a result, the Compensation Committee applied pay rate adjustments for all of the Named Executive Officers for 2024.
COMPENSATION DISCUSSION AND ANALYSIS
Consideration of Last Year's "Say-On-Pay"Vote
In accordance with the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the "Dodd-Frank Act"), we provide our shareholders with an opportunity to approve, on a nonbinding, advisory basis, the compensation of named executive officers. At our annual meetings of shareholders in both 2023 and 2024, our shareholders voted to approve compensation by a significant margin. In view of the favorable vote in 2024 (as well as a similar favorable vote in 2023), as well as other factors (including regulatory requirements, market considerations and Company and individual performance), we did not substantially change our executive compensation policies for 2024. |
At our 2024 Annual Meeting of Shareholders our executive compensation program was supported by 94% of votes cast. |
|
2024 Base Salaries
In
Executive Officer |
2024 Base Salary | 2023 Base Salary | Change | |||||||||
|
$ | 1,250,000 | $ | 1,000,000 | $ | 250,000 | (1) | |||||
|
$ | 800,000 | $ | 650,000 | $ | 150,000 | (2) | |||||
|
$ | 1,000,000 | $ | 800,000 | $ | 200,000 | (3) | |||||
|
$ | 800,000 | $ | 700,000 | $ | 100,000 | (4) | |||||
|
$ | 900,000 | $ | 800,000 | $ | 100,000 | (5) | |||||
(1) |
The decision to increase Mr. |
(2) |
The decision to increase |
(3) |
The decision to increase Mr. |
(4) |
The decision to increase |
(5) |
The decision to increase |
2024 Annual Cash Incentives
Our annual cash incentives are designed to further align executive officer compensation with our annual goals and objectives, and to create a direct link between compensation and financial and operational performance. During the first quarter of each year, the Compensation Committee approves the annual cash incentive components, consisting of financial performance measures, individual target cash incentive amounts and personal objectives, for each executive officer, including the relative weightings and goals against which performance is measured and payouts are determined for such fiscal year.
Target Amounts.In
Executive Officer |
2024 Target Cash Incentive Amount |
2023 Target Cash Incentive Amount |
Change | |||||||||
|
$ | 3,750,000 | $ | 3,000,000 | $ | 750,000 | (1) | |||||
|
$ | 1,000,000 | $ | 850,000 | $ | 150,000 | (2) | |||||
|
$ | 1,800,000 | $ | 1,400,000 | $ | 400,000 | (3) | |||||
|
$ | 1,000,000 | $ | 900,000 | $ | 100,000 | (4) | |||||
|
$ | 1,400,000 | $ | 1,000,000 | $ | 400,000 | (5) | |||||
(1) |
The decision to increase Mr. |
30 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
(2) |
The decision to increase |
(3) |
The decision to increase Mr. |
(4) |
The decision to increase |
(5) |
The decision to increase |
Payouts can range from 0% to 200% of the aggregate target cash incentive depending on the financial performance of the Company or the segment, as applicable, and the Named Executive Officer's performance against personal objectives.
For 2024, the Compensation Committee selected the following components and weightings for the annual cash incentives for the Named Executive Officers:
Financial Performance Measures(1) | Personal Objectives | |||||||||||
Executive Officer |
Weighting | Measure | Weighting | Measure | Weighting | Measure | ||||||
|
40% | Company Organic Revenue(2) growth | 40% |
Adjusted EBITDAC Margin(2) (applicable |
20% | Personal objectives established for each Named Executive Officer(4) |
||||||
|
40% | Retail segment Organic Revenue(2) |
40% |
Adjusted EBITDAC Margin(2) (applicable |
20% | Personal objectives established for each Named Executive Officer(4) |
||||||
|
40% | Programs segment Organic Revenue(2) |
40% |
Adjusted EBITDAC Margin(2) (applicable |
20% | Personal objectives established for each Named Executive Officer(5) |
(1) |
The Compensation Committee selected these financial performance measures in furtherance of our strategy to increase our Organic Revenue growth while maintaining, among other things, our strong, industry-leading operating margins. |
(2) |
See Annex Afor additional information regarding Organic Revenue, Organic Revenue growth and Adjusted EBITDAC Margin, which are non-GAAPfinancial measures, including a reconciliation to the most closely comparable GAAP financial measure. |
(3) |
The personal objectives for each of our Named Executive Officers were approved by the Compensation Committee in |
The target amounts for each financial performance measure were discussed over several months and then reviewed and approved by the Compensation Committee in
• |
our expectation that the economy would continue to grow, but would moderate back to more traditional growth levels due to higher interest rate benchmarks set by central banks; |
• |
our expectation that insurance premium rates would either remain relatively stable or decrease slightly for catastrophic-exposed property; |
• |
our expectation that "insurable exposure units," which are units that insurance companies use to measure or express insurance exposed to risk (such as property values, sales and payroll levels) to determine what premium to charge the insured, would continue to grow, but at a slower pace than in 2023; |
• |
our expectation that salary inflation would moderate as compared to 2023 and we would continue our incremental investments in technology, security and data that are intended to help improve the customer and teammate experience, as well as to protect our information technology systems and data and |
• |
our expectation that certain businesses we acquired in the previous three years, which in some cases had lower operating margins versus other comparable businesses we operate, would grow profitably and have a positive impact on our overall 2024 operating margins. |
COMPENSATION DISCUSSION AND ANALYSIS
For each financial performance measure, we make no payout for performance below a certain threshold. As part of our pay-for-performanceframework, the Compensation Committee adopted payout curves that are intended to incentivize performance generally within a "target payout corridor" and that provide for incrementally higher and lower payouts for performance outside of the target payout corridor. Payout percentages for each financial performance measure were calculated based on the following tables:
32 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
Determination of 2024 Annual Cash Incentive Payouts.In the first quarter of 2025, the Compensation Committee reviewed actual 2024 performance of each financial performance measure against the target performance for each such measure as set forth in the following table:
Financial Performance Measure |
Target(1) | Actual | Percentage of Target Performance |
Payout Percentage |
||||||||||||
Adjusted EBITDAC Margin |
34.4 | % | 35.3 | %(2) | - | 176 | % | |||||||||
Company Organic Revenue growth |
6.9 | % | 10.4 | % | 151 | % | 200 | % | ||||||||
Retail segment Organic Revenue growth |
6.4 | % | 5.8 | % | 91 | % | 93 | % | ||||||||
Programs segment Organic Revenue growth |
7.8 | % | 22.5 | % | 288 | % | 200 | % |
(1) |
These target amounts were based on our 2024 budget, as adjusted to reflect the alignment of the Company's business from four to three segments beginning in fiscal year 2024. Our 2024 budget, which was approved by the Board in |
(2) |
In calculating the Company's Adjusted EBITDAC Margin for 2024: |
1. |
The Committee excluded the negative impact of the Company's non-cashstock-based compensation expense in excess of what was reflected in the Company's Board-approved 2024 budget. The Committee based its decision upon the fact that the higher-than-budgeted non-cashstock-based compensation expense for 2024 was the result of above-target performance by the Company for those grants of restricted stock made in |
2. |
The Committee excluded the positive impact of the net gain on disposal resulting from sales of books of businesses in 2024. |
With respect to the achievement of personal objectives by each of the Named Executive Officers, which accounts for 20% of the 2024 cash incentive amount for each Named Executive Officer, the Compensation Committee evaluated the level of achievement for each Named Executive Officer's personal objectives in the first quarter of 2025. The evaluation for Mr.
COMPENSATION DISCUSSION AND ANALYSIS
|
Personal Objectives |
Personal Objective Portion of 2024 Cash Incentive (0-200% of Target) |
||
|
• contribution to delivering the Company's budgeted financial results and acquiring high-quality businesses • contribution to further enhancing the team by attracting, retaining and developing high-quality teammates in alignment with the Company's diversity, belonging and inclusion strategies • contribution to creating and delivering innovative solutions using technology, data and analytics • contribution to leveraging the Company's collective capabilities for the benefit of our customers • contribution to balancing the Company's capital allocation to drive shareholder returns |
200% | ||
|
• contribution to delivering the Company's budgeted financial results and acquiring high-quality businesses • contribution to attracting, retaining and developing high-quality teammates • contribution to advancing the Company's use of technology, data and analytics to provide better insight across the Company's businesses • contribution to maintaining the Company's control environment • contribution to balancing the Company's capital allocation to drive shareholder returns • contribution to delivering the Company's finance initiatives to help support scalable growth |
200% | ||
|
• contribution to delivering the Company's budgeted financial results and acquiring high-quality businesses • contribution to attracting, retaining and developing high-quality teammates • contribution to creating and delivering innovative solutions using technology, data and analytics • contribution to leveraging the Company's capabilities for the benefit of our customers • contribution to continuing to integrate and augment the Company's global operations |
100% | ||
|
• contribution to delivering the Company's budgeted financial results and acquiring high-quality businesses • contribution to attracting, retaining and developing high-quality teammates • contribution to ensuring a disciplined acquisitions process to drive strong shareholder value • contribution to ensuring completed acquisitions have robust integration plans and that such plans are effectively executed • contribution to continuing to integrate and augment the Company's global operations |
175% | ||
|
• contribution to delivering the Company's budgeted financial results and acquiring high-quality businesses • contribution to attracting, retaining and developing high-quality teammates • contribution to creating and delivering innovative solutions using technology, data and analytics • contribution to fostering deep and trusted insurance carrier relationships that help expand the Company's capacity and create differentiated offerings to write new business • contribution to continuing to integrate and augment the Company's global operations |
200% |
34 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
As illustrated in the table below, the final 2024 cash incentive amounts were calculated by combining the payout amounts for each of the components discussed above and then rounding the resulting number up to the nearest thousand dollars:
Executive Officer |
2024 Aggregate Target Cash Incentive Amount |
Organic Revenue Growth Payout Amount |
Adjusted EBITDAC Margin Payout Amount |
Personal Objective Payout Amount |
Total 2024 Cash Incentive Payout Amount(1) |
Payout vs. Target Cash Incentive Amount |
||||||||||||||||||||||||
|
$ | 3,750,000 | $ | 3,001,080 | $ | 2,634,633 | $ | 1,500,000 | $ | 7,136,000 | 190 | % | ||||||||||||||||||
|
$ | 1,000,000 | $ | 800,355 | $ | 702,569 | $ | 400,000 | $ | 1,903,000 | 190 | % | ||||||||||||||||||
|
$ | 1,800,000 | $ | 671,902 | $ | 1,264,624 | $ | 360,000 | $ | 2,297,000 | 128 | % | ||||||||||||||||||
|
$ | 1,000,000 | $ | 800,355 | $ | 702,569 | $ | 350,000 | $ | 1,853,000 | 185 | % | ||||||||||||||||||
|
$ | 1,400,000 | $ | 1,120,897 | $ | 983,596 | $ | 560,000 | $ | 2,665,000 | 190 | % |
(1) |
The 2024 cash incentive payouts are also shown in the Summary Compensation Table under the "Non-EquityIncentive Plan Compensation" column. |
While not exercised in 2024, the Compensation Committee expressly reserves the right, in its sole discretion, to reduce the annual cash incentive for any Named Executive Officer, or to pay no annual cash incentive at all, if the Company's performance is unexpectedly poor or if the intended recipient commits acts of malfeasance.
2024 Discretionary Bonuses
Each of the Named Executive Officers is eligible to receive an additional discretionary bonus upon such terms and conditions as might be determined by the Chief Executive Officer, subject to the approval of the Compensation Committee, or, in the case of the Chief Executive Officer, as might be determined by the Compensation Committee. None of our Named Executive Officers received a discretionary bonus for 2024.
Terms
|
Rationale
|
|
In general, 75% of shares granted to each executive officer as a Performance Stock Award ("PSA") that vest based on performance (over a three-year period) and time (over a five-year period from the date of grant); 25% of shares granted to each executive officer as a Restricted Stock Award ("RSA") that vest on time only (over a five-year period from the date of grant)
|
Tying a majority of our equity awards to
pre-established,
multi-year
corporate financial objectives which drive long-term shareholder returns should more closely align the long-term interests of our executive officers and our shareholders |
|
Vesting of PSA shares tied to increases in the Company's Organic Revenue growth (as further defined in the applicable award agreement) and compound annual growth rate of the Company's cumulative diluted earnings per share, excluding any impact for changes in acquisition
earn-out
liabilities, in each case measured over a three-year period beginning |
Organic Revenue growth and cumulative diluted earnings per share are easily understandable, directly influenced by our executive officers and are intended to drive our long-term shareholder value | |
PSAs granted to our executive officers contemplate a minimum payout of 0% and a maximum payout of 200% based upon the level of performance of each performance condition during the three-year measurement period
|
Payouts for above-target performance motivate our executive officers to overperform; recognition of performance that may be less than target | |
PSAs are subject to both performance-based and time-based vesting conditions. In addition to the performance conditions described above, PSAs granted in
|
A combination of performance- and time-based vesting conditions is intended to achieve a strong alignment between pay and performance and incentivize the long-term retention of our executive officers and key employees | |
RSAs are subject to a cliff vesting condition requiring five years of continuous employment from the date of grant; RSA recipients acquired voting and dividend rights at the time of grant but cannot dispose of the shares
|
Equity awards with time-based vesting conditions continue to operate as a complement to our traditional equity awards characterized by both performance-based and time-based vesting conditions to further incentivize and reward key personnel; continued inclusion of a longer-term equity award (e.g., five years) helps attract, motivate and retain individuals whose performance drives our results | |
For certain executive officers aged 60 and older, equity awards are structured as performance stock units ("PSUs") and restricted stock units ("RSUs"), rather than as PSAs and RSAs, to allow for the payment of awards following an executive officer's qualified retirement
|
Allowing for the payment of awards following an executive officer's qualified retirement more effectively rewards and incentivizes executive officers who are approaching an age at which retirement is more likely |
information, and we do not time the release of material
information based on equity award grant dates.
COMPENSATION DISCUSSION AND ANALYSIS
Based upon the recommendation of our Chief Executive Officer and, with respect to our Chief Executive Officer, based upon the Compensation Committee's annual evaluation of our Chief Executive Officer's performance, as well as input from FW Cook, the following long-term equity incentive awards for our Named Executive Officers were approved by our Compensation Committee in the first quarter of 2024:
Executive Officer |
2024 Performance Award (75%) |
2024 Restricted Award (25%) |
Total 2024 (100%) |
Total 2023 Long-Term Equity Incentive Awards |
Change | ||||||||||||||||||||
|
$ | 2,250,000 | $ | 750,000 | $ | 3,000,000 | $ | 3,000,000 | $ | - | |||||||||||||||
|
$ | 975,000 | $ | 325,000 | $ | 1,300,000 | $ | 1,000,000 | $ | 300,000 | (2) | ||||||||||||||
|
$ | 525,000 | $ | 175,000 | $ | 700,000 | $ | 500,000 | $ | 200,000 | (3) | ||||||||||||||
|
$ | 375,000 | $ | 125,000 | $ | 500,000 | $ | 500,000 | $ | - | |||||||||||||||
|
$ | 825,000 | $ | 275,000 | $ | 1,100,000 | $ | 500,000 | $ | 600,000 | (5) |
(1) |
The long-term equity incentive awards for Messrs. Powell |
(2) |
The decision to increase |
(3) |
The decision to increase Mr. |
(4) |
The Compensation Committee determined that to better reward and retain |
(5) |
The decision to increase |
Equity Incentive Plan Outcomes in 2024
In
Performance Level |
Average Organic Revenue Growth |
Awarded Percentage of Tranche 1 Performance Shares |
||
Maximum |
Equal to or greater than 5.5% | 200% | ||
High Target |
4.5% | 120% | ||
Target |
4.0% | 100% | ||
Low Target |
3.5% | 80% | ||
Threshold |
2.5% | 50% | ||
No Payout |
Less than 2.5% | 0% |
COMPENSATION DISCUSSION AND ANALYSIS
and (ii) for one-halfof the shares granted based on the CAGR of our Adjusted EPS during the three-year performance period ending
Performance Level |
Adjusted EPS | CAGR |
Awarded Percentage of Tranche 2 Performance Shares |
|||
Maximum |
Equal to or greater than |
Equal to or greater than 12.0% | 200% | |||
High Target |
10.0% | 120% | ||||
Target |
8.5% | 100% | ||||
Low Target |
7.0% | 80% | ||||
Threshold |
6.0% | 50% | ||||
No Payout |
Less than |
Less than 6.0% | 0% |
If the actual performance level for each performance condition falls in between any of the performance levels, the percentage of shares that are awarded is determined based on straight-line interpolation.
In
• |
our cumulative Average Organic Revenue Growth during the performance period was 9.6%1and, therefore, fell above the maximum performance level, resulting in a payout percentage of 200% of the target and |
• |
our Adjusted EPS during the performance period was |
The Compensation Committee concluded that it was desirable to make certain adjustments in the calculations of the Company's actual performance, as follows:
• |
Average Organic Revenue Growth in 2021, 2022 and 2023 excluded Foreign Currency Translation because fluctuations in Foreign Currency Translation are not related to the performance of the Company. |
• |
Average Organic Revenue Growth in 2022 and 2023 included guaranteed supplemental commissions ("GSCs") as part of core commissions and fees, and, therefore, as a component of Average Organic Sales Growth to align the treatment of GSCs with incentives received for the placement of employee benefits coverage, as how the Company earns GSCs and other incentives is substantially identical. |
• |
Adjusted EPS in 2022 excluded the positive impact of the decrease in expense we recognized related to a legal judgment entered into against the Company in 2020 because the underlying legal matter was related to the pre-acquisitionactivities of a business we acquired in 2012 and was not related to the performance of the Company. |
• |
Adjusted EPS in 2022 and 2023 excluded the negative impact of Acquisition/Integration Costs because these costs were related to the Company's acquisition of these business, and not the underlying performance of the businesses themselves, and the fact that they were not expected to occur on an ongoing basis in the future. |
• |
Adjusted EPS in 2023 excluded the negative impact of an amount expensed and substantially paid in the first quarter of 2023 to resolve a business matter, which is not considered to be normal, recurring or part of the ongoing operations. |
• |
Adjusted EPS in 2023 excluded the positive impact of the gain on disposal associated with the sale of certain third-party claims administration and adjusting services businesses in the fourth quarter of 2023 because the sale occurred in connection with, and in furtherance of, the Board's and the Company's broader strategic decision to focus on the Company's core brokerage businesses. |
Upon the Compensation Committee's certification of these performance conditions, the following Named Executive Officers gained dividend rights and voting entitlement with respect to the indicated number of shares: Mr.
See Annex Afor additional information regarding Adjusted EPS and Organic Revenue growth, which are non-GAAPfinancial measures, including a reconciliation to the most closely comparable GAAP financial measure.
1 |
Organic Revenue growth for 2021, 2022 and 2023 was determined by the Compensation Committee in |
38 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
2025 Compensation
In
In
• |
|
• |
|
• |
Argo was removed because it was acquired in |
• |
|
• |
|
For the
Survey Comparison
As part of the
Results of the
Based upon the results of the
• |
The total 2024 direct compensation for Mr. |
• |
The total 2024 direct compensation for |
As a result, the Compensation Committee did not make any market rate adjustments for Messrs. Powell
2025 Base Salaries
The Compensation Committee did not increase the base salaries for the Named Executive Officers in 2025.
COMPENSATION DISCUSSION AND ANALYSIS
2025 Annual Cash Incentives
The Compensation Committee did not change the components of our annual executive officer cash incentives, the weighting of each component or the target cash incentive amounts for the Named Executive Officers for 2025. The target cash incentive amounts for the Named Executive Officers for 2025, as determined by the Compensation Committee in
Executive Officer |
2025 Target Cash Incentive Amount |
||||
|
$ | 3,750,000 | |||
|
$ | 1,000,000 | |||
|
$ | 1,800,000 | |||
|
$ | 1,000,000 | |||
|
$ | 1,400,000 |
2025 Equity Incentive Grants
Based upon the recommendation of our Chief Executive Officer and, with respect to our Chief Executive Officer, based upon the Compensation Committee's annual evaluation of our Chief Executive Officer's performance, the following long-term equity incentive awards for our Named Executive Officers were approved by our Compensation Committee in the
Executive Officer |
2025 Performance Award (75%) |
2025 Restricted Award (25%) |
Total 2025 Long-Term Equity Incentive Awards (100%) |
Total 2024 Long-Term Equity Incentive Awards |
Change | ||||||||||||||||||||
|
$ | 2,250,000 | $ | 750,000 | $ | 3,000,000 | $ | 3,000,000 | $ | - | |||||||||||||||
|
$ | 975,000 | $ | 325,000 | $ | 1,300,000 | $ | 1,300,000 | $ | - | |||||||||||||||
|
$ | 525,000 | $ | 175,000 | $ | 700,000 | $ | 700,000 | $ | - | |||||||||||||||
|
$ | 375,000 | $ | 125,000 | $ | 500,000 | $ | 500,000 | $ | - | |||||||||||||||
|
$ | 675,000 | $ | 225,000 | $ | 900,000 | (3) | $ | 1,100,000 | (4) | $ | (200,000 | )(5) |
(1) |
The long-term equity incentive awards for Messrs. Powell |
(2) |
The Compensation Committee determined that to better reward and retain |
(3) |
|
(4) |
|
(5) |
The amount in this column reflects the difference between the one-timeincremental award of |
Other Compensation
We also provide the following compensation and benefits to attract and retain key employees.
Benefits Generally
Along with all other full-time employees, each of the Named Executive Officers is eligible: (a) to receive matching contributions to the Company's 401(k) Plan; (b) to participate in our ESPP; (c) to participate in group medical, dental and other benefit plans and (d) to the extent permitted by applicable law, for reimbursement of amounts earned by the Company on personal lines insurance such as homeowners and flood insurance purchased by such Named Executive Officer. Our 401(k) Plan provides for matching contributions of up to four percent (4.0%) of the contributions made by each participant. The 401(k) Plan also permits discretionary profit-sharing contributions, but the Company made no such contributions to the accounts of Named Executive Officers for 2024.
40 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
Dividend Payments on Unvested Stock Awards
The Named Executive Officers receive dividends on unvested shares, or dividend equivalents on unvested units, granted pursuant to the Company's equity incentive compensation plans (i) that have exclusively time-based vesting requirements (e.g., time-based RSAs or RSUs) or (ii) for which the applicable performance conditions have been satisfied in accordance with the applicable award agreements, but the time-based vesting requirements have not been satisfied (e.g., performance-based PSAs or PSUs).
Deferred Compensation Plan
The Named Executive Officers are eligible to participate in the Company's non-qualifieddeferred compensation plan, which provides the opportunity to defer receipt of up to 75% of base salary and up to 100% of cash incentive and bonus compensation. Participant deferrals are credited to the participant's deferral contribution account. The participant's account is credited with earnings based on the performance of the participant's investment allocation among a menu of investment options designated by the Company. The Company is permitted, but not required, to make matching contributions and other discretionary contributions under this plan. The Company made no matching or other discretionary contributions to the accounts of Named Executive Officers for 2024.
A participant's account under the Company's non-qualifieddeferred compensation plan generally is distributed in a lump sum or installments upon the participant's retirement, other termination of employment or death. However, in some circumstances (including hardship), all or a portion of the participant's deferral account may be distributed on one or more specified dates prior to termination of employment. Participants elect at the time of deferral to have the distributions made in a lump sum or annual installments.
Personal Benefits
Certain social club membership dues paid by the Named Executive Officers who have responsibility for the entertainment of clients, prospective clients and principals of acquisition prospects may be reimbursed by the Company or paid on behalf of the Named Executive Officer. Additionally, the Company reimburses the costs of annual physical examinations that are not otherwise covered by insurance, certain car service expenses and for the costs of certain financial and tax planning services for the Named Executive Officers, as well as for the costs associated with a Named Executive Officer's spouse's attendance at the Company's annual sales conclave.
Policy on Tax Deductibility
The deductibility of compensation payments can depend upon numerous factors, including the nature of the payment and the time that income is recognized under various plans, agreements and programs. Interpretations of and changes in applicable tax laws and regulations and other factors beyond the Compensation Committee's control also can affect the deductibility of compensation. The Compensation Committee considers the anticipated tax treatment of the Company's compensation programs and payments, including the potential impact of Section 162(m) of the United States Internal Revenue Code of 1986, as amended. Section 162(m) disallows a tax deduction for any publicly held corporation for individual compensation exceeding
As a result of the Tax Reform Act, the exemption from the Section 162(m) deduction limit for performance-based compensation has been repealed, effective for taxable years beginning after
COMPENSATION DISCUSSION AND ANALYSIS
Payments Upon Termination or Change in Control
With the exception of
The 2010 SIP and 2019 SIP provide for double-trigger vesting under which all participants, including all of the Named Executive Officers, would become vested in the following amounts if the participant's service with us is involuntarily or constructively terminated (other than for specified causes, as set forth in the 2010 SIP and 2019 SIP) within 12 months after a change-in-controltransaction, which is defined in each plan and designated as a "Transfer of Control" in the 2010 SIP and a "Change in Control" the 2019 SIP:
• |
for all grants, except those performance-based restricted stock grants for which the Compensation Committee has not yet determined the level of achievement of the applicable performance goal, 100% of all unvested restricted stock grants granted pursuant to such 2010 SIP or 2019 SIP grants agreements and |
• |
for all performance-based restricted stock grants for which the Compensation Committee has not yet determined the level of achievement of the applicable performance goal, the greater of: (a) 100% of such unvested restricted stock grants or (b) the percentage of unvested restricted stock grants determined in accordance with the applicable performance schedule based upon the actual level of achievement (up to the applicable maximum level of achievement) from the first day of the performance period to the date on which the change-in-controltransaction occurs. |
For information concerning the value of the vested shares that each of the Named Executive Officers would have under the 2010 SIP and the 2019 SIP in the event that termination of employment after a change-in-controltransaction had occurred on the last business day of 2024, see the table titled "Potential Payments Upon Termination or Change in Control - 2024."
The PSP (which was terminated in 2010) provides that all outstanding grants of PSP stock shall become fully vested and non-forfeitablein the event of: (i) the Company's entry into any agreement to sell all or substantially all of its assets or to enter into any merger, consolidation, reorganization, division or other corporate transaction in which Company stock is converted into another security or into the right to receive securities or property, where such agreement does not provide for the assumption or substitution of PSP stock; (ii) any tender or exchange offer for the Company's stock accepted by a majority of the shareholders of the Company; or (iii) the death of
42 | BROWN &
COMPENSATION DISCUSSION AND ANALYSIS
Employment and Deferred Compensation Arrangements
MESSRS.
Messrs.
In connection with his hiring in 2014,
The above descriptions of our employment agreements with our Named Executive Officers are summaries and are qualified by reference to the copies of such agreements that have been filed as exhibits to our
• |
With respect to Messrs. |
• |
With respect to |
• |
With respect to |
Hedging and Pledging Policies; Stock Ownership Requirements; Clawback Policy
The Board has adopted policies prohibiting the hedging (as defined below) of our stock by directors, executive officers and other members of our Senior Leadership Team and prohibiting the pledging of our stock by directors, as well prohibiting the pledging of our stock held pursuant to our stock ownership requirements by our executive officers and other members of our Senior Leadership Team. For the purposes of this policy, "hedging" includes engaging in short sales
COMPENSATION DISCUSSION AND ANALYSIS
Our stock ownership requirements provide that members of the Company's Senior Leadership Team must accumulate Company stock valued at the following multiples of their base salaries within three years of hire or promotion, and retain such stock until retirement, separation from employment or removal from one of the categories set forth below:
(1) |
Ownership levels include: (i) shares owned directly or indirectly, excluding shares owned by immediate family members as to which beneficial ownership is disclaimed; (ii) unvested PSP shares that have met the applicable performance conditions under the applicable award agreements and (iii) unvested 2010 SIP and 2019 SIP shares or units that (a) are subject to a time-based-only vesting condition or (b) have met the applicable performance conditions under the applicable award agreements. For Messrs. |
(2) |
The ownership requirements are as follows: Chief Executive Officer - six times base salary; Senior Leadership Team members who are "officers" pursuant to Section 16 of Securities Exchange Act 1934 - three times base salary and Senior Leadership Team members who are not "officers" pursuant to Section 16 of the Securities Exchange Act of 1934 - one times base salary. |
In addition, each non-employeedirector is required to accumulate
On average, each of our non-employeedirectors owns stock valued at |
47x the current annual cash retainer as of
|
We have a Policy Regarding the Mandatory Recovery of Compensation (the "Clawback Policy"), which requires the Compensation Committee, subject to certain narrow exceptions permitted by the NYSE listing standards, to recover from current and former Section 16 officers erroneously awarded compensation in the event of a restatement of our financial statements due to material noncompliance with federal securities laws. Incentive-based compensation that was "received" during the three completed fiscal years preceding the restatement is subject to recoupment. A copy of the Clawback Policy was filed as an exhibit to our Annual Report on Form 10-Kfor fiscal 2023.
44 | BROWN &
The following table sets forth the compensation received by our Named Executive Officers for services rendered to us in such capacity for the years ended
Summary Compensation Table 2022-2024
|
Fiscal Year |
Salary ($) |
Bonus ($) |
Stock Awards ($)(1) |
Non-Equity Incentive Plan Compensation ($) |
All Other Compensation ($)(2) |
Total ($) |
||||||||||||||||||||||||||||
Chief Executive Officer and President |
2024 | 1,240,385 | - | 2,952,920 | 7,136,000 | 349,472 | 11,678,777 | ||||||||||||||||||||||||||||
2023 | 1,000,000 | - | 2,941,861 | 5,500,000 | 344,884 | 9,786,745 | |||||||||||||||||||||||||||||
2022 | 1,000,000 | - | 2,953,648 | 2,501,000 | 286,985 | 6,741,633 | |||||||||||||||||||||||||||||
Chief Financial Officer Executive Vice President and Treasurer |
2024 | 794,231 | - | 1,279,571 | 1,903,000 | 86,284 | 4,063,086 | ||||||||||||||||||||||||||||
2023 | 648,077 | - | 980,620 | 1,559,000 | 81,161 | 3,268,858 | |||||||||||||||||||||||||||||
2022 | 600,000 | 60,000 | 2,689,057 | 981,000 | 78,459 | 4,408,516 | |||||||||||||||||||||||||||||
Executive Vice President and President - Retail Segment |
2024 | 992,308 | - | 688,987 | 2,297,000 | 126,616 | 4,104,911 | ||||||||||||||||||||||||||||
2023 | 800,000 | - | 490,253 | 2,100,000 | 47,475 | 3,437,728 | |||||||||||||||||||||||||||||
2022 | 798,077 | - | 2,492,134 | 1,489,000 | 331,134 | 5,110,345 | |||||||||||||||||||||||||||||
Executive Vice President and Chief Acquisitions Officer |
2024 | 796,154 | - | 492,098 | 1,853,000 | 80,621 | 3,221,873 | ||||||||||||||||||||||||||||
2023 | 700,000 | - | 490,253 | 1,651,000 | 86,942 | 2,928,195 | |||||||||||||||||||||||||||||
2022 | 698,077 | 20,000 | 2,492,134 | 1,261,000 | 89,583 | 4,560,794 | |||||||||||||||||||||||||||||
Executive Vice President and President - Programs Segment |
2024 | 896,154 | - | 1,082,883 | 2,665,000 | 40,064 | 4,684,101 | ||||||||||||||||||||||||||||
2023 | 800,000 | 300,000 | 490,253 | 1,834,000 | 30,233 | 3,454,486 | |||||||||||||||||||||||||||||
2022 | 798,077 | - | 2,492,134 | 1,501,000 | 41,666 | 4,832,877 |
(1) |
Amounts shown under the "Stock Awards" column reflect the aggregate grant date fair value of awards computed in accordance with Statement of Financial Accounting Standards ASC Topic 718 (formerly "SFAS 123(R)") with respect to stock granted under the 2019 SIP to our Named Executive Officers rather than the dollar amount recognized during the fiscal year for financial statement purposes. The assumptions used for the valuations are set forth in Note 12 to our audited consolidated financial statements in our Annual Report on Form 10-Kfor the fiscal year ended |
Amounts shown under the "Stock Awards" column include the aggregate grant date fair value of all awards. For 2022, 2023 and 2024, a portion of the shares granted to each Named Executive Officer were either PSAs or PSUs, and portion of the shares granted to each Named Executive Officer were either RSAs or RSUs. Assuming the highest level of performance conditions will be achieved for the PSAs and PSUSs in this column (200% for 2022, 2023 and 2024), the grant date fair value for each Named Executive Officer, including both PSAs or PSUs, as applicable, and RSAs or RSUs, as applicable, would be as follows: |
|
Fiscal Year* | Maximum Value ($) | Fiscal Year | Maximum Value ($) | Fiscal Year | Maximum Value ($) | ||||||||||||||||||||||||
|
2022 | 5,157,334 | 2023 | 5,133,724 | 2024 | 5,155,842 | ||||||||||||||||||||||||
|
2022 | 3,203,216 | 2023 | 1,711,241 | 2024 | 2,234,170 | ||||||||||||||||||||||||
|
2022 | 2,859,372 | 2023 | 855,536 | 2024 | 1,203,002 | ||||||||||||||||||||||||
|
2022 | 2,859,372 | 2023 | 855,536 | 2024 | 859,252 | ||||||||||||||||||||||||
|
2022 | 2,859,372 | 2023 | 855,536 | 2024 | 1,890,795 |
* |
The long-term equity incentive awards reported for 2022 include the time-based-only long-term equity incentive awards, effective |
(2) |
These dollar amounts include the items identified in the table titled "All Other Compensation Table - 2024." |
EXECUTIVE COMPENSATION TABLES
All Other Compensation Table 2022-2024
|
Year | Perquisites and Other Personal Benefits ($)(1) |
Insurance Commissions ($)(2) |
Company ($) |
Cash Dividends ($)(3) |
Other ($) |
Total ($) |
||||||||||||||||||||||||||||
|
2024 | 17,344 | (4) | - | 13,800 | 318,328 | - | 349,472 | |||||||||||||||||||||||||||
2023 | 5,908 | 59 | 13,200 | 289,170 | 36,267 | (5) | 344,884 | ||||||||||||||||||||||||||||
2022 | 4,119 | 59 | 12,200 | 270,607 | - | 286,985 | |||||||||||||||||||||||||||||
|
2024 | 17,214 | (6) | 2,458 | 13,800 | 52,812 | - | 86,284 | |||||||||||||||||||||||||||
2023 | 16,675 | 2,616 | 13,200 | 48,670 | - | 81,161 | |||||||||||||||||||||||||||||
2022 | 18,052 | 2,335 | 12,200 | 45,872 | - | 78,459 | |||||||||||||||||||||||||||||
|
2024 | - | - | 13,800 | 38,596 | 74,220 | (7) | 126,616 | |||||||||||||||||||||||||||
2023 | - | - | 13,200 | 34,275 | - | 47,475 | |||||||||||||||||||||||||||||
2022 | - | - | 12,200 | 32,525 | 286,409 | (8) | 331,134 | ||||||||||||||||||||||||||||
|
2024 | 16,675 | (9) | 10,641 | 13,800 | 39,505 | - | 80,621 | |||||||||||||||||||||||||||
2023 | 16,675 | 15,144 | 13,200 | 41,923 | - | 86,942 | |||||||||||||||||||||||||||||
2022 | 16,675 | 12,473 | 12,200 | 48,235 | - | 89,583 | |||||||||||||||||||||||||||||
|
2024 | 12,485 | (10) | - | - | 27,577 | - | 40,064 | |||||||||||||||||||||||||||
2023 | 4,736 | - | - | 25,497 | - | 30,233 | |||||||||||||||||||||||||||||
2022 | 12,670 | - | - | 28,996 | - | 41,666 |
(1) |
For additional information about these perquisites and other personal benefits, see "Compensation Discussion and Analysis - Other Compensation." |
(2) |
These amounts include amounts earned by the Company and reimbursed to these employees for personal lines insurance purchased by these employees through the Company or its subsidiaries. |
(3) |
These amounts represent cash dividends paid on granted PSP, 2010 SIP and 2019 SIP shares for which conditions of vesting other than time-based conditions have been satisfied. |
(4) |
Amount represents reimbursement of the cost of certain car service expenses. |
(5) |
Amount represents costs associated with the temporary relocation of Mr. |
(6) |
Amount represents reimbursement of the cost of certain financial and tax planning services. |
(7) |
Amount represents costs associated with the temporary relocation of Mr. |
(8) |
Amount represents costs associated with the temporary relocation of Mr. |
(9) |
Amount represents reimbursement of the cost of certain financial and tax planning services. |
(10) |
Amount represents reimbursement of |
46 | BROWN &
EXECUTIVE COMPENSATION TABLES
Grants of Plan-Based Awards in Fiscal 2024
The following table provides information about the range of possible annual incentive cash payouts in respect of 2024 performance, the range of shares that may be earned pursuant to the stock grants made to our Named Executive Officers under our 2019 SIP in 2024 and the grant date fair value of these stock grants computed under Statement of Financial Accounting Standards ASC Topic 718 (formerly "SFAS 123(R)").
Estimated Future Payouts Under Non-EquityIncentive Plan Awards(1) |
Estimated Future Payouts Under Equity Incentive Plan Awards(2) |
Grant Date Stock Awards |
||||||||||||||||||||||||||||||||||||||
|
Grant Date |
Threshold ($)(3) |
Target ($) |
Maximum ($)(4) |
Threshold (#) |
Target (#) |
Maximum (#) |
|||||||||||||||||||||||||||||||||
|
0 | 3,750,000 | 7,500,000 | |||||||||||||||||||||||||||||||||||||
0 | 27,210 | 54,420 | 2,202,922 | |||||||||||||||||||||||||||||||||||||
- | 9,070 | 9,070 | 749,998 | |||||||||||||||||||||||||||||||||||||
|
0 | 1,000,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||
0 | 11,791 | 23,582 | 954,599 | |||||||||||||||||||||||||||||||||||||
- | 3,930 | 3,930 | 324,972 | |||||||||||||||||||||||||||||||||||||
|
0 | 1,800,000 | 3,600,000 | |||||||||||||||||||||||||||||||||||||
0 | 6,349 | 12,698 | 514,015 | |||||||||||||||||||||||||||||||||||||
- | 2,116 | 2,116 | 174,972 | |||||||||||||||||||||||||||||||||||||
|
0 | 1,000,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||
0 | 4,535 | 9,070 | 367,154 | |||||||||||||||||||||||||||||||||||||
- | 1,511 | 1,511 | 124,945 | |||||||||||||||||||||||||||||||||||||
|
0 | 1,400,000 | 2,800,000 | |||||||||||||||||||||||||||||||||||||
0 | 5,442 | 10,884 | 440,584 | |||||||||||||||||||||||||||||||||||||
- | 1,814 | 1,814 | 150,000 | |||||||||||||||||||||||||||||||||||||
0 | 4,386 | 8,772 | 367,328 | |||||||||||||||||||||||||||||||||||||
- | 1,462 | 1,462 | 124,972 |
(1) |
For additional information related to the annual cash incentive awards, including performance targets and measures, see "Compensation Discussion and Analysis." |
(2) |
The "Estimated Future Payouts Under Equity Incentive Plan Awards" column shows the range of shares that may be earned pursuant to the stock awards granted under our 2019 SIP in 2023. For additional information related to these grants, see "Compensation Discussion and Analysis." |
(3) |
For additional information related to the annual cash incentive awards, including performance targets and measures, see "Compensation Discussion and Analysis." |
(4) |
For additional information related to the annual cash incentive awards, including performance targets and measures, see "Compensation Discussion and Analysis." |
(5) |
The "Grant Date Fair Value of Stock Awards" column shows the full grant date fair value of the shares granted to our Named Executive Officers under our 2019 SIP in 2024. The grant date fair value of the awards is determined under Statement of Financial Accounting Standards ASC Topic 718 (formerly "SFAS 123(R)") and represents the amount we would expense in our financial statements over the vesting schedule for the grants. In accordance with |
EXECUTIVE COMPENSATION TABLES
Outstanding Equity Awards at Fiscal Year-End- 2024
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) |
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
Option Price ($) |
Option Date |
Grant Date |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have ($)(1) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units That Have Not Vested (#) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units That Have Not Vested ($)(2) |
||||||||||||||||||||||||||||||||||||||||
|
- | - | - | - | - | 32,000 | (3) | 3,264,640 | ||||||||||||||||||||||||||||||||||||||||||
299,264 | (4) | 30,530,913 | ||||||||||||||||||||||||||||||||||||||||||||||||
15,460 | (5) | 1,577,229 | ||||||||||||||||||||||||||||||||||||||||||||||||
92,764 | (6) | 9,463,783 | ||||||||||||||||||||||||||||||||||||||||||||||||
16,240 | (7) | 1,656,805 | ||||||||||||||||||||||||||||||||||||||||||||||||
97,444 | (8) | 9,941,237 | ||||||||||||||||||||||||||||||||||||||||||||||||
11,339 | (9) | 1,156,805 | ||||||||||||||||||||||||||||||||||||||||||||||||
13,005 | (10) | 1,326,770 | ||||||||||||||||||||||||||||||||||||||||||||||||
9,070 | (11) | 925,321 | ||||||||||||||||||||||||||||||||||||||||||||||||
68,036 | (12) | 6,941,033 | ||||||||||||||||||||||||||||||||||||||||||||||||
78,030 | (13) | 7,960,621 | ||||||||||||||||||||||||||||||||||||||||||||||||
54,420 | (14) | 5,551,928 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
- | - | - | - | - | 3,607 | (5) | 367,986 | ||||||||||||||||||||||||||||||||||||||||||
21,644 | (6) | 2,208,121 | ||||||||||||||||||||||||||||||||||||||||||||||||
4,601 | (7) | 469,394 | ||||||||||||||||||||||||||||||||||||||||||||||||
27,608 | (8) | 2,816,568 | ||||||||||||||||||||||||||||||||||||||||||||||||
28,457 | (15) | 2,903,183 | ||||||||||||||||||||||||||||||||||||||||||||||||
2,645 | (9) | 269,843 | ||||||||||||||||||||||||||||||||||||||||||||||||
4,335 | (10) | 442,257 | ||||||||||||||||||||||||||||||||||||||||||||||||
3,930 | (11) | 400,939 | ||||||||||||||||||||||||||||||||||||||||||||||||
15,874 | (12) | 1,619,465 | ||||||||||||||||||||||||||||||||||||||||||||||||
26,010 | (13) | 2,653,540 | ||||||||||||||||||||||||||||||||||||||||||||||||
23,582 | (14) | 2,405,836 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
- | - | - | - | - | 2,576 | (5) | 262,804 | ||||||||||||||||||||||||||||||||||||||||||
15,460 | (6) | 1,577,229 | ||||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 2,706 | (7) | 276,066 | |||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 16,240 | (8) | 1,656,805 | |||||||||||||||||||||||||||||||||||||||||||||||
1/1/2022 | 28,457 | (15) | 2,903,183 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 1,889 | (9) | 192,716 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 2,167 | (10) | 221,077 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 2,116 | (11) | 215,874 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 11,338 | (12) | 1,156,703 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 13,004 | (13) | 1,326,668 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 12,698 | (14) | 1,295,450 |
48 | BROWN &
EXECUTIVE COMPENSATION TABLES
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) |
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
Option Price ($) |
Option Date |
Grant Date |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have ($)(1) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units That Have Not Vested (#) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units That Have Not Vested ($)(2) |
||||||||||||||||||||||||||||||||||||||||
|
- | - | - | - | - | 2/21/2020 | 2,576 | (5) | 262,804 | |||||||||||||||||||||||||||||||||||||||||
2/21/2020 | 15,460 | (6) | 1,577,229 | |||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 2,706 | (7) | 276,066 | |||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 16,240 | (8) | 1,656,805 | |||||||||||||||||||||||||||||||||||||||||||||||
1/1/2022 | 28,457 | (15) | 2,903,183 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 1,889 | (9) | 192,716 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 2,167 | (10) | 221,077 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 1,511 | (11) | 154,152 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 11,338 | (12) | 1,156,703 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 13,004 | (13) | 1,326,668 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 9,070 | (14) | 925,321 | |||||||||||||||||||||||||||||||||||||||||||||||
|
- | - | - | - | - | 2/21/2020 | 2,576 | (5) | 262,804 | |||||||||||||||||||||||||||||||||||||||||
2/21/2020 | 3,092 | (6) | 315,446 | |||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 2,706 | (7) | 276,066 | |||||||||||||||||||||||||||||||||||||||||||||||
2/23/2021 | 6,496 | (8) | 662,722 | |||||||||||||||||||||||||||||||||||||||||||||||
1/1/2022 | 28,457 | (16) | 2,903,183 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 1,889 | (17) | 192,716 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 2,167 | (18) | 221,077 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 1,814 | (19) | 185,064 | |||||||||||||||||||||||||||||||||||||||||||||||
3/20/2024 | 1,462 | (20) | 149,153 | |||||||||||||||||||||||||||||||||||||||||||||||
2/21/2022 | 11,338 | (21) | 1,156,703 | |||||||||||||||||||||||||||||||||||||||||||||||
2/20/2023 | 13,004 | (22) | 1,326,668 | |||||||||||||||||||||||||||||||||||||||||||||||
2/19/2024 | 10,884 | (23) | 1,110,386 | |||||||||||||||||||||||||||||||||||||||||||||||
3/20/2024 | 8,772 | (24) | 894,919 |
(1) |
The market value shown was determined by multiplying the number of shares of stock that have not vested by $102.02, the closing market price of our common stock on December 31, 2024. |
(2) |
The market value shown was determined by multiplying the number of unearned stock shares (at target) by $102.02, the closing market price of our common stock on December 31, 2024. |
(3) |
These PSAs will vest on July 21, 2029, the 20th anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death or disability, or in the event of (i) the Company's entry into any agreement to sell all or substantially all of its assets or to enter into any merger, consolidation, reorganization, division or other corporate transaction in which Company stock is converted into another security or into the right to receive securities or property, where such agreement does not provide for the assumption or substitution of PSP stock; (ii) any tender or exchange offer for the Company's stock accepted by a majority of the shareholders of the Company; or (iii) the death of |
(4) |
These PSAs will vest on July 21, 2029, the 20th anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death or disability, or in the event of (i) the Company's entry into any agreement to sell all or substantially all of its assets or to enter into any merger, consolidation, reorganization, division or other corporate transaction in which Company stock is converted into another security or into the right to receive securities or property, where such agreement does not provide for the assumption or substitution of PSP stock; (ii) any tender or exchange offer for the Company's stock accepted by a majority of the shareholders of the Company; or (iii) the death of |
(5) |
These RSAs vested on February 21, 2025, the fifth anniversary of the grant date. |
(6) |
These PSAs vested on February 21, 2025, the fifth anniversary of the grant date. |
(7) |
These RSAs will vest on February 23, 2026, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
EXECUTIVE COMPENSATION TABLES
(8) |
These PSAs will vest on February 23, 2026, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(9) |
These RSAs will vest on February 21, 2027, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(10) |
These RSAs will vest on February 19, 2029, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(11) |
These RSAs will vest on February 20, 2028, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(12) |
The amount shown represents the maximum number of PSAs that could have been earned during the three-year performance period of January 1, 2022, to December 31, 2024. The actual number of PSAs earned could have been between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. In February 2025, the Compensation Committee determined the Average Organic Revenue Growth and Adjusted EPS during the performance period fell above the maximum performance levels, resulting in a payout percentage of 200% of the target. These earned PSAs will vest on February 21, 2027, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(13) |
The amount shown represents the maximum number of PSAs that can be earned during the three-year performance period of January 1, 2023, to December 31, 2025. The actual number of PSAs earned will be between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. Performance for 2023 and 2024 was above target but the results could change during the remaining year of the performance period. Earned PSAs will vest on February 20, 2028, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(14) |
The amount shown represents the maximum number of PSAs that can be earned during the three-year performance period of January 1, 2024, to December 31, 2026. The actual number of PSAs earned will be between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. Performance for 2024 was above target but the results could change during the remaining two years of the performance period. Earned PSAs will vest on February 19, 2029, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of the attainment of age 64, death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(15) |
These RSAs will vest in increments of 25%, 25% and 50% on July 1, 2027, July 1, 2028 and July 1, 2029, respectively, assuming continuous employment through such vesting dates, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. |
(16) |
These RSUs will be awarded in five equal installments on the first five anniversaries of the date of grant and, once awarded, will vest in increments of 25%, 25% and 50% on July 1, 2027, July 1, 2028 and July 1, 2029, respectively, assuming continuous employment through such vesting dates, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(17) |
These RSUs vest on February 21, 2027, the fifth anniversary of the grant date, assuming continuous employment through such date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(18) |
These RSUs vest on February 20, 2028, the fifth anniversary of the grant date, assuming continuous employment through such date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(19) |
These RSUs vest on February 19, 2029, the fifth anniversary of the grant date, assuming continuous employment through such date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(20) |
These RSUs vest on March 20, 2029, the fifth anniversary of the grant date, assuming continuous employment through such date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(21) |
The amount shown represents the maximum number of PSUs that could have been earned during the three-year performance period of January 1, 2022, to December 31, 2024. The actual number of PSUs earned could have been between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. In February 2025, the Compensation Committee determined the Average Organic Revenue Growth and Adjusted EPS during the performance period fell above the maximum performance levels, resulting in a payout percentage of 200% of the target. These PSUs vest on February 21, 2027, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
50 | BROWN &
EXECUTIVE COMPENSATION TABLES
(22) |
The amount shown represents the maximum number of PSUs that can be earned during the three-year performance period of January 1, 2023, to December 31, 2025. The actual number of PSUs earned will be between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. Performance for 2023 and 2024 was above target but the results could change during the remaining year of the performance period. Earned PSUs vest on February 20, 2028, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(23) |
The amount shown represents the maximum number of PSUs that can be earned during the three-year performance period of January 1, 2024, to December 31, 2026. The actual number of PSUs earned will be between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. Performance for 2024 was above target but the results could change during the remaining two years of the performance period. Earned PSUs vest on February 19, 2029, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
(24) |
The amount shown represents the maximum number of PSUs that can be earned during the three-year performance period of January 1, 2024, to December 31, 2026. The actual number of PSUs earned will be between 0% and 200% of target based on the Average Organic Revenue Growth and Adjusted EPS during the performance period, as set forth in the applicable award agreements and as determined by the Compensation Committee. Performance for 2024 was above target but the results could change during the remaining two years of the performance period. Earned PSUs vest on March 20, 2029, the fifth anniversary of the grant date, assuming continuous employment through such vesting date, provided that vesting will accelerate in the event of death, disability or termination (including constructive termination) without cause within 12 months following a change in control of the Company. If |
EXECUTIVE COMPENSATION TABLES
Option Exercises and Stock Vested - 2024
Option Awards | Stock Awards | |||||||||||||||||||
|
Number of Shares Acquired on (#) |
Value Realized on Exercise ($) |
Number of Shares Acquired on (#) |
Value Realized on Vesting ($)(1) |
||||||||||||||||
|
- | - | 118,603 | 9,991,117 | ||||||||||||||||
|
- | - | 35,581 | 2,997,343 | ||||||||||||||||
|
- | - | 17,789 | 1,498,545 | ||||||||||||||||
|
- | - | 26,684 | 2,247,860 | ||||||||||||||||
|
- | - | 21,220 | 1,781,642 |
(1) |
The value realized upon the vesting of stock awards is the number of shares multiplied by the market value (being the closing market price as of the previous trading day) of the underlying shares on the vesting date. The value realized was determined without considering any taxes that were owed upon vesting. |
Nonqualified Deferred Compensation at Fiscal Year-End- 2024
|
Executive Contributions in 2024(1) $ |
Registrant Contributions in 2024 $ |
Aggregate Earnings in 2024 $ |
Aggregate Withdrawals/ Distributions $ |
Aggregate Balance at 12/31/2024 $ |
||||||||||||||||||||
|
1,375,000 | - | 1,566,119 | - | 10,676,181 | ||||||||||||||||||||
|
545,650 | - | 259,096 | - | 2,806,077 | ||||||||||||||||||||
|
- | - | - | - | - | ||||||||||||||||||||
|
- | - | 26,583 | - | 166,525 | ||||||||||||||||||||
|
179,231 | - | 142,475 | - | 840,950 |
(1) |
In each instance, the indicated executive contribution is included in the amounts reported for that Named Executive Officer in the Summary Compensation Table for 2024. |
Potential Payments Upon Termination or Change in Control - 2024
|
Benefit(1) |
Before Change in Control Termination w/o Cause Resignation for ($) |
After Change in Control Termination w/o Cause or Good Reason ($)(2) |
Voluntary ($) |
Death ($) |
Disability ($) |
Change in Control ($) |
||||||||||||||||||||||||||||
|
PSP | - | - | - | 3,264,640 | 3,264,640 | 4,870,859 | (3) | |||||||||||||||||||||||||||
2010 SIP | - | - | 30,530,913 | 30,530,913 | 30,530,913 | (4) | |||||||||||||||||||||||||||||
2019 SIP | 46,501,532 | - | 32,529,173 | 32,529,173 | - | ||||||||||||||||||||||||||||||
|
PSP | - | - | - | - | - | - | ||||||||||||||||||||||||||||
2010 SIP | - | - | - | - | - | - | |||||||||||||||||||||||||||||
2019 SIP | - | 16,557,132 | - | 11,787,986 | 11,787,986 | - | |||||||||||||||||||||||||||||
|
PSP | - | - | - | - | - | - | ||||||||||||||||||||||||||||
2010 SIP | - | - | - | - | - | - | |||||||||||||||||||||||||||||
2019 SIP | - | 11,084,575 | - | 8,437,269 | 8,437,269 | - | |||||||||||||||||||||||||||||
|
PSP | - | - | - | - | - | - | ||||||||||||||||||||||||||||
2010 SIP | - | - | - | - | - | - | |||||||||||||||||||||||||||||
2019 SIP | - | 10,652,724 | - | 8,324,141 | 8,324,141 | - | |||||||||||||||||||||||||||||
|
PSP | - | - | - | - | - | - | ||||||||||||||||||||||||||||
2010 SIP | - | - | - | - | - | ||||||||||||||||||||||||||||||
2019 SIP | - | 9,656,907 | - | 6,398,337 | 6,398,337 | - |
52 | BROWN &
EXECUTIVE COMPENSATION TABLES
(1) |
All figures shown for the value of stock granted under the PSP, 2010 SIP and 2019 SIP that would vest upon death, disability or following a change in control are calculated based on the assumption that the triggering event(s) for such vesting took place on December 29, 2024, the last business day of the Company's last completed fiscal year, and that the price per share of our common stock is $102.02, the closing market price as of that date. Other than the amounts shown in the column captioned "Change in Control" payable under the PSP, the figures shown in this table do not reflect the impact of the excise tax under Sections 280G and 4999 of the Internal Revenue Code, which may effectively reduce the amounts of change-in-controlpayments that a Named Executive Officer may receive, and do not reflect the assignment of any value to non-competitionand other restrictive covenants or determinations of reasonable compensation that may reduce the amounts of change-in-controlpayments subject to the excise tax. For more detailed information concerning the change-in-controlprovisions of the PSP, the 2010 SIP and the 2019 SIP, see "Compensation Discussion and Analysis - Payments Upon Termination or Change in Control." All figures shown in this table would be paid in lump-sumpayments by us in accordance with the applicable grant agreements. |
(2) |
The figures shown in this column were determined as follows: (a) for all grants, except those performance-based restricted stock grants in or after February 2022, the amount contemplates 100% of all unvested restricted stock grants granted pursuant to such 2019 SIP grant agreements, and (b) for those performance-based restricted stock grants in or after February 2022, the amount contemplates the greater of: (i) 100% of such unvested restricted stock grants or (ii) the estimated percentage of unvested restricted stock grants determined in accordance with the applicable performance schedule based upon the actual level of achievement (up to the applicable maximum level of achievement and assuming the applicable performance level is adjusted, pursuant to the Compensation Committee's exercise of its discretion, from the first day of the performance period to December 31, 2024, the date on which the Transfer of Control occurs, as follows: (w) in 2022, to exclude the positive impact of the decrease in expense we recognized related to a legal judgment entered into against the Company in 2020; (x) in 2022 and 2023, to exclude the negative impact of Acquisition/Integration Costs; (y) in 2023, to exclude the negative impact of the 1Q23 Nonrecurring Cost and (z) in 2023 and 2024, to exclude the positive impact of the gain on disposal associated with the sale of certain third-party claims administration and adjusting services businesses in the fourth quarter of 2023. |
(3) |
These figures represent amounts that would be paid pursuant to the terms of the PSP in the event of a change in control as defined in the PSP and include the following excise tax gross-upamount to be paid by the Company on PSP shares on behalf of the participant in the event of change in control: Mr. |
(4) |
This amount would be paid pursuant to that certain grant under our 2010 SIP made on April 29, 2010 for 374,080 shares. This grant replaced 374,080 shares granted under our PSP on July 21, 2009, which had inadvertently exceeded the maximum number of shares permitted to be awarded in a particular calendar year. In order to assure achievement of the full intent of the original PSP grant, the replacement grant under the 2010 SIP has identical performance-based and other vesting conditions, including those associated with a change in control, to the original PSP grant. |
As required by Section 953(b) of the Dodd-Frank Act, and Item 402(u) of Regulation S-K,we are providing the following information about the relationship of the annual total compensation of our employees and the annual total compensation of Mr.
Chief Executive Officer Pay Ratio
For 2024, our last completed fiscal year:
• |
the median of the annual total compensation of all employees of our company, other than Mr. |
• |
the annual total compensation of Mr. |
• |
Based on this information, for 2024, the ratio of the annual total compensation of Mr. |
Methodology
To identify the median of the annual total compensation of all our employees, other than Mr.
1. |
Our median employee for 2023 experienced anomalous compensation characteristics. Because we believe that during 2024 there was no change in our employee population or employee compensation arrangements that we reasonably believe would significantly impact our pay ratio disclosure for 2024, in accordance with |
2. |
We determined that, as of December 22, 2023, the last day of our last regular pay period of 2023, our employee population consisted of approximately 16,781 full-time, part-time, seasonal and temporary employees, with 12,719 of these individuals located in |
3. |
As permitted by |
4. |
To identify the "median employee" from our employee population, we compared the amount of compensation of our employees as reflected in our payroll records as reported for 2023 to the |
54 | BROWN &
PAY RATIO
5. |
We identified our median employee, as well as our substitute median employee, as of December 22, 2023, using this compensation measure, which was consistently applied to all our employees included in the calculation. We did not make any cost-of-living adjustments in identifying the "median employee." |
6. |
Once we identified our substitute median employee, we combined all of the elements of such employee's compensation for 2024 in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K, resulting in annual total compensation of $74,035. The difference between such employee's annual total compensation and such employee's Form W-2 compensation represents (a) $2,931 in pre-tax contributions made by such employee in connection with certain Company-sponsored benefit plans; and (b) an increase of $1,000 in the performance-based bonus paid to such employee in January 2025 for service in 2024 as compared to the performance-based bonus paid to such employee in January 2024 for service in 2023. |
7. |
With respect to the annual total compensation of Mr. |
requirements regarding pay versus performance ("PVP"), this section presents the
"Compensation Actually Paid" ("CAP"). Also required by
Year
|
Summary
Compensation Table Total for CEO ($) |
Compensation
Actually Paid to CEO ($) (1)
|
Average
Summary Compensation Table Total for Non-CEO NEOs ($) |
Average
Compensation Actually Paid to Non-CEO NEOs ($) (2)
|
Value of Initial Fixed $100
Investment Based on: |
Net
Income (in millions)
|
Organic
Revenue growth (4)
|
|||||||||||||||||||||||||
Total
Shareholder Return |
Total Shareholder Retu (3)
|
|||||||||||||||||||||||||||||||
2024
|
11,678,777 | 39,126,284 | 4,018,493 | 8,443,857 | $ | 268 | $ | 222 | $ | 1,002 | 10.4 | % | ||||||||||||||||||||
2023
|
9,786,745 | 23,865,891 | 3,272,317 | 5,477,863 | $ | 185 | $ | 182 | $ | 871 | 10.3 | % | ||||||||||||||||||||
2022
|
6,741,633 | (5,295,763 | ) | 4,728,133 | 2,800,269 | $ | 148 | $ | 163 | $ | 672 | 8.1 | % | |||||||||||||||||||
2021
|
9,201,035 | 32,778,563 | 3,508,148 | 6,939,244 | $ | 181 | $ | 158 | $ | 587 | 10.4 | % | ||||||||||||||||||||
2020
|
7,254,300 | 15,105,043 | 2,573,911 | 4,184,212 | $ | 121 | $ | 112 | $ | 481 | 3.8 | % |
(1)
|
The Compensation Actually Paid to
|
Year
|
Reported summary
compensation table total for CEO ($) (a) |
Reported value
of equity awards ($) (b) |
Equity
award adjustments ($) (c)* |
Reported change
in the actuarial present value of pension benefits ($) (d) |
Pension benefit
adjustments ($) (e)
|
Compensation
actually paid to CEO ($) (a - b + c - d + e)
|
||||||||||||||
2024
|
11,678,777 | 2,952,920 | 30,400,427 | - | - | 39,126,284 | ||||||||||||||
2023
|
9,786,745 | 2,941,861 | 17,021,007 | - | - | 23,865,891 | ||||||||||||||
2022
|
6,741,633 | 2,953,648 | (9,083,748 | ) | - | - | (5,295,763 | ) | ||||||||||||
2021
|
9,201,035 | 2,940,017 | 26,517,545 | - | - | 32,778,563 | ||||||||||||||
2020
|
7,254,300 | 2,948,008 | 10,798,751 | - | - | 15,105,043 |
* |
The equity award adjustments shown in this column are calculated as follows:
|
Year
|
Year end fair
value of equity awards granted during the year ($) |
Year over year
change in fair value of outstanding and unvested equity awards ($) |
Fair value as of
vesting date of equity awards granted and vested in the year ($) |
Year over year
change in fair value of equity awards granted in prior years that vested in the year ($) |
Fair value at
the end of the prior year of equity awards that failed to meet vesting conditions in the year ($) |
Value of
dividends or other earnings paid on stock or option awards not otherwise reflected in fair value or total compensation ($) |
Total equity
award adjustments ($) |
|||||||||||||||
2024
|
6,477,250 | 22,365,920 | - | 1,557,257 | - | - | 30,400,427 | |||||||||||||||
2023
|
6,473,499 | 10,621,261 | - | (73,753 | ) | - | - | 17,021,007 | ||||||||||||||
2022
|
2,506,468 | (10,904,630 | ) | - | (685,586 | ) | - | - | (9,083,748 | ) | ||||||||||||
2021
|
7,989,712 | 18,728,632 | - | (200,798 | ) | - | - | 26,517,545 | ||||||||||||||
2020
|
4,031,415 | 6,639,119 | - | 128,217 | - | - | 10,798,751 |
(2)
|
The average Compensation Actually Paid to our Named Executive Officers, other than
|
Year
|
Average
reported summary compensation table total for non-CEO NEOs
($) (a) |
Average
reported value of equity awards ($) (b) |
Average
equity award adjustments ($) (c)* |
Average
reported change in the actuarial present value of pension benefits ($) (d) |
Average
pension benefit adjustments ($) (e) |
Average
compensation actually paid to non-CEO NEOs ($) (a - b + c - d + e)
|
||||||||||||||||||
2024
|
4,018,493 | 885,885 | 5,311,249 | - | - | 8,443,857 | ||||||||||||||||||
2023
|
3,272,317 | 612,845 | 2,818,391 | - | - | 5,477,863 | ||||||||||||||||||
2022
|
4,728,133 | 2,541,365 | 613,501 | - | - | 2,800,269 | ||||||||||||||||||
2021
|
3,508,148 | 575,709 | 4,006,805 | - | - | 6,939,244 | ||||||||||||||||||
2020
|
2,573,911 | 540,422 | 2,150,723 | 4,184,212 |
* |
The equity award adjustments shown in this column are calculated as follows:
|
Year
|
Average year end
fair value of equity awards granted during the year ($) |
Average year over
year change in fair value of outstanding and unvested equity awards ($) |
Average fair
value as of vesting date of equity awards granted and vested in the year ($) |
Average year
over year change in fair value of equity awards granted in prior years that vested in the year ($) |
Average
fair value at the end of the prior year of equity awards that failed to meet vesting conditions in the year ($) |
Average
value of dividends or other earnings paid on stock or option awards not otherwise reflected in fair value or total compensation ($) |
Average
total equity award adjustments ($) |
|||||||||||||||||||||
2024 | 1,934,274 | 3,046,026 | - | 330,949 | - | - | 5,311,249 | |||||||||||||||||||||
2023 | 1,348,566 | 1,483,272 | - | (13,447 | ) | - | - | 2,818,391 | ||||||||||||||||||||
2022 | 2,080,633 | (1,255,815 | ) | - | (211,317 | ) | - | - | 613,501 | |||||||||||||||||||
2021 | 1,564,556 | 2,529,319 | - | (87,070 | ) | - | - | 4,006,805 | ||||||||||||||||||||
2020 | 739,039 | 1,304,049 | 107,635 | 2,150,723 |
(3)
|
Peer average among
|
(4)
|
See
Annex A
for additional information regarding Organic Revenue growth, which is a non-GAAP financial measure, including a reconciliation to the most closely comparable GAAP financial measure. |
fixed investment of $100) and the peer group's total shareholder retu(assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2024, 2023, 2022, 2021 and 2020:
.
Financial Performance Measure
|
||
Organic Revenue
(1)
growth |
||
Adjusted EBITDAC Margin
(1)
|
||
Adjusted EPS
(1)
|
||
Total Shareholder Retu
(2)
|
(1) |
For additional information related to how we link our executive compensation programs to Adjusted EBITDAC Margin, Organic Revenue growth and Adjusted EPS, see "Compensation Discussion and Analysis."
|
(2) |
While Total Shareholder Retuis not used as one of the metrics tied to the payouts under our incentive plans, the actual value realized under our equity incentive awards is based upon the Company's Total Shareholder Retu(i.e., stock price and dividends paid) over the applicable performance and vesting periods.
|
PAY VERSUS PERFORMANCE
PROPOSAL 4: AN AMENDMENT TO 2019 SIP TO INCREASE THE SHARES AVAILABLE FOR ISSUANCE AND EXTEND THE TERM
On March 24, 2025, the Compensation Committee approved, pursuant to approval by the Board of Directors, an amendment to the 2019 SIP, which provides for a 6,930,000 share increase in the aggregate number of shares of the Company's common stock that may be subject to future awards under the 2019 SIP, subject to shareholder approval. Therefore, this amendment will not become effective if the shareholders do not approve it.
The Board believes that the Company's use of equity incentives is an integral part of our compensation program, and that grants of equity-based compensation are an essential factor in attracting and retaining effective and capable teammates who contribute to the growth and success of the Company, and in establishing a direct link between the financial interests of our teammates and our shareholders.
If this amendment is approved by shareholders, the shares available for future awards will increase by 6,930,000 to 9,512,143 based on the 2,582,143 shares remaining available for grant under the 2019 SIP as of December 31, 2024.
In addition, if this amendment is approved by shareholders, then, unless sooner terminated in accordance with its terms, the 2019 SIP will terminate on May 7, 2035.
Vote Required; Board Recommendation
In order to pass, this Proposal 4 must receive the affirmative vote of a majority of the votes cast on the Proposal. The Board of Directors believes that the approval of Proposal 4 is in the best interests of the Company and its shareholders.
The Board unanimously recommends a vote "FOR"this proposal. |
|
60 | BROWN &
PAY VERSUS PERFORMANCE
Summary of Outstanding Awards under Our Equity Compensation Plans
A summary of the number of shares subject to outstanding awards under the 2019 SIP, 2010 SIP and the PSP as of December 31, 2024, is as follows:
Shares underlying unvested and vested stock options |
0 | |||
Shares underlying unearned PSAs and PSUs(1) |
3,061,465 | |||
Shares underlying earned unvested PSAs and PSUs(2) |
2,458,988 | |||
Shares underlying unvested RSAs and RSUs |
1,375,822 | |||
Total number of shares subject to outstanding awards(1) (2) |
6,896,275 |
(1) |
Of this amount, the payout for (a) 1,450,804 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained. |
(2) |
The amount reflected in the table assumes all unearned PSAs ad PSUs will vest at a target payout of 100%. |
Shareholder-Friendly Features of the 2019 SIP
We endeavor to ensure that the design and administration of the 2019 SIP, including the 2019 SIP amendment that is the subject of this proposal, drive long-term shareholder value and are consistent with the policies and limitations recommended by independent shareholder advisory groups, such as
Shareholder-Friendly Plan Features and Grant Practices under the 2019 SIP |
||
• Double-trigger" change in control vesting provisions |
• Cliff vesting on all awards subject to time-based vesting conditions, except in limited circumstances |
|
• No excise tax gross-up provisions |
• Majority of awards tied to both time-and performance-based vesting conditions |
|
• No liberal share recycling of awards |
• Lengthy service conditions on all awards that extend beyond measurement period for performance-based awards |
|
• For awards with both time-and performance-based vesting conditions, dividends and voting rights entitlement only on shares that have achieved performance goals |
• Performance-based vesting conditions tied to metrics that are aligned with long-termshareholder interests, including adjusted earnings per share and organic revenue growth |
|
• Minimum vesting period of at least one year on all types of awards, except in limited circumstances |
• No option repricing |
PAY VERSUS PERFORMANCE
Shares Available for Future Grant
Based on the proposed shares to be available for grants under the 2019 SIP and the outstanding awards under the 2019 SIP, 2010 SIP and the PSP as of December 31, 2024, if the shareholders approve the amendment to the 2019 SIP, the number of shares subject to outstanding awards and available for future grants would be as follows:
Shares subject to outstanding awards under the 2019 SIP, 2010 SIP and PSP(1) |
6,896,275 | |||
Shares available for future grants under the 2019 SIP |
2,582,143 | |||
Total shares |
9,478,418 |
(1) |
Of this amount, the payout for (a) 1,450,804 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained. The amount reflected in the table is calculated assuming the maximum payout for all PSAs and PSUs. |
Based on the 285,956,689 shares outstanding on December 31, 2024, this total number of shares subject to outstanding awards and available for future grants under the 2019 SIP, if the shareholders approve the amendment to the 2019 SIP, would be 3.21% of the fully diluted outstanding shares.
Calculation of our Average BuRate
The Company's three-year average burate, based upon the total number of options, RSAs, RSUs, PSAs and PSUs granted, is shown below:
Year |
Options Granted |
RSAs and RSUs Granted |
PSAs and PSUs Granted |
Weighted Average Number of Common Shares Outstanding - Basic |
BuRate | |||||||||||||||
2024 |
0 | 249,952 | 1,154,634 | (1) | 285,455,942 | 0.49 | % | |||||||||||||
2023 |
0 | 235,738 | 1,323,088 | (2) | 283,932,610 | 0.55 | % | |||||||||||||
2022 |
0 | 693,802 | 784,811 | (3) | 282,864,919 | 0.52 | % | |||||||||||||
Three-year average burate |
0.52 | % |
(1) |
Of this amount, the payout for 587,205 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained. The amount reflected in the table includes all PSAs and PSUs at a target payout of 100%. |
(2) |
Of this amount, the payout for (a) 615,575 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 17,338 shares underlying our outstanding PSAs and PSUs may be increased up to 120% of the target or decreased to zero, subject to the level of performance attained. The amount reflected in the table includes all PSAs and PSUs at a target payout of 100%. |
(3) |
Of this amount, the payout for (a) 378,836 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 15,114 shares underlying our outstanding PSAs and PSUs may be increased up to 120% of the target or decreased to zero, subject to the level of performance attained. The amount reflected in the table includes all PSAs and PSUs at a target payout of 100%. |
However, the Company's three-year average burate, taking into consideration only granted RSAs and RSUs and PSAs and PSUs for which the performance conditions have been satisfied (i.e., awarded PSAs and PSUs), is shown below:
Year |
Options Granted |
RSAs and RSUs Granted and PSAs and PSUs Awarded |
Weighted Average Number of Common Shares Outstanding - Basic |
BuRate | ||||||||||||
2024 |
0 | 1,478,627 | 285,455,942 | 0.52 | % | |||||||||||
2023 |
0 | 1,213,185 | 283,932,610 | 0.43 | % | |||||||||||
2022 |
0 | 2,077,018 | 282,864,919 | 0.73 | % | |||||||||||
Three-year average burate |
0.56 | % |
62 | BROWN &
PAY VERSUS PERFORMANCE
Description of the 2019 SIP
The principal terms of the 2019 SIP are summarized below. This summary is qualified in its entirety by the complete text of the 2019 SIP, which is attached to this Proxy Statement as Appendix A.
Overview.The purpose of the 2019 SIP is to attract, incentivize and retain our key employees by offering those persons an opportunity to acquire or increase a direct proprietary interest in our operations and future success.
Shares Subject to the 2019 SIP; Share Counting.Subject to adjustment upon a change in capitalization, the number of shares of the Company's common stock that may be subject to awards under the 2019 SIP cannot exceed (i) 2,283,475 shares, plus (ii) the 6,957,897 shares authorized for issuance under the 2010 SIP that are not subject to awards outstanding or previously issued as of the effective date of the 2019 SIP, plus (iii) an additional 6,930,000 shares if this amendment is approved by shareholders, plus (iv) certain additional shares recaptured from expired, terminated, canceled, or forfeited portions of awards under the 2010 SIP and the PSP. If any portion of an outstanding award under the 2019 SIP, the 2010 SIP or the PSP for any reason expires or is terminated or canceled or forfeited, the shares allocable to the expired, terminated, canceled, or forfeited portion of such award shall be available for issuance under the 2019 SIP. However, the following shares are not available for issuance under the 2019 SIP: shares tendered as payment for option exercises, shares withheld to cover tax withholding requirements and shares that have been repurchased by the Company using stock option exercise proceeds. As of March 3, 2025, a total of 6,951,540 shares were subject to outstanding equity awards under the 2019 SIP, assuming a target payout of all PSAs and PSUs of 100%. Of these 6,951,540 shares, the payout for (i) 1,448,942 shares underlying our outstanding PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (ii) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained.
Eligibility.All employees of the Company and its subsidiaries, and all members of the Board, are eligible to participate in the 2019 SIP. As of December 31, 2024, there were approximately 17,403 employees and 13 non-employee directors who were eligible to participate in the 2019 SIP.
Administration.The Compensation Committee has authority to grant awards to employees under the 2019 SIP and is responsible for the general administration and interpretation of the 2019 SIP. The 2019 SIP provides that members of the Compensation Committee have a right to indemnification with respect to claims arising against them individually as a result of their administration of the 2019 SIP, except in the case of gross negligence, bad faith or intentional misconduct. The Compensation Committee has authority to establish the terms of each award, including the number of awards granted, the vesting schedule and exercisability. The Compensation Committee may establish performance goals as a prerequisite to exercisability or vesting, and such goals and other terms need not be uniform among various participants. Each employee or director granted awards under the 2019 SIP will be required to enter into an award agreement with the Company setting forth the terms and conditions of the grant, including any performance goals that are a prerequisite to exercising or vesting of the grant. The Board may, in its discretion, make a limited delegation of authority to the Company's Chief Executive Officer to grant awards under the 2019 SIP to individuals who are not subject to Section 16 of the Securities Exchange Act of 1934.
Types of Awards Available for Grant under the 2019 SIP
Options.Options granted under the 2019 SIP may be either "incentive stock options," as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), or non-qualified stock options.
As a general rule, the exercise price for any stock option must be no less than the fair market value of the stock subject to such option as of the date of grant, except for incentive stock options granted to a grantee who owns 10% or more of the voting power of the Company, in which case the exercise price must be at least 110% of the fair market value of such stock as of the date of grant. To the extent that the fair market value of that portion of any grant of incentive stock options that is exercisable for the first time in any given year exceeds $100,000, such options will be treated as non-qualified stock options.
Options granted under the 2019 SIP generally will not be exercisable after the expiration of 10 years after the effective date of the grant. In addition, no incentive stock option granted to a beneficial owner of 10% or more of the Company's outstanding shares will be exercisable after the expiration of five years after the effective date of the grant.
Generally, options may be exercised only while the award holder is an employee or director of the Company or within a limited period after the award holder leaves employment or service with the Company or after the award holder's retirement, disability or
PAY VERSUS PERFORMANCE
death. During the award holder's lifetime, an award is exercisable only by the award holder. Awards generally are not transferable except upon the death of the award holder.
On the date of exercise, the award holder may pay the full option price in cash, in shares of common stock previously acquired by the award holder valued at fair market value or in any other form of consideration approved by the Compensation Committee. The use of previously acquired shares to pay the option price enables the award holder to avoid the need to fund the entire purchase with cash. Upon exercise of an award, the number of shares subject to the option and the number of shares available under the 2019 SIP for future option grants will be reduced by the number of shares with respect to which the option is exercised.
Stock Appreciation Rights.The Compensation Committee also may grant stock appreciation rights that will entitle the award recipient to receive the excess of the fair market value of a share of the Company's common stock over the exercise price for each share with respect to which the stock appreciation right is exercised. Payment upon exercise of a stock appreciation right may be in cash, shares or a combination of cash and shares, as determined by the Compensation Committee.
Restricted Stock.The Compensation Committee also may grant awards in the form of shares of the Company's common stock that are subject to forfeiture and restrictions on transferability in such amounts and upon such terms and conditions as the Compensation Committee specifies in the award agreement. The restricted stock award agreement shall set forth the conditions, if any, which will need to be timely satisfied before the restricted stock grant will be effective, and the conditions, if any, which will need to be timely satisfied before the restricted stock grant will be vested and settled, and the conditions, if any, under which the grantee's interest in the shares will be forfeited. Any such conditions for effectiveness or vesting and settlement or nonforfeitability may be based upon the passage of time and continued service by the grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions.
Restricted Stock Units.The Compensation Committee also may grant awards in the form of units representing rights to receive shares in such amounts and upon such terms and conditions as the Compensation Committee specifies in the award agreement, including forfeiture and other restrictions. The restricted stock unit award agreement shall set forth the conditions, if any, which will need to be timely satisfied before the restricted stock unit award will be effective, and the conditions, if any, which will need to be timely satisfied before the restricted stock units will be vested and settled, and the conditions, if any, under which the grantee's interest in the related units will be forfeited. Any such conditions for effectiveness or vesting and settlement or nonforfeitability may be based upon the passage of time and continued service by the Grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions.
Other Stock-Based Awards.The Compensation Committee also may grant other stock-based awards in such forms and in such amounts and upon such terms and conditions as the Compensation Committee specifies in the award agreement. Other stock-based awards are valued based on shares of the Company's common stock. The other stock-based award agreement shall set forth the conditions, if any, which will need to be timely satisfied before the award will be effective, and the conditions, if any, which will need to be timely satisfied before the award will be vested and settled, and the conditions, if any, under which the grantee's interest in the award will be forfeited. Any such conditions for effectiveness or vesting and settlement or nonforfeitability may be based upon the passage of time and continued service by the Grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions.
Performance-Based Awards.The Compensation Committee may grant options, SARs, restricted stock, restricted stock units and other stock-based awards for which the amount, awarding, vesting or settlement is contingent on the achievement of specific performance goals during a performance period, determined using a specific performance measure, all as specified in the award agreement. The performance goals and performance period will be established by the Compensation Committee. In establishing performance goals, the Compensation Committee may use performance measures based on any one or combination of performance criteria selected by the Compensation Committee. Although examples of certain performance measures are listed in the 2019 SIP, the Compensation Committee may use any performance measure that it determines to be appropriate. Performance may be measured on an absolute or relative basis and are related to the performance of the Company, a subsidiary, the grantee, the segment, department or function within the Company or subsidiary in which the grantee is employed, a region, a product-line or any other manner that the Compensation Committee determines appropriate in its discretion.
The Compensation Committee may adjust performance goals and the related level of achievement if the Compensation Committee determines in its discretion that events or transactions that are unusual in nature or infrequently occurring have occurred after the date of grant that are unrelated to the performance of the grantee and result in distortion of the performance targets or the related level of achievement. The Compensation Committee may provide in the applicable award agreement additional rules and procedures relating to its ability to adjust aspects of a performance-based award, its ability to increase or decrease the amount of
64 | BROWN &
PAY VERSUS PERFORMANCE
compensation provided by a performance-based award, and the certification or other determination of the extent to which performance goals have or have not been attained.
Adjustment for Certain Events.If the Company undergoes certain events or changes regarding its capital structure, such as a stock dividend, stock split, reverse stock split, recapitalization, reclassification or a similar event, appropriate adjustments will be made to the number and class of shares available for issuance under the 2019 SIP and the number and class of shares and, if applicable, exercise price relating to any outstanding awards. Appropriate adjustments would also be made if a majority of the shares which are the same class as the shares that are subject to outstanding awards are exchanged for, converted into, or otherwise become shares of another corporation. If such an event occurs, the Compensation Committee will amend the outstanding awards to provide that such awards are exercisable or will be settled for or with respect to such new shares.
Minimum Vesting.Except with respect to a maximum of 5% of the shares available for grant under the 2019 SIP, and except for a provision in the 2019 SIP or an individual award agreement for an acceleration of vesting in the event of the death or disability of the grantee or termination of the grantee's employment after a change in control, no award will provide for vesting that is any more rapid than vesting on the one-year anniversary of the date of grant.
Effect of Change in Control.In the event of the involuntary or constructive termination of an award holder's employment within twelve (12) months after a change in control transaction, as defined in the 2019 SIP, the vesting of any outstanding award that is subject to a time-based vesting schedule will be accelerated, and the vesting of any outstanding performance-based award will be accelerated based on the greater of the performance goal(s) target or the actual level of achievement of the applicable performance goal(s) from the first day of the performance period to the date on which the change in control occurs.
No Repricing.The Compensation Committee may not modify or amend any outstanding option or stock appreciation right so as to specify a lower exercise price or accept the surrender of an outstanding option or stock appreciation right and authorize the granting of a new option or stock appreciation right with a lower exercise price in substitution for such surrendered option or stock appreciation right.
Application of Clawback Policy to 2019 SIP Awards.In the event that the Company is required to prepare a "Financial Restatement," the Company will recover any "Recoverable Amount" of any "Incentive-Based Compensation" received by a current or former "Executive Officer" during the "Look-Back Period." Incentive-Based Compensation includes means any compensation that is granted, earned or vests based wholly or in part upon the attainment of a "Financial Reporting Measure" and may include equity awards issued pursuant to the 2019 SIP. Awards under the 2019 SIP will be subject to the Company's clawback policy, as amended from time to time, to the extent covered by such policy pursuant to the terms thereof.
Amendment or Termination of the 2019 SIP.Except as may be required by law, the Compensation Committee may terminate or amend the 2019 SIP at any time without further shareholder or regulatory approval. However, no termination or amendment of the 2019 SIP may adversely affect any then outstanding award without the consent of the award holder. Unless earlier terminated by the Compensation Committee, the 2019 SIP will be in effect until awards have been granted and exercised with respect to all shares available for the 2019 SIP. However, no award can be granted under the 2019 SIP more than 10 years after the 2019 SIP has been approved by the Company's shareholders. If this amendment is approved by shareholders, then, unless sooner terminated, the 2019 SIP will terminate on May 7, 2035.
Tax Consequences
The
Options.Options granted under the 2019 SIP may be either incentive stock options or non-qualified stock options. Options that are designated as incentive stock options are intended to qualify as such under Section 422 of the Code. With respect to incentive stock options, neither the grant nor the exercise of the option will subject the employee to taxable income, other than under the Alternative Minimum Tax (Section 56(b)(3) of the Code), which is not discussed in detail in this summary. There is no required tax withholding in connection with the exercise of incentive stock options. Upon the ultimate disposition of the stock obtained on an exercise of an incentive stock option, the employee's entire gain will be taxed at the rates applicable to long-term capital gains, provided the employee has satisfied the prescribed holding periods relating to incentive stock options and the underlying stock. This treatment will apply to the entire amount of gain recognized on the sale of the stock, including the portion of gain that reflects the spread on
PAY VERSUS PERFORMANCE
the date of exercise between the fair market value of the stock at the time of grant and the fair market value of the stock at the time of exercise.
The Company does not receive a compensation deduction for tax purposes with respect to incentive stock options. However, if the employee disposes of the stock purchased on exercise of the incentive stock option prior to the expiration of the applicable holding periods required by Section 422 of the Code, the Company will be entitled to a deduction equal to the employee's realization of ordinary income by virtue of the employee's disqualifying disposition.
Non-qualified stock options granted under the 2019 SIP will not qualify for any special tax benefits to the option holder. An option holder generally will not recognize any taxable income at the time he or she is granted a non-qualified option. However, upon its exercise, the option holder will recognize ordinary income for federal tax purposes measured by the excess of the fair market value of the shares at the time of exercise over the exercise price. The income realized by the option holder will be subject to income and other employee withholding taxes.
The option holder's basis for determination of gain or loss upon the subsequent disposition of shares acquired upon the exercise of a non-qualified stock option will be the amount paid for such shares plus any ordinary income recognized as a result of the exercise of such option. Upon disposition of any shares acquired pursuant to the exercise of a non-qualified stock option, the difference between the sale price and the option holder's basis in the shares will be treated as a capital gain or loss and generally will be characterized as long-term capital gain or loss if the shares have been held for more than one year at the time of their disposition.
In general, there will be no federal income tax deduction allowed to the Company upon the grant or termination of a non-qualified stock option or a sale or disposition of the shares acquired upon the exercise of a non-qualified stock option. However, upon the exercise of a non-qualified stock option by a holder, the Company will be entitled to a deduction for federal income tax purposes equal to the amount of ordinary income that an option holder is required to recognize as a result of the exercise, provided that the deduction is not otherwise disallowed under the Code.
Restricted Stock, Restricted Stock Units and Stock Appreciation Rights.With respect to restricted stock, restricted stock units and stock appreciation rights that may be settled either in cash or in shares that are either transferable or not subject to a substantial risk of forfeiture, the grantee will realize ordinary taxable income, subject to tax withholding, equal to the amount of the cash or the fair market value of the shares received. The Company will be entitled to a deduction in the same amount and at the same time as the compensation income is received by the grantee. With respect to restricted stock award shares that are both nontransferable and subject to a substantial risk of forfeiture, the award recipient will realize ordinary taxable income equal to the fair market value of the shares at the first time the shares are either transferable or not subject to a substantial risk of forfeiture. The Company will be entitled to a deduction in the same amount and at the same time as the ordinary taxable income realized by the grantee.
Some awards, such as restricted stock unit awards, may be considered to be deferred compensation subject to special federal income tax rules under Section 409A of the Code. Failure to satisfy the applicable requirements under Section 409A of the Code for such awards would result in the acceleration of income and additional income tax liability to the grantee, including certain penalties. The 2019 SIP and awards under the 2019 SIP are intended to be designed and administered so that any awards that are considered to be deferred compensation will not result in negative tax consequences to the grantees under Section 409A of the Code.
All of the above-described deductions are subject to the limitations on deductibility described in Section 162(m) of the Code. Therefore, there can be no assurance that compensation attributable to 2019 SIP awards will be fully deductible under all circumstances. In addition, as a result of the provisions of Section 280G of the Code, compensation paid to certain employees resulting from vesting of awards in connection with a change in control of the Company also may not be deductible.
Past Grants Under the 2019 SIP
The only grants made under the 2019 SIP are PSA, PSU, RSA, RSU grants to eligible employees, and annual grants of fully vested stock to non-employee directors as described in this Proxy Statement in the section titled, "Director Compensation." No stock options or stock appreciation rights have been granted under the 2019 SIP.
66 | BROWN &
PAY VERSUS PERFORMANCE
All awards under the 2019 SIP are made at the discretion of the Compensation Committee. Therefore, the benefits and amounts that will be received or allocated under the 2019 SIP in the future are not determinable at this time. The stock grants made under the SIP during 2024, which would not have changed if the proposed 2019 SIP amendment to increase the number of shares authorized for issuance under Proposal 4 had been in place, were as follows:
|
Dollar Value(1) | Number of Shares underlying Awards(2) |
||||||
|
$ | 2,999,993 | 36,280 | |||||
|
$ | 1,299,969 | 15,721 | |||||
|
$ | 699,971 | 8,465 | |||||
|
$ | 499,944 | 6,046 | |||||
|
$ | 1,099,886 | 13,104 | |||||
Current executive officers as a group |
$ | 8,499,731 | 102,593 | |||||
Current non-employee directors as a group |
$ | 1,439,192 | 16,884 | |||||
Employees other than executive officers as a group |
$ | 108,015,335 | 1,301,993 |
(1) |
Amounts reflect the aggregate grant date fair value of awards computed in accordance with Statement of Financial Accounting Standards ASC Topic 718 (formerly "SFAS 123(R)"). |
(2) |
PSAs and PSUs granted to our employees in 2024 may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained. The amount reflected in the table includes all RSAs and RSUs at a target payout of 100%. |
The following table sets forth information as of December 31, 2024, with respect to compensation plans under which the Company's equity securities are authorized for issuance:
Plan Category |
Number of securities to |
Weighted-average exercise price of outstanding options, warrants and rights(b) |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a),(c)(1) |
|||||||||
Equity compensation plans approved by shareholders: |
||||||||||||
|
- | - | 2,582,143 | (2) | ||||||||
|
- | - | - | |||||||||
|
- | - | 2,273,356 | |||||||||
|
- | - | - | |||||||||
Total |
4,855,499 | |||||||||||
Equity compensation plans not approved by shareholders |
- | - | - |
(1) |
All of the shares available for future issuance under and the |
(2) |
The payout for (a) 1,450,804 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained. The amount reflected in the table is calculated assuming the maximum payout for all RSAs and RSUs. |
68 | BROWN &
The following is the Company's overhang information, which measures the number of shares subject to equity-based awards outstanding but unexercised or unvested, as of March 3, 2025, for all of the Company's existing equity compensation plans, as well as certain other information relating to outstanding awards under the plans:
●Stock options outstanding: |
0 | |||
●Weighted average exercise price of outstanding stock options: |
N/A | |||
●Weighted average remaining contractual term of outstanding stock options: |
N/A | |||
●PSAs and PSUs not yet earned: |
3,106,540 | (1) | ||
●Earned unvested PSAs and PSUs: |
1,382,592 | |||
●Unvested RSA and RSU grants: |
2,462,408 | |||
●Shares available for future grants under the 2019 SIP: |
1,434,059 | (2) | ||
●Total shares of common stock shares outstanding: |
286,627,605 |
(1) |
Of this amount, the payout for (a) 1,450,804 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained. The amount reflected in this row includes all PSAs and PSUs at a target payout of 100%. |
(2) |
The payout for (a) 1,450,804 shares underlying PSAs and PSUs may be increased up to 200% of the target or decreased to zero, subject to the level of performance attained, and (b) 60,112 shares underlying our outstanding PSAs and PSUs may be increased up to 150% of the target or decreased to 50% of the target, subject to the level of performance attained. The amount reflected in this row is calculated assuming the maximum payout for all RSAs and RSUs. |
Supplemental Information
The Company intends to register the additional shares of common stock issuable under the 2019 SIP under the Securities Act of 1933, as amended, on Form S-8 as soon as reasonably practicable.
Security Ownership of Management and Certain Beneficial Owners
The following table sets forth, as of March 3, 2025, the record date for the Meeting, information as to our common stock beneficially owned by (1) each of our directors, all of whom are director nominees, (2) each Named Executive Officer named in the Summary Compensation Table, (3) all of our directors and current executive officers as a group and (4) any person or entity whom we know to be the beneficial owner of more than five percent of the outstanding shares of our common stock.
|
Amount and Nature of Beneficial Ownership(2)(3) |
Percent of Total | ||||||
|
35,998,968 | 12.56 | % | |||||
|
5,394,305 | 1.88 | % | |||||
Lawrence L. Gellerstedt III |
19,539 | * | ||||||
|
118,483 | * | ||||||
|
23,407 | * | ||||||
|
54,157 | * | ||||||
|
1,407 | * | ||||||
|
32,321 | * | ||||||
|
5,407 | * | ||||||
|
3,255 | * | ||||||
|
44,353 | * | ||||||
|
234,383 | * | ||||||
|
1,407 | * | ||||||
|
57,904 | * | ||||||
|
1,430,340 | * | ||||||
|
702,589 | * | ||||||
|
165,903 | * | ||||||
|
194,828 | * | ||||||
All current directors and executive officers as a group (21 persons)(8) |
44,694,156 | 15.59 | % | |||||
50 Hudson Yards |
16,347,696 | 5.72 | % | |||||
The Vanguard Group, Inc.(10) 100 Vanguard Boulevard |
28,695,553 | 10.01 | % |
* |
Less than 1%. |
(1) |
Unless otherwise indicated, the address of such person is c/o |
(2) |
Beneficial ownership of shares, as determined in accordance with applicable |
(3) |
The number and percentage of shares owned by the following persons include the indicated number of shares owned through our 401(k) plan as of March 3, 2025: Mr. |
The number and percentage of shares owned by the following persons also include the indicated number of unvested shares which such persons have been granted under our PSP as of March 3, 2025: Mr. |
70 | BROWN &
OTHER IMPORTANT INFORMATION
executive officers as a group - 32,000. These PSP shares have voting and dividend rights due to satisfaction of the first condition of vesting based on stock price performance, but the holders thereof currently have no power to sell or dispose of the shares, and the shares are subject to forfeiture. |
In addition, the number and percentage of shares owned by the following persons also include the indicated number of unvested shares which such persons have been granted under our 2010 SIP as of March 3, 2025 and for which the first condition of vesting has been satisfied: Mr. |
In addition, the number and percentage of shares owned by the following persons also include the indicated number of unvested shares which such persons have been granted under our 2019 SIP as of March 3, 2025 and for which the first condition of vesting has been satisfied: Mr. |
In addition, the number and percentage of shares owned by the following persons include the indicated number of unvested shares which such persons have been granted under our 2019 SIP in the form of time-based-only grants as of March 3, 2025: Mr. |
(4) |
The shares beneficially owned by |
(5) |
Mr. |
(6) |
Mr. |
(7) |
|
(8) |
Includes amounts beneficially owned by all our current directors and executive officers as of March 3, 2025, as a group. |
(9) |
The amount shown is derived from a Schedule 13G/A filed by |
(10) |
The amount shown is derived from a Schedule 13G/A filed by The Vanguard Group ("Vanguard") on July 10, 2024 reporting beneficial ownership as of June 28, 2024. According to the Schedule 13G/A, Vanguard has sole voting power over 0 shares, shared voting power over 304,047 shares, sole dispositive power over 27,650,940 shares and shared dispositive power over 1,044,613 shares. |
Delinquent Section 16(a) Reports
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors, officers and persons who own more than ten percent (10%) of our outstanding shares of common stock to file reports of ownership and changes in ownership with the Securities and Exchange Commission. Directors, officers and 10% shareholders are required by
Based solely on our review of such reports and written representations from reporting persons, we believe that during 2024, our directors, officers and 10% beneficial owners timely complied with all applicable filing requirements, except that
Annual Meeting and Proxy Solicitation Information
These proxy materials are made available to shareholders in connection with the solicitation of proxies by the Board of Directors of
Notice of Internet Delivery
As permitted by
OTHER IMPORTANT INFORMATION
Attending the Virtual Annual Meeting
Both shareholders of record and shareholders who hold their shares in "street name" will need to register to be able to attend the Annual Meeting via live audio webcast, submit their questions during the Meeting and vote their shares electronically at the Meeting by following the instructions below.
If you are a shareholder of record, you must:
• |
Follow the instructions provided on your proxy card to first register at https://web.viewproxy.com/BBrown/2025 by 11:59 p.m. (EDT) on May 4, 2025. You will need to enter your name, phone number and email address as part of the registration, following which you will receive an email confirming your registration, as well as the password to attend the Annual Meeting. |
• |
On the day of the Annual Meeting, if you have properly registered, you may enter the Annual Meeting by logging in using the link and password you received via email in the registration confirmation you received when you registered at https://web.viewproxy.com/BBrown/2025. |
• |
If you wish to vote your shares electronically at the Annual Meeting, you will need to visit www.AALvote.com/BRO during the Annual Meeting while the polls are open (you will need the virtual control number included on your proxy card). |
If your shares are held in a "street name," you must:
• |
Register at https://web.viewproxy.com/BBrown/2025 by 11:59 p.m. (EDT) on May 4, 2025. |
You will need to enter your name, phone number and email address, and provide a copy of the legal proxy (which may be uploaded to the registration website or sent via email to VirtualMeeting@viewproxy.com) as part of the registration if you plan to vote at the Meeting, following which you will receive an email confirming your registration and a virtual control number if you plan to vote at the Meeting, as well as the password to attend the Annual Meeting.
Please note, if you do not provide a copy of the legal proxy, you may still attend the Annual Meeting by showing proof of ownership but will be unable to vote your shares electronically at the Annual Meeting.
• |
On the day of the Annual Meeting, if you have properly registered, you may enter the Annual Meeting by logging in using the link and password you received via email in the registration confirmation you received when you registered at https://web.viewproxy.com/BBrown/2025. |
• |
If you wish to vote your shares electronically at the Annual Meeting, you will need to visit www.AALvote.com/BRO during the Annual Meeting while the polls are open (you will need the virtual control number assigned to you in your registration confirmation email). |
Further instructions on how to attend the Annual Meeting via live audio webcast, including how to vote your shares electronically at the Annual Meeting are posted on https://web.viewproxy.com/BBrown/2025 under Frequently Asked Questions (FAQ). The Annual Meeting live audio webcast will begin promptly at 9:00 a.m. (EDT) on May 7, 2025. We encourage you to access the Meeting prior to the start time. Online check-in will begin at 8:30 a.m. (EDT), and you should allow ample time for the check-in procedures.
Technical Difficulties
We will have technicians ready to assist you with any technical difficulties you may have accessing the Annual Meeting live audio webcast. Please be sure to check in by 8:30 a.m. (EDT) on May 7, 2025, the day of the Annual Meeting, so we may address any technical difficulties before the Annual Meeting live audio webcast begins. If you encounter any difficulties accessing the Annual Meeting live audio webcast during the check-in or meeting time, please email VirtualMeeting@viewproxy.com or call (866) 612-8937.
Voting Your Shares; Required Votes
Shares represented by duly executed proxies in the accompanying form that we receive prior to the Meeting will be voted at the Meeting. If you specify in the proxy a choice with respect to any matter to be acted upon, the shares represented by such proxy will be voted as specified. If your proxy card is signed and returned without specifying a vote or an abstention, the shares represented by such proxy will be voted according to the recommendation of the Board of Directors.
The Board of Directors knows of no other matters that may be brought before the Meeting. However, if any other matters are properly presented for action, it is the intention of the named proxies to vote on them according to their best judgment.
72 | BROWN &
OTHER IMPORTANT INFORMATION
If your shares are held in "street name," a stock brokerage account or by a bank or other nominee, you have the right to provide instructions on voting as requested by your broker, bank or nominee. Under the NYSE's rules, your broker, bank or nominee is permitted to vote your shares on the second proposal concerning the ratification of the appointment of
After you have returned a proxy, you may revoke it at any time before it is voted by taking one of the following actions: (i) giving written notice of the revocation to our Corporate Secretary at 300 North Beach St.,
Shares of the common stock represented by proxies received by the Company (whether through the retuof the enclosed proxy card, by telephone or over the Internet), where the shareholder has specified his or her choice with respect to the proposals described in this Proxy Statement (including the election of directors), will be voted in accordance with the specification(s) so made. If your proxy is properly executed but does not contain voting instructions, or if you vote via telephone or the Internet without indicating how you want to vote with respect to any item, your shares will be voted "FOR" the election of all nominees for the Board of Directors; "FOR" the ratification of the appointment of
A valid proxy also gives the individuals named as proxies authority to vote in their discretion when voting the shares on any other matters that are properly presented for action at the Meeting.
If the shares you own are held in "street name" by a broker or other nominee entity and you provide instructions to the broker or nominee as to how to vote your shares, your broker or other nominee entity, as the record holder of your shares, is required to vote your shares according to your instructions. Under the NYSE rules, certain proposals, such as the ratification of the appointment of the Company's registered public accountants, are considered "routine" matters, and brokers and other nominee entities generally may vote on such matters on behalf of beneficial owners who have not furnished voting instructions. For "non-routine" matters, such as the election of directors, the "say on pay" advisory vote and the approval of the amendment of the 2019 SIP, brokers and other nominee entities may not vote unless they have received voting instructions from the beneficial owner. A "broker non-vote" occurs when a broker or other nominee entity does not vote on a particular proposal because it does not have authority under the NYSE rules to vote on that particular proposal without receiving voting instructions from the beneficial owner.
Broker non-votes, as well as properly executed proxies marked "ABSTAIN," will be counted for purposes of determining whether a quorum is present at the Meeting.
For information regarding the voting standard for Proposal 1, see "Vote Required; Majority Voting; Board Recommendation." In order to pass, each of Proposals 2, 3 and 4 must receive the affirmative vote of a majority of the votes cast on the proposal. Abstentions and broker non-votes will not have an effect on these proposals. Withhold votes will be counted as votes cast, and therefore will have the same effect as a vote against the election of a director nominee in Proposal 1.
Proxies may be solicited by our officers, directors and regular supervisory and executive employees, none of whom will receive any additional compensation for their services. Also,
Our executive office is located at 300 N. Beach St.,
Proposals of Shareholders
Pursuant to applicable requirements of Rule 14a-8 under the Securities Exchange Act of 1934, proposals of shareholders intended to be presented at the 2026 Annual Meeting of Shareholders must be received by us no later than November 24, 2025, in order to be
OTHER IMPORTANT INFORMATION
considered for inclusion in our Proxy Statement and form of proxy/voting instruction related to that meeting. Such proposals will need to be in writing and comply with
For a shareholder's notice of nomination of one or more director nominations to be included in our Proxy Statement and form of proxy/voting instructions pursuant to the proxy access right included in Section 1.9 of our By-Laws, the Company must receive such written notice no earlier than the close of business on December 8, 2025 and no later than the close of business on January 7, 2026. The notice must contain the information required in our By-Laws, and the shareholder(s) and nominee(s) must comply with the information and other requirement in our By-Laws relating to the inclusion of nominees in our proxy materials.
In addition, our By-Laws require that for any shareholder proposal for other business or director nomination to be properly brought before the 2026 Annual Meeting of Shareholders, the shareholder proposal or director nomination must comply with the advance notice requirements set forth in our By-Laws (which include information required under Rule 14a-19), and the Company must receive written notice of the matter no earlier than the close of business on January 7, 2026 and no later than the close of business on February 6, 2026. Each such written notice must contain the information set forth in our By-Laws. The advance notice requirement in our By-Laws supersedes the notice period in Rule 14a-4(c)(1) under the Securities Exchange Act of 1934 regarding discretionary proxy authority with respect to shareholder business.
Any shareholder proposals or nominations should be sent to our Corporate Secretary at 300 N. Beach St.,
74 | BROWN &
Our 2024 Annual Report to Shareholders (the "Annual Report") accompanies this Proxy Statement. We will provide to any shareholder, upon the written request of such person, a copy of our Annual Report on Form 10-K, including the financial statements and the exhibits thereto, for the fiscal year ended December 31, 2024, as filed with the
Only one copy of this Proxy Statement and the accompanying Annual Report is being delivered to shareholders who share an address unless we have received contrary instructions from one or more of such shareholders. We will promptly deliver a separate copy of this Proxy Statement and the accompanying Annual Report to any shareholder at a shared address to which a single copy of these documents has been delivered upon our receipt of a written or oral request from that shareholder directed to the address shown above, or to us at (386) 252-9601. Any shareholder sharing a single copy of the Proxy Statement and Annual Report who wishes to receive a separate mailing of these materials in the future, or any shareholders sharing an address and receiving multiple copies of these materials who wish to share a single copy of these documents, should also notify us at the address and telephone number shown above.
The material referred to in this Proxy Statement under the captions "Compensation Discussion and Analysis," "Compensation Committee Report," and "Report of the Audit Committee" shall not be deemed soliciting material or otherwise deemed filed and shall not be deemed to be incorporated by any general statement of incorporation by reference in any filings made under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
By Order of the Board of Directors
Secretary
March 24, 2025
This Proxy Statement contains references to Organic Revenue, Adjusted EBITDAC, Adjusted EBITDAC Margin and Adjusted EPS, which are non-GAAP financial measures. These measures are not in accordance with, or an alternative to the GAAP information provided in the financial statements contained in our Annual Report on Form 10-K. A reconciliation of this non-GAAP financial information to our GAAP information is contained in this Annex A.
Organic Revenue.We view Organic Revenue and Organic Revenue growth as important indicators when assessing and evaluating our performance on a consolidated basis and for each of our three segments, because they allow us to determine a comparable, but non-GAAP, measurement of revenue growth that is associated with the revenue sources that were a part of our business in both the current and prior year, and that are expected to continue in the future. We believe presenting these non-GAAP financial measures allows readers of our financial statements to measure, analyze and compare our consolidated growth, and the growth of each of our segments, in a meaningful and consistent manner.
Adjusted EBITDAC and Adjusted EBITDAC Margin.We view Adjusted EBITDAC and Adjusted EBITDAC Margin as important indicators when assessing and evaluating our performance because they present more comparable measurements of our operating margins in a meaningful and consistent manner.
Adjusted EPS.Adjusted EPS means our earnings per share, excluding the impact of the change in estimated acquisition earn-out payables and any other items (for example, extraordinary, nonrecurring items) that the Compensation Committee determines to be appropriately disregarded for all grants subject to a vesting condition of Adjusted EPS. We believe that Adjusted EPS provides a meaningful representation of our operating performance and is also presented to improve the comparability of our results between periods by eliminating the impact of certain items that have a high degree of variability.
We present such non-GAAP supplemental financial information, as we believe such information provides additional meaningful methods of evaluating certain aspects of our operating performance from period to period on a basis that may not be otherwise apparent on a GAAP basis. Our industry peers may provide similar supplemental non-GAAP information with respect to one or more of these measures, although they may not use the same or comparable terminology and may not make identical adjustments. This supplemental financial information should be considered in addition to, not in lieu of, our Consolidated Financial Statements.
76 | BROWN &
ANNEX A INFORMATION REGARDING NON-GAAPFINANCIAL MEASURES
Reconciliation of Total Commissions and Fees to Organic Revenue Growth
The reconciliation of total commissions and fees, included in the Consolidated Statement of Income, to Organic Revenue growth for the year ended December 31, 2024, is as follows:
(in millions, except percentages) |
Total Commissions and Fees |
Total Net Change |
Total Net Growth % |
Contingents | Core Commissions and Fees(2) |
Acquisition Revenues |
Divested Business |
Foreign Currency Translation |
Organic Revenue(3) |
Organic Revenue Growth |
Organic Revenue Growth % |
|||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Retail(1) |
2,720 | 2,500 | 220 | 8.8 | % | 44 | 50 | 2,676 | 2,450 | 81 | 6 | 8 | 2,595 | 2,452 | 143 | 5.8 | % | |||||||||||||||||||||||||||||||||||||||||||
Programs |
1,375 | 1,160 | 215 | 18.5 | % | 95 | 65 | 1,280 | 1,095 | 57 | 97 | 1 | 1,223 | 999 | 224 | 22.4 | % | |||||||||||||||||||||||||||||||||||||||||||
Wholesale Brokerage |
610 | 539 | 71 | 13.2 | % | 27 | 15 | 583 | 524 | 8 | 2 | 1 | 575 | 527 | 48 | 9.1 | % | |||||||||||||||||||||||||||||||||||||||||||
Total Company |
4,705 | 4,199 | 506 | 12.1 | % | 166 | 130 | 4,539 | 4,069 | 146 | 101 | 10 | 4,393 | 3,978 | 415 | 10.4 | % |
(1) |
The Retail segment includes commissions and fees reported as "Other" in the Segment Information table in Note 15 of the Notes to the Consolidated Financial Statements, which includes corporate and consolidation items. |
(2) |
Core commissions and fees is defined as total commissions and fees, less (i) profit-sharing contingent commissions, and less (ii) for 2021 and earlier, GSCs. |
(3) |
"Organic Revenue," which is a non-GAAP financial measure, is defined as our core commissions and fees less (i) the core commissions and fees earned for the first twelve months by newly acquired operations, less (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period), less (iii) for 2022 and later, Foreign Currency Translation. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth. |
The reconciliation of total commissions and fees, included in the Consolidated Statement of Income, to Organic Revenue growth for the year ended December 31, 2023, is as follows:
(in millions, except percentages) |
Total Commissions and Fees |
Total Net Change |
Total Net Growth % |
Contingents | Core Commissions and Fees(2) |
Acquisition Revenues |
Divested Business |
Foreign Currency Translation |
Organic Revenue(3) |
Organic Revenue Growth |
Organic Revenue Growth % |
|||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Retail(1) |
2,500 | 2,153 | 347 | 16.1 | % | 50 | 49 | 2,450 | 2,104 | 203 | 20 | 9 | 2,247 | 2,093 | 154 | 7.4 | % | |||||||||||||||||||||||||||||||||||||||||||
Programs |
1,160 | 957 | 203 | 21.2 | % | 65 | 28 | 1,095 | 929 | 47 | 26 | - | 1,048 | 903 | 145 | 16.1 | % | |||||||||||||||||||||||||||||||||||||||||||
Wholesale Brokerage |
539 | 453 | 86 | 19.0 | % | 15 | 12 | 524 | 441 | 34 | 5 | 1 | 490 | 437 | 53 | 12.1 | % | |||||||||||||||||||||||||||||||||||||||||||
Total Company |
4,199 | 3,563 | 636 | 17.9 | % | 130 | 89 | 4,069 | 3,474 | 284 | 51 | 10 | 3,785 | 3,433 | 352 | 10.3 | % |
(1) |
The Retail segment includes commissions and fees reported as "Other" in the Segment Information table in Note 15 of the Notes to the Consolidated Financial Statements, which includes corporate and consolidation items. |
(2) |
Core commissions and fees is defined as total commissions and fees, less (i) profit-sharing contingent commissions, and less (ii) for 2021 and earlier, GSCs. |
(3) |
"Organic Revenue," which is a non-GAAP financial measure, is defined as our core commissions and fees less (i) the core commissions and fees earned for the first twelve months by newly acquired operations, less (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period), less (iii) for 2022 and later, Foreign Currency Translation. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth. |
The reconciliation of total commissions and fees, included in the Consolidated Statement of Income, to Organic Revenue growth for the year ended December 31, 2022, is as follows:
(in millions, except percentages) |
Total Commissions and Fees |
Total Net Change |
Total Net Growth % |
Contingents | Core Commissions and Fees(1) |
Acquisition Revenues |
Divested Business |
Foreign Currency Translation |
Organic Revenue(2) |
Organic Revenue Growth |
Organic Revenue Growth % |
|||||||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total Company |
3,563 | 3,048 | 515 | 16.9 | % | 89 | 82 | 3,474 | 2,966 | 289 | 14 | 5 | 3,185 | 2,947 | 238 | 8.1 | % |
(1) |
Core commissions and fees is defined as total commissions and fees, less (i) profit-sharing contingent commissions, and less (ii) for 2021 and earlier, GSCs. |
(2) |
"Organic Revenue," which is a non-GAAP financial measure, is defined as our core commissions and fees less (i) the core commissions and fees earned for the first twelve months by newly acquired operations, less (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period), less (iii) for 2022 and later, Foreign Currency Translation. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth. |
The reconciliation of total commissions and fees, included in the Consolidated Statement of Income, to Organic Revenue growth for the year ended December 31, 2021 is as follows:
(in millions, except percentages) |
Total Commissions and Fees |
Total Net Change |
Total Net Growth % |
Contingents | GSCs | Core Commissions and Fees(1) |
Acquisition Revenues |
Divested Business |
Foreign Currency Translation |
Organic Revenue(2) |
Organic Revenue Growth |
Organic Revenue Growth % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Company |
3,048 | 2,606 | 442 | 17.0 | % | 82 | 71 | 19 | 16 | 2,947 | 2,519 | 170 | 4 | (1 | ) | 2,777 | 2,516 | 261 | 10.4 | % |
(1) |
Core commissions and fees is defined as total commissions and fees, less (i) profit-sharing contingent commissions, and less (ii) for 2021 and earlier, GSCs. |
(2) |
"Organic Revenue," which is a non-GAAP financial measure, is defined as our core commissions and fees less (i) the core commissions and fees earned for the first twelve months by newly acquired operations, less (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period), less (iii) for 2022 and later, Foreign Currency Translation. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth. |
ANNEX A INFORMATION REGARDING NON-GAAPFINANCIAL MEASURES
The reconciliation of total commissions and fees, included in the Consolidated Statement of Income, to Organic Revenue for the year ended December 31, 2020, is as follows:
(in millions, except percentages) |
Total Commissions and Fees |
Total Net Change |
Total Net Growth % |
Contingents | GSCs | Core Commissions and Fees(1) |
Acquisition Revenues |
Divested Business |
Organic Revenue(2) |
Organic Growth |
Organic % |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Company |
2,606 | 2,385 | 221 | 9.3 | % | 71 | 59 | 16 | 23 | 2,519 | 2,303 | 141 | 12 | 2,378 | 2,291 | 87 | 3.8 | % |
(1) |
Core commissions and fees is defined as total commissions and fees, less (i) profit-sharing contingent commissions, and less (ii) for 2021 and earlier, GSCs. |
(2) |
"Organic Revenue," which is a non-GAAP financial measure, is defined as core commissions and fees less (i) the first twelve months of commission and fee revenues generated from acquisitions, less (ii) divested business (net commissions and fees generated from offices, and books of business sold by the Company) with the associated revenue removed from the corresponding period of the prior year, less (iii) for 2022 and later, Foreign Currency Translation. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth. |
Reconciliation of Income Before Income Taxes to Adjusted EBITDAC and
Reconciliation of Income Before Income Taxes Margin to Adjusted EBITDAC Margin
The reconciliation of income before income taxes, included in the Consolidated Statement of Income, to Adjusted EBITDAC for the years ended December 31, 2024 and 2023, and the reconciliation of Income Before Income Taxes Margin, included in the Consolidated Statement of Income, to Adjusted EBITDAC Margin for the years ended December 31, 2024 and 2023 is as follows:
For the Year Ended December 31, |
||||||||
(in millions, unaudited) |
2024 | 2023 | ||||||
Income Before Income Taxes |
1,303 | 1,146 | ||||||
Amortization |
178 | 166 | ||||||
Depreciation |
44 | 40 | ||||||
Interest |
193 | 190 | ||||||
Change in estimated acquisition earn-out payables |
2 | 21 | ||||||
EBITDAC(1) |
1,720 | 1,563 | ||||||
Income Before Income Taxes Margin(2) |
27.1 | % | 26.9 | % | ||||
EBITDAC Margin(3) |
35.8 | % | 36.7 | % | ||||
Loss/(Gain) on disposal |
(31 | ) | (143 | ) | ||||
Non-cash stock-based compensation expense impact in excess of budget |
8 | 10 | ||||||
Acquisition/Integration Costs |
- | 13 | ||||||
1Q23 Nonrecurring Cost |
- | 11 | ||||||
Adjusted EBITDAC(4) |
1,697 | 1,454 | ||||||
Adjusted EBITDAC Margin(4) |
35.3 | % | 34.2 | % |
(1) |
"EBITDAC," which is a non-GAAP financial measure, is defined as income before interest, income taxes, depreciation, amortization and the change in estimated acquisition earn-out payables. |
(2) |
Income Before Income Taxes Margin is calculated as the Company's income before income taxes, as reported, divided by total revenues, as reported. |
(3) |
"EBITDAC Margin," which is a non-GAAP financial measure, is defined as EBITDAC divided by total revenues. |
(4) |
"Adjusted EBITDAC" and "Adjusted EBITDAC Margin," which are both non-GAAP financial measures, are defined as EBITDAC and EBITDAC Margin, respectively, in each case adjusted to exclude (i) for 2023 and 2024, the positive impact of the net gain on disposal resulting from sales of books of business, (ii) for 2023 and 2024, the negative impact of the Company's non-cash stock-based compensation expense in excess of what was reflected in the Company's Board-approved annual budget, (iii) for 2023, the negative impact of the Acquisition/Integration Costs and (iv) for 2023, the negative impact of the 1Q23 Nonrecurring Cost. |
78 | BROWN &
ANNEX A INFORMATION REGARDING NON-GAAPFINANCIAL MEASURES
Reconciliation of Diluted Net Income Per Share to Adjusted EPS
The reconciliation of diluted earnings per share, included in the Consolidated Statement of Income, to Adjusted EPS for the 12-month periods ended December 31, 2023, 2022 and 2021, is as follows:
(in thousands, except for diluted net income per share and Adjusted EPS, unaudited)
Calendar Year |
Diluted Net Income Per Share |
Weighted Average Number of Shares Outstanding- Diluted |
Net Income Attributable to Common Shares ($) |
Change in Estimated Acquisition Earnout Payables (Pre-Tax) ($) |
After-Tax Effect of Adjustment ($)(1) |
After-Tax Adjustments ($)(2) |
Adjusted Net Income Attributable to Common Shares |
Adjusted EPS(3) |
||||||||||||||||||||||||
2021 |
2.07 | 277,414 | 574,162 | 40,445 | 31,128 | 605,290 | 2.18 | |||||||||||||||||||||||||
2022 |
2.37 | 278,658 | 660,419 | (38,900 | ) | (29,829 | ) | 7,922 | 638,512 | 2.29 | ||||||||||||||||||||||
2023 |
3.05 | 280,818 | 856,495 | 21,800 | 16,558 | (81,095 | ) | 791,957 | 2.82 | |||||||||||||||||||||||
$ | 7.29 |
(1) |
After-tax effect of adjustments calculated using the Company's effective tax rate for the respective year. |
(2) |
The after-tax adjustments are: (i) for 2022, adjustments to exclude the positive impact of the 2022 Legal Matter and to exclude the negative impact of Acquisition/Integration Costs, and (ii) for 2023, adjustments to exclude the negative impact of Acquisition/Integration Costs, the negative impact of an amount expensed and substantially paid in the first quarter of 2023 to resolve a business matter, and the positive impact of the gain on disposal associated with the sale of certain third-party claims administration and adjusting services businesses in the fourth quarter of 2023. |
(3) |
A non-GAAP financial measure. |
1. Purpose of Plan.
2. Establishment and Amendment History.The Company's Board of Directors ("Board") adopted the Plan on March 18, 2019, subject to approval by the Company's shareholders. The Company's shareholders approved the Plan on May 1, 2019 ("Effective Date").
3. Term of Plan.The Plan will continue in effect until the tenth (10th) anniversary of the Effective Date, unless terminated earlier by the Board in accordance with Section 22 of the Plan.
4. Definitions. For purposes of the Plan and any Award Agreement, the following terms will have the following meanings:
"Award" means an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, or Other Stock-Based Award granted pursuant to the Plan.
"Award Agreement" means a written or electronic agreement between the Company and a Grantee setting forth the terms, conditions and restrictions of an Award granted to the Grantee.
"Board" means the Board of Directors of the Company.
"Change in Control"means the occurrence of any of the following with respect to the Company:
(i)the direct or indirect sale or exchange in a single or series of related transactions by the shareholders of the Company of more than fifty percent (50%) of the voting stock or beneficial ownership of the Company;
(ii)consummation of a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation or other entity, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, provided that "surviving entity" includes, if applicable, the ultimate parent entity that directly or indirectly has beneficial ownership of sufficient voting securities eligible to elect a majority of the members of the board of directors (or the analogous governing body) of the surviving entity; or
APPENDIX A
(iii)the sale, exchange, or transfer (in one transaction or a series of related transactions) of all or substantially all of the assets of the Company, other than to an entity at least fifty percent (50%) of the total voting power of which is owned, directly or indirectly, by the Company or by shareholders of the Company in substantially the same proportions as their ownership of voting securities of the Company immediately prior to such sale, exchange or other transfer.
For purposes of the definition of Change in Control, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting stock of one or more corporations which, as a result of the applicable transaction, own the Company or the surviving entity or the corporation or corporations to which the assets of the Company were transferred, as the case may be, either directly or through one or more subsidiary corporations. The Committee will have the authority to determine whether multiple sales or exchanges or transfers of the voting stock of the Company or assets of the Company are related, and its determination will be final, binding and conclusive. Notwithstanding this definition of Change in Control, if it is determined that an outstanding Award is subject to the requirements of Section 409A of the Code and the Change in Control is a "payment event" under Section 409A of the Code for such Award, the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A of the Code.
"Code" means the Internal Revenue Code of 1986, as amended, and any applicable interpretations, rulings, and regulations promulgated thereunder.
"Committee" means the Compensation Committee of the Board or such other committee of the Board duly appointed to administer the Plan, and being composed and having such powers as are specified in the Plan or by the Board as generally provided for in the Plan. The composition of the Committee will at all times comply with the requirements of Rule 16b-3under the Exchange Act, and all members of the Committee will be "non-employeedirectors" as defined by Rule 16b-3.
"Company"means
"Constructive Termination"means any one or more of the following:
(i)without the Grantee's express written consent, the assignment to the Grantee of any duties, or any limitation of the Grantee's responsibilities, substantially inconsistent with the Grantee's positions, duties, responsibilities and status with the Company immediately prior to the date of a Change in Control;
(ii)without the Grantee's express written consent, the relocation of the principal place of the Grantee's employment to a location that is more than fifty (50) miles from the Grantee's principal place of employment immediately prior to the date of a Change in Control, or the imposition of travel requirements substantially more demanding of the Grantee than such travel requirements existing immediately prior to the date of a Change in Control;
(iii)any failure by the Company to pay, or any material reduction by the Company of, (A) the Grantee's base salary in effect immediately prior to the date of the Change in Control (unless reductions comparable in amount an duration are concurrently made for all other employees of the Company with responsibilities, organizational level and title comparable to the Grantee's), or (B) the Grantee's bonus compensation, if any, in effect immediately prior to the date of the Change in Control (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned by the Grantee); or
(iv)any failure by the Company to (A) continue to provide the Grantee with the opportunity to participate, on terms no less favorable than those in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with Company then held by the Grantee, in any benefit or compensation plans and programs, including, but not limited to, the Company's life, disability, health, dental, medial, savings, profit sharing, stock purchase and retirement plans, if any, in which the Grantee was participating immediately prior to the date of the Change in Control, or their equivalent, or (B) provide the Grantee with all other fringe benefits (or their equivalent) from time to time in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the Company then held by the Grantee.
"Date of Grant"means the date as of which the Committee grants an Award. If the Committee contemplates an immediate grant to a Grantee, the Date of Grant will be the date of the Committee's action. If the Committee contemplates a date on which the grant is to be made other than the date of the Committee's action, the Date of Grant will be the date so contemplated and set forth in or determinable from the records of action of the Committee; provided, however, that the Date of Grant will not precede the date of the Committee's action.
"Directormeans a member of the Board.
A-2 | BROWN &
APPENDIX A
"Disability" means, with respect to a particular Grantee, that he or she is entitled to receive benefits under the long-term disability plan of the Company or a Subsidiary, as applicable, or, in the absence of such a plan, the complete and permanent inability by reason of illness or accident to perform the duties of the person's occupation at the time when such disability commenced, or, if the Grantee was retired when such disability commenced, the inability to engage in any substantial gainful activity, in either case as determined by the Committee based upon medical evidence acceptable to it.
"Dividend Equivalent"means, with respect to a Restricted Stock Unit or an Other Stock-Based Award that is a Full Value Award, a right to receive a payment equal to the amount of cash dividends and value of other distributions that would have been payable on Shares subject to an Award during a period of time had such Shares been issued to the Grantee during such period of time.
"Employee"means any person treated as an employee (including an officer or a Director who is also treated as an employee) in the records of the Company or its Subsidiaries.
"Exchange Act"means the Securities Exchange Act of 1934, as amended, including all rules and regulations promulgated thereunder.
"Fair Market Value"means, as of any date, the closing price of the Stock on the
"Full Value Award"means any Award other than an Option, a Stock Appreciation Right, or any other Award for which the Grantee pays (or the value or amount payable under the Award is reduced by) an amount less than the Fair Market Value of the Shares, determined as of the Date of Grant.
"Grantee" means a person who has been granted one or more Awards under this Plan.
"Incentive Stock Option"means an Option that is intended to be and is specifically designated as an "incentive stock option" within the meaning of Section 422 of the Code.
"Nonqualified Stock Option"means an Option that is not an Incentive Stock Option.
"Option"means an Award of a right to purchase Shares that is granted pursuant to Section 10 of the Plan. An Option may be either an Incentive Stock Option or a Nonqualified Stock Option.
"Other Stock-Based Award"means an Award granted pursuant to Section 14 of the Plan.
"Performance-Based Award"means an Award with respect to which the amount, awarding, vesting, or settlement is contingent on the achievement of specific Performance Goals during a Performance Period, determined using a specific Performance Measure, all as specified in the related Award Agreement. Performance-Based Awards may be granted in the form of Options, SARs, Restricted Stock, Restricted Stock Units, and/or Other Stock-Based Awards.
"Performance Goal(s)"mean, with respect to a Performance-Based Award, one or more targets, goals or levels of attainment selected by the Committee required to be achieved in terms of the specified Performance Measure during the specified Performance Period.
"Performance Measure"means, with respect to a Performance-Based Award, one or more of the criteria selected by the Committee for the purpose of establishing, and measuring attainment of, Performance Goals for a Performance Period in respect of such Award, as provided in the applicable Award Agreement. For purposes of clarity, the Committee may establish Performance Measures that are measured on an absolute or relative basis and are related to the performance of the Company, a Subsidiary, the Grantee, the division, department, or function within the Company or Subsidiary in which the Grantee is employed, a region, a product-line, or any other manner that it determines appropriate in its discretion.
"Performance Period"means, with respect to a Performance-Based Award, the one or more periods of time, which may be of varying and overlapping durations, as the Committee may select during which the attainment of one or more Performance Goals will be measured.
"Prior Plan"means each of the Company's Performance Stock Plan and 2010 Stock Incentive Plan.
APPENDIX A
"Restricted Stock"means an Award of Shares issued pursuant to Section 12 of the Plan with a restriction on transferability, risk of forfeiture, or such other restrictions or conditions as the Committee, in its discretion may impose, which restrictions generally will expire on a specified date, upon the occurrence of a specified event, and/or on an accelerated basis under certain circumstances, as specified in the Plan and set forth in the related Award Agreement.
"Restricted Stock Unit" or "RSU"means an Award of an unsecured and unfunded promise to deliver Shares or value equal to such Shares in the future pursuant to Section 13 of the Plan, the terms and conditions of which will be specified in the related Award Agreement.
"Rule 16b-3"means Rule 16b-3under the Exchange Act, as amended from time to time, or any successor rule or regulation.
"Section162(m) Grandfathered Award"means an Award that is intended to constitute "qualified performance-based compensation" within the meaning of Section 162(m) of the Code and that is eligible for transition relief from the changes to Section 162(m) provided under the Tax Cuts and Jobs Act.
"Share"means a share of the Company's common stock, $.10 par value, as adjusted from time to time in accordance with Section 7 of the Plan.
"Stock Appreciation Right" or "SAR" means an Award granted pursuant to Section 11 of the Plan that entitles a Grantee to receive, in the form of a cash payment or Shares (as specified by the Committee), an amount equal to the excess of the Fair Market Value of a specified number of Shares at the date of exercise over an exercise price established by the Committee on the Date of Grant.
"Subsidiary"means any present or future "subsidiary corporation" of the Company, as defined in Section 424(f) of the Code.
"Ten Percent Owner Grantee"means a Grantee who, at the time an Option is granted to the Grantee, owns stock constituting more than ten percent (10%) of the total combined voting power of all classes of stock
"Termination After Change in Control" means either of the following events occurring after a Change in Control:
(i)termination by the Company of the Grantee's employment or service with Company, within twelve (12) months following a Change in Control, for any reason other than Termination for Cause; or
(ii)upon Grantee's Constructive Termination, the Grantee's resignation from employment or service with the Company within twelve (12) months following the Transfer of Control.
Notwithstanding any provision herein to the contrary, Termination After Transfer of Control will not include any termination of the Grantee's employment or service with the Company which: (A) is a Termination for Cause; (B) is a result of the Grantee's death or Disability; (C) is a result of the Grantee's voluntary termination of employment or service other than upon Constructive Termination; or (D) occurs prior to the effectiveness of a Change in Control.
"Termination for Cause"means termination by the Company of the Grantee's employment or service with the Company for any of the following reasons: (i) theft, dishonesty, or falsification of any employment or Company records; (ii) improper use or disclosure of the Company's confidential or proprietary information; (iii) the Grantee's failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such continued failure or inability; (iv) any material breach by the Grantee of any employment agreement between the Grantee and Company, which breach is not cured pursuant to the terms of such agreement; or (v) the Grantee's conviction of any criminal act which, in the Company's sole discretion, impairs Grantee's ability to perform his or her duties with Company. Termination for Cause pursuant to the foregoing will be determined in the sole but reasonably exercised discretion of the Company.
5. Administration.
(a) The Plan will be administered by the Committee. All questions of interpretation of the Plan or of any Award will be determined by the Committee, and such determination will be final and binding upon all persons having an interest in the Plan or such Award. The Committee will have full power and authority with respect to the Plan, except those specifically reserved to the
A-4 | BROWN &
APPENDIX A
Board or otherwise delegated pursuant to Section 5(b) of the Plan, and subject at all times to the terms of the Plan and any applicable limitations imposed by law. In addition to any other powers set forth in the Plan and subject to the provisions of the Plan, including without limitation Section 5(b) of the Plan, the Committee will have the full and final power and authority, in its discretion:
(i)to grant Awards, and to determine the persons to whom, and the time or times at which, Awards will be granted and the types and amounts of such Awards, which determination need not be uniform among persons similarly situated and may be made selectively among Employees and Directors;
(ii)to designate Options as Incentive Stock Options or Nonqualified Stock Options;
(iii)to determine the original or amended terms, conditions and restrictions applicable (which need not be identical) to each Award, including, without limitation, (A) the exercise price of an Option or SAR, (B) the method of payment for Shares purchased upon the exercise of an Option, (C) the method for satisfaction of any tax withholding obligations arising in connection with an Award, including by the withholding or delivery of Shares, (D) the terms and conditions of Awards, including without limitation the timing and other terms and conditions of the effectiveness, awarding, vesting, exercisability, acceleration, deferral, and settlement, as applicable, of Awards, (E) the time of the expiration of an Award, (F) the effect of the Grantee's termination of employment or service with the Company on any of the foregoing, and (G) all other terms, conditions and restrictions applicable to an Award or such Shares not inconsistent with the terms of the Plan;
(iv)to approve one or more forms of Award Agreement;
(v)to establish guidelines, criteria, and overall numbers of and limits of Awards;
(vi)to prescribe, amend, or rescind rules, guidelines and policies relating to the Plan, or to adopt supplements to, or alternative versions of, the Plan, including, without limitation, as the Committee deems necessary or desirable to comply with the laws of, or to accommodate the tax policy or custom of, foreign jurisdictions whose citizens may be granted Awards;
(vii)to correct any defect, supply any omission, or reconcile any inconsistency in the Plan or any Award Agreement and to make all other determinations and take such other actions with respect to the Plan or any Award as the Committee may deem advisable for the administration and operation of the Plan and Awards;
(viii)to establish Performance Goals, Performance Measures, and Performance Periods;
(ix)to establish procedural requirements for Performance-Based Awards, including without limitation certification or other determination that Performance Goals have been met;
(x)to construe and interpret the Plan and any Award and make any determination of fact incident to the administration of the Plan; and
(xi)to modify or amend each Award, provided however that the Committee may not modify or amend any outstanding Option or SAR so as to specify a lower exercise price, or accept the surrender of an outstanding Option or SAR and authorize the granting of a new Option or SAR with a lower exercise price in substitution for such surrendered Option or SAR, or buy out, for a payment in cash or shares of Stock, an outstanding Option or SAR.
(b) Delegation to Chief Executive Officer.To the extent permitted by applicable law, the Board may, in its discretion, delegate to the Company's Chief Executive Officer the power and authority to grant Awards to individuals other than (i) Employees who are or may become, upon hiring, subject to Section 16 of the Exchange Act, and (ii) Directors. Any delegation hereunder will be in writing and will be subject to the restrictions and limitations that the Board specifies in writing at the time of such delegation, which must include a limitation on the total number of Shares that may be subject to Awards granted by the Chief Executive Officer pursuant to such delegation. The Board's delegation of authority to the Chief Executive Officer may be revoked or modified by the Board at any time.
6. Shares Subject to Plan.
(a) Subject to adjustment as provided in Section 7 of the Plan and this Section 6, the aggregate number of Shares that are authorized to be issued under the Plan is 9,241,372, which consists of (i) the 6,957,897 Shares that were authorized to be issued under the Company's 2010 Stock Incentive Plan and that were not subject to awards granted under the Company's 2010 Stock Incentive Plan and outstanding as of the Effective Date, plus (ii) an additional 2,283,475 Shares.
APPENDIX A
(b) If any portion of an outstanding Award for any reason expires or is terminated or canceled or forfeited, the Shares allocable to the expired, terminated, canceled, or forfeited portion of such Award will again be available for issuance under the Plan.
(c) If any portion of an outstanding award that was granted prior to the Effective Date under a Prior Plan for any reason expires or is terminated or canceled or forfeited on or after the Effective Date, the Shares allocable to the expired, terminated, canceled, or forfeited portion of such Prior Plan award will be available for issuance under the Plan. Notwithstanding this Section 6(c), the provisions of the Plan will have no effect on awards granted pursuant to the Prior Plans, including without limitation Section 162(m) Grandfathered Awards, which will continue to be governed by the terms and provisions of the agreements and the plan documents governing such grants, as applicable.
(d) All of the shares of Stock available for Awards under the Plan will be available for issuance pursuant to the exercise of Incentive Stock Options granted under the Plan.
(e) With respect to Stock Appreciation Rights, if the payment upon exercise of a SAR is in the form of Shares, the Shares subject to the SAR will be counted against the available Shares as one Share for every Share subject to the SAR, regardless of the number of Shares used to settle the SAR upon exercise. Similarly, in the event that any Option or other Award is exercised through the tendering of Shares or by the withholding of Shares by the Company, or withholding tax liabilities arising from such Option or other Award are satisfied by the tendering of Shares or by the withholding of Shares by the Company, the Shares subject to such Option or other Award will be counted against the available Shares as one Share for every Share subject to the Option or other Award, regardless of the number of Shares issued upon exercise of the Option or other Award. In the event that (i) any Option or other Award granted under the Plan or any other plan maintained by the Company is exercised through the tendering of Shares or by the withholding of Shares by the Company, or (ii) withholding tax liabilities arising from such Options or Awards are satisfied by the tendering of Shares or by the withholding of Shares by the Company, or (iii) Shares are repurchased by the Company using Option exercise proceeds, then the Shares so tendered or withheld or repurchased will not again be available for issuance under the Plan. Awards made in connection with the assumption of, or substitution for, outstanding awards previously granted to individuals who become Employees of the Company or a Subsidiary as a result of any merger, consolidation, acquisition of property or stock, or reorganization, will not count against the limitations set forth in this Section 6.
(f) The Shares issued by the Company under this Plan may be, at the Company's option, evidenced by a Share certificate delivered to the Grantee, or other physical or electronic evidence of Share ownership, including, without limitation, deposit of Shares into a stock brokerage account maintained for the Grantee or credit to a book-entry account for the benefit of the Grantee maintained by the Company's stock transfer agent or its designee.
7. Adjustments for Changes in Capital Structure.In the event of any stock dividend, stock split, reverse stock split, recapitalization, combination, reclassification or similar event or change in the capital structure of the Company, the Board will make appropriate adjustments in (a) the number and class of Shares available for issuance under the Plan as set forth in Section 6 of the Plan, (b) the number and class of Shares subject to any outstanding Awards, (c) the per Share exercise price of any outstanding Option or SAR, (d) the limitations set forth in Section 9, and (e) any other term or condition of any outstanding Award affected by any such change. Notwithstanding the foregoing, any fractional share resulting from an adjustment pursuant to this Section 7 will be rounded down to the nearest whole number, and in no event may the exercise price be decreased to any amount less than the par value, if any, of the stock subject to an Option or SAR. Adjustments pursuant to this Section 7 will be made in accordance with the rules and regulations of Section 409A of the Code, and no such adjustment will be authorized to the extent that such adjustment would cause the Plan to violate Section 422(b)(1) of the Code. Notwithstanding the foregoing, any adjustments made pursuant to this Section 7 that are considered "deferred compensation" under Section 409A of the Code will be made in compliance with the requirements of Section 409A of the Code and any adjustments that are not considered "deferred compensation" subject to Section 409A of the Code will be made in such manner as to ensure that after such adjustment, the Awards either continue not to be subject to Section 409A of the Code or comply with the requirements of Section 409A of the Code. The adjustments determined by the Board pursuant to this Section 7 will be final, binding and conclusive.
8. Eligibility. Awards may be granted only to Employees and Directors, as designated by the Committee in its discretion. Only Employees will be eligible to receive grants of Incentive Stock Options. The Committee's designation of a person as a Grantee in any year does not require the Committee to designate that person to receive an Award under the Plan in any other year or, if so designated, to receive the same Award as any other Grantee in any year. The Committee may consider such factors as it deems pertinent in selecting Grantees and in determining the amount of their respective Awards, including, but without being limited to: (a) the financial condition of the Company or a Subsidiary; (b) expected profits for the current or future years; (c) the contributions of a prospective participant to the profitability and success of the Company or a Subsidiary; and (d) the adequacy of the prospective participant's other compensation. The Committee, in its discretion, may grant Awards to a Grantee under this Plan, even though
A-6 | BROWN &
APPENDIX A
stock, stock options, stock appreciation rights, and other benefits previously were granted to him or her under this or another plan of the Company or a Subsidiary, whether or not the previously granted benefits have been exercised, but the Grantee may hold such Awards only on the terms and subject to the restrictions hereafter set forth. A person who has participated in another benefit plan of the Company or a Subsidiary may also participate in this Plan.
9. Limitations
(a) Fair Market Value Limitation on Incentive Stock Options.To the extent that the aggregate Fair Market Value of stock with respect to which Options designated as Incentive Stock Options are exercisable by a Grantee for the first time during any calendar year (under all stock option plans of the Company, including this Plan) exceeds One Hundred Thousand Dollars ($100,000), that portion of such Options which exceeds such amount will be treated as Nonqualified Stock Options. For purposes of this Section 9(b), Options designated as Incentive Stock Options will be taken into account in the order in which they were granted, and the Fair Market Value of Stock will be determined as of the time the Option with respect to such Stock is granted. If the Code is amended to provide for a different limitation from that set forth in this Section 9(b), such different limitation will be deemed incorporated herein, effective as of the date of and with respect to such Options as required or permitted by, such amendment to the Code. If an Option is treated as an Incentive Stock Option in part and as a Nonqualified Stock Option in part by reason of the limitation set forth in this Section 9(b), the Grantee may designate which portion of such Option the Grantee is exercising and may request that separate stock certificates (or other applicable evidence of Stock ownership, in accordance with Section 6(e) of the Plan) representing each such portion be issued upon the exercise of the Option. In the absence of such designation, the Grantee will be deemed to have exercised the Incentive Stock Option portion of the Option first.
(b) Limitation on Maximum Value.The Committee may establish, at the Date of Grant, terms and conditions regarding any Award that limit the maximum value that a Grantee may realize upon the exercise or vesting of such Award.
(c) Minimum Vesting Requirement.Except with respect to a maximum of five percent (5%) of the Shares that are authorized to be issued under the Plan, as may be adjusted pursuant to Section 7 of the Plan, and except for the death or Disability of the Grantee, or a Termination After Change in Control, no Award will provide for vesting that is any more rapid than vesting on the one (1) year anniversary of the Date of Grant.
10. Options.
(a) In General.The Committee may grant Options to Employee and Directors. Options may be Incentive Stock Options or Nonqualified Stock Options. Only Employees will be eligible to receive grants of Incentive Stock Options. The Committee will determine, in its discretion, the Employees and Directors to whom Options will be granted, the timing of the grants of such Awards, and the number of Shares subject to each Option. All Options will be subject to the terms and conditions of the Plan and may contain such additional terms and conditions, not inconsistent with the express provisions of the Plan, as the Committee determines in its discretion. Options may be granted in addition to, in tandem with, or independent of other Awards under the Plan.
(b) Exercise Price.The per Share exercise price of each Option will be determined by the Committee on the Date of Grant, but in no event will the per share exercise price of any Option be less than one hundred percent (100%) of the Fair Market Value of the Share on the Date of Grant, and in no event will the per Share exercise price of any Incentive Stock Option granted to any Grantee who, on the Date of Grant, owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Subsidiary, be less than one hundred and ten percent (110%) of the Fair Market Value of the Share on the Date of Grant.
(c) Term.The term of each Option will be fixed by the Committee on the Date of Grant, provided that the term will not exceed ten (10) years from the Date of Grant, and the term of an Incentive Stock Option granted to any Grantee who on the Date of Grant, owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Subsidiary, will not exceed five (5) years from the Date of Grant.
(d) Exercisability.An Option will be exercisable at such time or times and subject to such terms and conditions as determined by the Committee on the Date of Grant. No Option may be exercised unless the Grantee is at the time of exercise an Employee or Director and has been continuously an Employee or Director since the Date of Grant, except that the Committee may permit the exercise of any Option for any period following the Participant's termination of employment or directorship not in excess of the original term of the Option on such terms and conditions as the Committee deems appropriate and specified in the related Award Agreement.
BROWN & BROWN, INC. | A-7
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
(e) Method of Exercise.A Grantee may exercise an Option, in whole or in part, by giving notice of exercise to the Company, in such form(s) as may be established by the Company, specifying the number of Shares to be purchased. Such notice will be accompanied by payment in full of the exercise price, plus any required withholding taxes, by any combination of the following methods of exercise as may be permitted by the Committee in its discretion and specified in the applicable Award Agreement:
(i)cash;
(ii)by surrender to the Company (either by actual delivery or attestation to the ownership) of Shares with an aggregate Fair Market Value on the date of exercise that is equal to or less than the aggregate exercise price and payment of cash to the extent of any remaining balance of the aggregate exercise price;
(iii)by a net exercise arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares with an aggregate Fair Market Value on the date of exercise that is equal to or less than the aggregate exercise price and will receive cash from the Grantee to the extent of any remaining balance of the aggregate exercise price;
(iv)by delivery of irrevocable instructions to a broker designated by the Committee to deliver promptly to the Company an amount equal to the aggregate exercise price for the Shares of Common Stock being purchased, along with any applicable tax withholdings, subject to applicable law ("broker-assisted exercise"); or
(v)by such other consideration as may be approved by the Committee from time to time to the extent permitted by applicable law.
(f) Termination of Service. The effect of a Grantee's Termination of Service on his or her outstanding Option(s) will be set forth in the applicable Award Agreement(s).
11. Stock Appreciation Rights (SARs).
(a) In General.The Committee may grant SARs to Employees and Directors. All SARs will be subject to the terms and conditions of the Plan and may contain such additional terms and conditions, not inconsistent with the express provisions of the Plan, as the Committee determines in its discretion. The Committee will determine, in its discretion, the Employees and Directors to whom SARs will be granted, the timing of such grants, and the number of shares subject to each SAR. SARs may be granted in addition to, in tandem with, or independent of other Awards under the Plan.
(b) Exercise Price.The per Share exercise price of each SAR granted under the Plan will be determined by the Committee on the Date of Grant, but in no event will the per Share exercise price of any SAR be less than one hundred percent (100%) of the Fair Market Value of the Share on the Date of Grant.
(c) Term.The term of each SAR will be fixed by the Committee on the Date of Grant, provided that the term will not exceed ten (10) years from the Date of Grant.
(d) Exercisability.A SAR will be exercisable at such time or times and subject to such terms and conditions as determined by the Committee in its discretion at the Date of Grant. No SAR may be exercised unless the holder of the SAR is at the time of such exercise an Employee or Director and has been continuously an Employee or Director since the date such SAR was granted, except that the Committee may permit the exercise of any SAR for any period following the Participant's termination of employment or directorship not in excess of the original term of the SAR on such terms and conditions as the Committee deems appropriate and specified in the applicable Award Agreement.
(d) Form of Settlement.A SAR may be settled in the form of Shares or in cash, as may be established by the Committee in its discretion and specified in the related Award Agreement.
(e) Termination of Service. The effect of a Grantee's Termination of Service on his or her outstanding SAR(s) will be set forth in the applicable Award Agreement(s).
12. Restricted Stock.
(a) In General.Subject to the terms and conditions of the Plan, the Committee may grant Restricted Stock to Employees or Directors from time to time. Shares of Restricted Stock are actual Shares issued to a Grantee and may be awarded either alone or in addition to other Awards. The Committee will determine, in its discretion, the Employees and Directors to whom Restricted Stock will be granted, the timing of such grants, and the number of shares subject to each Award of Restricted Stock. Restricted Stock may be granted in addition to, in tandem with, or independent of other Awards under the Plan.
A-8 | BROWN & BROWN, INC.
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
(b) Terms and Conditions.Each Award of Restricted Stock will be evidenced by an Award Agreement that will set forth (i) the conditions, if any, that must be timely satisfied before the Award will be effective, and the conditions, if any, that must be timely satisfied before the Award will be vested, (ii) the conditions, if any, under which the Grantee's interest in the related Shares will be forfeited, and (iii) and any other terms and conditions of the Award. Any such conditions for effectiveness or vesting will be determined on the Date of Grant, and may be based upon the passage of time and continued service by the Grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions. The conditions for effectiveness or vesting and the other provisions of Awards of Restricted Stock are not required to be the same with respect to each Grantee. For the avoidance of doubt, the Committee may grant Restricted Stock without any conditions for effectiveness or vesting.
(c) Dividends, Voting, and Other Ownership Rights.Unless otherwise provided by the Committee in the Award Agreement, an Award of Restricted Stock will entitle the Grantee to dividend, voting, and other ownership rights during the period for which the Share(s) remain subject to forfeiture and/or other conditions, provided, however, that in the case of an Award of Restricted Stock that is conditioned on the attainment of performance goals, the Grantee will not receive payment of any dividends unless and not earlier than such time as the Restricted Stock becomes earned or awarded based on the attainment of the performance goals.
(d) Termination of Service. The effect of a Grantee's Termination of Service on his or her outstanding Award(s) of Restricted Stock will be set forth in the applicable Award Agreement(s).
13. Restricted Stock Units (RSUs).
(a) In General.Subject to the terms and conditions of the Plan, the Committee may grant RSUs to Employees or Directors from time to time. RSUs are Awards denominated in Shares that will be settled, subject to the terms and conditions of the RSUs, in a specified number of Shares or an amount of cash equal to the Fair Market Value of a specified number of Shares. The Committee will determine, in its discretion, the Employees and Directors to whom RSUs will be granted, the timing of such grants, and the number of shares subject to each Award of RSUs. RSUs may be granted in addition to, in tandem with, or independent of other Awards under the Plan.
(b) Terms and Conditions.Each Award of RSUs will be evidenced by an Award Agreement that will set forth (i) the conditions, if any, that must be timely satisfied before the Award will be effective, and the conditions, if any, that must be timely satisfied before the Award will be vested, (ii) the conditions, if any, under which the Grantee's interest in the RSUs will be forfeited, and (iii) and any other terms and conditions of the Award. Any such conditions for effectiveness or vesting will be determined on the Date of Grant, and may be based upon the passage of time and continued service by the Grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions. The conditions for effectiveness or vesting and the other provisions of RSUs are not required to be the same with respect to each Grantee. For the avoidance of doubt, the Committee may grant RSUs without any conditions for effectiveness or vesting.
(c) Dividends, Voting, and Other Ownership Rights.Unless otherwise provided by the Committee in the Award Agreement, a Grantee will not have any rights as a shareholder with respect to Shares underlying an Award of RSUs until such time, if any, as the RSUs are settled and the underlying Shares are actually issued to the Grantee. The Committee may provide in the Award Agreement for the payment of Dividend Equivalents (as defined below) to the Grantee at such times as paid to shareholders generally or at the time of vesting or other payout of the RSUs, provided, however, that in the case of such an Award that is conditioned on the attainment of performance goals, the Grantee will not receive payment of any Dividend Equivalents unless and not earlier than such time as the RSUs become earned or awarded based on the attainment of the performance goals, and provided further, that if the payment or crediting of Dividend Equivalents is in respect of an Award that is subject to Section 409A of the Code, then the payment or crediting of such dividends or Dividend Equivalents will conform to the requirements of Section 409A of the Code.
(d) Deferral of Receipt of Payment.The Committee may permit or require a Grantee to defer receipt of the delivery of Shares that would otherwise be due by virtue of the grant of or the lapse or waiver of restrictions with respect to RSUs. If any such deferral is required or permitted, the Committee will establish such rules and procedures for such deferral, including rules and procedures implemented pursuant to Section 28 of the Plan for compliance with Section 409A of the Code.
(e) Termination of Service. The effect of a Grantee's Termination of Service on his or her outstanding RSU(s) will be set forth in the applicable Award Agreement(s).
14. Other Stock-Based Awards.The Committee may grant Share-based or Share-related awards not otherwise described in Sections 10, 11, 12, or 13 of the Plan to Employees and Directors in such amounts and subject to such terms and conditions consistent with the terms of this Plan as the Committee determines. Without limiting the generality of the preceding sentence, each such Other
BROWN & BROWN, INC. | A-9
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
Stock-Based Award may: (a) involve the transfer of actual Shares to Grantees, either on the Date of Grant or later, or payment in cash or otherwise of amounts based on the value of Shares; (b) be subject to performance-based and/or service-based conditions; (c) be in the form of phantom stock, restricted stock, restricted stock units, performance shares, deferred share units, or share-denominated performance units, or other awards denominated in, or with a value determined by reference to, a number of Shares that is specified on the Date of Grant; and (d) be designed to comply with applicable laws of jurisdictions other than the United States.
15. Performance-Based Awards.
(a) In General.The Committee may grant Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, and Other Stock-Based Awards that are Performance-Based Awards. On the Date of Grant of each Performance-Based Award, the Committee will establish the Performance Period, the Performance Measure(s), and the Performance Goals in respect of such Performance-Based Awards. Each Performance-Based Award will provide that, in order for the Award to be earned or awarded or for the Grantee to receive all or a portion of the Shares or cash subject to such Performance-Based Award, certain Performance Goals must be attained over a designated Performance Period, with attainment of the Performance Goals determined using specific Performance Measures. The Performance Goals and Performance Period will be established by the Committee in its discretion.
(b) Performance Measures.The Performance Measure will be based on one or more of the following criteria: stock price; market share; sales; earnings per share, core earnings per share or variations thereof; retuon equity; costs; revenue; cash to cash cycle; days payables outstanding; days of supply; days sales outstanding; cash flow; operating income; profit after tax; profit before tax; retuon assets; retuon sales; inventory turns; invested capital; net operating profit after tax; retuon invested capital; total shareholder return; earnings; retuon equity or average shareowners' equity; total shareowner return; retuon capital; retuon investment; income or net income; operating income or net operating income; operating profit or net operating profit; operating margin; retuon operating revenue; contract awards or backlog; overhead or other expense reduction; growth in shareowner value relative to the moving average of the S&P 500 Index or a peer group index; credit rating; strategic plan development and implementation; net cash provided by operating activities; gross margin; economic value added; customer satisfaction; financial returatios; market performance; or any other performance criteria.
(c) Adjustments and Procedure.The Committee may adjust Performance Goals and the related level of achievement if the Committee determines in its discretion that events or transactions that are unusual in nature or infrequently occurring have occurred after the Date of Grant that are unrelated to the performance of the Grantee and result in distortion of the performance targets or the related level of achievement. The Committee may provide in the applicable Award Agreement additional rules and procedures relating to the Committee's ability to adjust aspects of a Performance-Based Award, the Committee's ability to increase or decrease the amount of compensation provided by a Performance-Based Award, and the Committee's certification or other determination of the extent to which Performance Goals have or have not been attained.
16. Change in Control.Subject to the requirements of Section 409A of the Code and any additional conditions set forth in the applicable Award Agreements, if a Grantee experiences a Termination After Change in Control:
(a) each of the Grantee's outstanding Awards that is subject to a time-based vesting schedule will become fully vested and nonforfeitable as of the date of such Termination After Change in Control; and
(b) each of the Grantee's outstanding Awards that is a Performance-Based Award will become fully vested and nonforfeitable as of the date of such Termination After Change in Control based on the greater of (i) the target level of achievement of the Performance Goals(s) applicable to the Award, or (ii) the actual level of achievement of the Performance Goal(s) applicable to the Award from the first day of the Performance Period to the date on which the Change in Control occurs.
17. Nontransferability of Awards.
(a) In General.Unless the Committee, in its discretion, determines otherwise at the time an Award is granted, neither an Award nor the Shares subject to an Award nor any interest or right therein or part thereof will be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means, whether such disposition is voluntary or involuntary or by operation of law, by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy) and any attempted disposition thereof will be null and void and of no effect; provided, however, that this Section 17 will not prevent transfers by will or by the applicable laws of descent and distribution or by a beneficiary designation in accordance with Section 17(b) below. An Option or SAR may be exercised during the Grantee's lifetime only by the Grantee or, if permissible under applicable law, by the Grantee's guardian or legal representative.
A-10 | BROWN & BROWN, INC.
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
(b) Authorized Transfers.To the extent the Committee authorizes the transferability of an Award, in no event will any transfer be made to any person or persons other than such Grantee's spouse, children or grandchildren, or a trust for the exclusive benefit of one or more such persons, which transfer must be made as a gift and without any consideration. All other transfers and any re-transfer byany permitted transferee are prohibited and any such purported transfer will be null and void. Each Award that becomes the subject of permitted transfer (and the Grantee to whom it was granted by the Company) will continue to be subject to the same terms and conditions as were in effect immediately prior to such permitted transfer. The Grantee will remain responsible to the Company for the payment of all withholding taxes including but not limited to those incurred as a result of any grant, vesting, or exercise of such Award, as applicable. In no event will any permitted transfer of an Award create any right in any party in respect of any Award, other than the rights of the qualified transferee in respect of such Award specified in the related Award Agreement.
(c) Beneficiary Designations.Each Grantee may designate a beneficiary or beneficiaries to exercise any rights or receive any benefits under an Award following the Grantee's death. To be effective, such designation must be made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. If a Grantee fails to designate a beneficiary, or if no designated beneficiary survives the Grantee's death, the Grantee's estate will be deemed the Grantee's beneficiary. A beneficiary designation may be changed or revoked by the Grantee's sole action, provided that the change or revocation is made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. Unless otherwise provided in the beneficiary designation, each designation made will revoke all prior designations made by the same Grantee.
18. Awards to Grantees Outside the United States.The Committee may grant Awards to Employees and Directors who reside in countries outside of the United States. Notwithstanding anything in the Plan to the contrary, the Committee may, in its sole discretion:
(a) amend or vary the terms of the Plan in order to conform such terms with the requirements of each country where a Grantee or Subsidiary is located;
(b) amend or vary the terms of the Plan in each country where a Grantee or Subsidiary is located as it considers necessary or desirable to take into account or to mitigate or reduce the burden of taxation and social insurance contributions for the Grantee or the Subsidiary; or
(c) amend or vary the terms of the Plan in a country where an Employee or a Subsidiary is located as it considers necessary or desirable to meet the goals and objectives of the Plan.
The Committee may, where it deems appropriate in its sole discretion, establish one or more sub-plansof the Plan for these purposes. The Committee may, in its sole discretion, establish administrative rules and procedures to facilitate the operation of the Plan in such jurisdictions.
19. Construction.Captions and titles contained in the Plan are for convenience only and will not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular will include the plural, the plural will include the singular, the term "or" will include the conjunctive as well as the disjunctive, and words in the masculine or neuter gender will include the feminine, masculine or neuter gender where applicable.
20. No Right of Grant or Employment.No Employee or Director will have any claim or right to be granted an Award under the Plan, or, having been selected for the grant of an Award, to be selected for a grant of any other Award. Neither the Plan nor any action taken hereunder will be construed as giving any Grantee any right to be retained in the employ or service of the Company or a Subsidiary, or interfere in any way with the right of the Company or its Subsidiaries to terminate such Grantee's employment or service at any time. Participation in the Plan is a matter separate from any contract of employment or other agreement and any benefit conferred by the Plan will not be counted for pension or any other purpose. The rights and obligations of any individual under the terms of his office or employment with the Company or any Subsidiary will not be affected by his participation in the Plan, and neither the Plan nor any Award form any part of any contract of employment between any individual and the Company or a Subsidiary. A Grantee will have no entitlement by way of compensation or damages resulting from termination of the office or employment (for any reason and whether lawful or not) by virtue of which he is or may be eligible to participate in the Plan or for the loss or reduction of any right or benefit or prospective right or benefit under the Plan or any Award that he might otherwise have enjoyed whether the compensation is claimed for wrongful dismissal or otherwise.
21. Indemnification. In addition to such other rights of indemnification as they may have as members of the Board or a committee thereof or as officers or employees of the Company, members of the Board, the Committee and any officers or employees of the Company to whom authority to act for the Board or Committee is delegated will be indemnified by the Company against all
BROWN & BROWN, INC. | A-11
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
reasonable expenses, including attorneys' fees, incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be party by reason of any action taken or failure to act under or in connection with the Plan, Award, or any right granted hereunder, and against all amounts in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it will be adjudged in such action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60) days after the institution of such action, suit or proceeding, such person will offer to the Company, in writing, the opportunity at its own expense to handle and defend the same. Without limiting the generality of the foregoing, the Company will pay the expenses (including reasonable attorneys' fees) of defending any such claim, action, suit or proceeds in advance of its final disposition, upon receipt of such person's written agreement to repay all amounts advanced if it should ultimately be determined that such person is not entitled to be indemnified under this Section 21.
22. Termination or Amendment of Plan. The Committee, without further approval of the shareholders of the Company, may terminate or amend this Plan at any time in any respect as the Committee deems advisable, subject to any required shareholder or regulatory approval and to any conditions established by the terms of such amendment. In any event, no termination or amendment of the Plan may adversely affect any then outstanding Award or any unexercised portion thereof without the consent of the Grantee, unless such termination or amendment is required to enable an Option designated as an Incentive Stock Option to qualify as an Incentive Stock Option or is necessary to comply with any applicable law or government regulation.
23. Dissolution of Company.Upon the dissolution of the Company, the Plan will terminate and any and all Awards previously granted hereunder will lapse on the date of such dissolution.
24. Rights as Stockholders.No Grantee, nor any beneficiary or other person claiming through a Grantee, will have any interest in any Shares allocated for the purposes of the Plan or that are subject to an Award until such Shares will have been issued to the Grantee or such beneficiary or other person. Furthermore, the existence of the Awards will not affect the right or power of the Company or its shareholders to make adjustments, or to effect any recapitalization, reorganization, or other changes in the Company's capital structure or its business; to issue bonds, debentures, preferred or prior preference stocks affecting the Shares or the rights thereof; to dissolve the Company or sell or transfer any part of its assets or business; or to do any other corporate act, whether of a similar character or otherwise.
25. Application of Funds.The proceeds received by the Company from the sale of Stock pursuant to Options granted under this Plan will be used for general corporate purposes.
26. Choice of Law.The validity, interpretation, and administration of the Plan and of any rules, regulations, determinations, or decisions made thereunder, and the rights of any and all person having or claiming to have any interest therein or thereunder, will be determined exclusively in accordance with the internal laws of the State of Florida. Without limiting the generality of the foregoing, the period within which any action in connection with Plan must be commenced will be governed by the internal laws of the State of Florida without regard to the place where the act or omission complained of took place or the resident of any party to such action. Any action in connection with the Plan must be brought in the State of Florida, County of Hillsborough.
27. Shareholder Approval.The Plan or any increase in the maximum number of Shares issuable as provided in Section 6 of the Plan (the "Maximum Shares") will be approved by the stockholders of the Company within twelve (12) months of the date of adoption thereof by the Board. Awards granted prior to shareholder approval of the Plan or in excess of the Maximum Shares previously approved by the shareholders will become exercisable no earlier than the date of shareholder approval of the Plan or such increase in the Maximum Shares, as the case may be.
28. Code Section409A.It is intended that the Plan and all Awards hereunder be administered in a manner that will comply with the applicable requirements of Section 409A of the Code. The Committee is authorized to adopt rules or regulations deemed necessary or appropriate to qualify for an exception from or to comply with the requirements of Section 409A of the Code. Without limiting the generality of the foregoing, if any amount will be payable with respect to any Award hereunder as a result of a Grantee's "separation from service" at such time as the Grantee is a "specified employee" (as those terms are defined for purposes of Section 409A of the Code), and such amount constitutes a deferral of compensation subject to Section 409A of the Code, then no payment will be made, except as permitted under Section 409A of the Code, prior to the date six months after the Grantee's separation from service (or the date of his or her earlier death). The Company may adopt a specified employee policy that will apply to identify the specified employees for all deferred compensation plans subject to Section 409A of the Code; otherwise, specified employees will be identified using the default standards contained in the regulations under Section 409A of the Code.
A-12 | BROWN & BROWN, INC.
APPENDIX A BROWN & BROWN, INC. 2019 STOCK INCENTIVE PLAN
29. Tax Withholding. Each Award will be made subject to any applicable withholding for taxes. The Company or the Subsidiary that employs a Grantee will have the right to deduct from any amount payable under the Plan, including delivery of Shares to be made under the Plan, all federal, state, local, or foreign taxes of any kind required by law to be withheld with respect to such payment (including social insurance contributions) and to take such other actions as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes. If Shares are used to satisfy withholding taxes, such Shares will be valued, unless otherwise provided for in an Award Agreement, based on the Fair Market Value of the Shares on the date when the withholding for taxes is determined. The Company or the Subsidiary that employs a Grantee will have the right to require the Grantee to pay cash to satisfy withholding taxes as a condition to the payment or settlement of any amount (whether in cash or Shares) under the Plan.
BROWN & BROWN, INC. | A-13
THIS AMENDMENT ("Amendment") to the Brown & Brown, Inc. 2019 Stock Incentive Plan (the "Plan") shall be effective as of May 7, 2025.
1. Subsection 2 of the Plan shall be deleted in its entirety and replaced with the following:
"2. Establishment and Amendment History. The Company's Board of Directors ("Board") adopted the Plan on March 18, 2019, subject to approval by the Company's shareholders. The Company's shareholders approved the Plan on May 1, 2019 ("Effective Date"). The Committee approved an amendment to the Plan on March 24, 2025, which increased the number of Shares authorized to be issued under the Plan, as provided in Section 6(a) of the Plan, and extended the term of the Plan to May 7, 2035 (the "Amendment"), subject to approval by the Company's shareholders. The Company's shareholders approved the Amendment on May 7, 2025 (the "Amendment Effective Date")."
2. Subsection 3 of the Plan shall be deleted in its entirety and replaced with the following:
"3. Term of Plan. The Plan will continue in effect until the tenth (10th) anniversary of the Amendment Effective Date, unless terminated earlier by the Board in accordance with Section 22 of the Plan."
3. Subsection (a) of Section 6 of the Plan shall be deleted in its entirety and replaced with the following:
"(a) Subject to adjustment as provided in Section 7 of the Plan and this Section 6, the aggregate number of Shares that are authorized to be issued under the Plan is 16,171,372, which consists of (i) 2,283,475 Shares, plus (ii) the 6,957,897 Shares authorized for issuance under the Company's 2010 Stock Incentive Plan that are not subject to awards outstanding or previously issued as of the Effective Date, plus (iii) an additional 6,930,000 Shares."
4. The Plan, as modified by the terms of this Amendment, shall continue in full force and effect from and after the date of the adoption of this Amendment.
BROWN & BROWN, INC. | ||
By: | ||
Name: | ||
Title: |
BROWN & BROWN, INC. | B-1
ANNUAL MEETING OF SHAREHOLDERS
BROWN & BROWN, INC.
Virtual Meeting
THIS PROXY IS BEING SOLICITED BY THE BOARD OF DIRECTORS FOR
THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD MAY 7, 2025, 9:00 A.M. (EDT)
The undersigned hereby appoints Anthony M. Robinson and R. Andrew Watts, and each of them as proxies with full power of substitution, with all the powers the undersigned would possess if personally present, to vote all shares of Common Stock of Brown & Brown, Inc. which the undersigned is entitled to vote at the Annual Meeting of Shareholders and any adjournment(s) thereof.
The Annual Meeting of Shareholders will be held virtually. In order to attend the meeting, you must register at https://web.viewproxy.com/BBrown/2025 by 11:59 P.M. (EDT) on May 4, 2025. On the day of the Annual Meeting of Shareholders, if you have properly registered, you may enter the meeting by clicking on the link provided and the password you received via email in your registration confirmation. Further instructions on how to attend and vote at the Annual Meeting of Shareholders are contained in the Proxy Statement in the section titled "Attending the Virtual Annual Meeting."
(Continued and to be signed on the reverse side)
p PLEASE DETACH ALONG PERFORATED LINE AND MAIL IN THE ENVELOPE PROVIDED. p
All shareholders who wish to attend the Virtual Meeting, must register at:
https://web.viewproxy.com/BBrown/2025
The deadline for registration is May 4, 2025 at 11:59 P.M. (EDT)
NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS:
The Notice of Meeting, Proxy Statement, and Annual Report to Shareholders are available at
https://web.viewproxy.com/BBrown/2025
The Board of Directors recommends a vote FOR all director nominees and FOR Proposals 2, 3 and 4:
1. Election of Directors.
01 J. Hyatt Brown | 05 James S. Hunt | 09 Bronislaw E. Masojada | 13 Kathleen A. Savio | ☐FOR ALL | ☐WITHHOLD | ☐FOR ALL EXCEPT | ||||||
02 J. Powell Brown | 06 Toni Jennings | 10 Jaymin B. Patel | NOMINEES | AUTHORITY FOR | (SEE INSTRUCTIONS | |||||||
03 Lawrence L. Gellerstedt III | 07 Paul J. Krump | 11 H. Palmer Proctor, Jr. | ALL NOMINEES | BELOW) | ||||||||
04 Theodore J. Hoepner | 08 Timothy R.M. Main | 12 Wendell S. Reilly |
(Instructions: To withhold authority to vote for any indicated nominee, mark "FOR ALL EXCEPT" and write the number(s) of the nominee(s) in the box provided to the right.) |
2. |
To ratify the appointment of Deloitte & Touche LLP as Brown & Brown, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2025. |
☐ FOR ☐ AGAINST ☐ ABSTAIN
Address Change/Comments: (If you noted any Address Changes and/or Comments above, please mark box.) ☐
3. |
To approve, on an advisory basis, the compensation of named executive officers. |
☐ FOR ☐ AGAINST ☐ ABSTAIN
4. |
To approve an amendment to Brown & Brown, Inc.'s 2019 Stock Incentive Plan to increase the number of shares available for issuance under the plan and extend the term. |
☐ FOR ☐ AGAINST ☐ ABSTAIN
In their discretion the Proxies are authorized to vote upon such other business as may properly come before the Annual Meeting or any adjournment(s) thereof.
Persons who do not indicate attendance at the Annual Meeting on this proxy card may be required to present proof of stock ownership to attend.
This proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this proxy will be voted FOR the election of all of the director nominees listed on this proxy card and FOR Proposals 2, 3 and 4.
Date _________________________________________________________
Signature _____________________________________________________
Signature _____________________________________________________
(Joint Owners)
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.
p PLEASE DETACH ALONG PERFORATED LINE AND MAIL IN THE ENVELOPE PROVIDED. p
PROXY VOTING INSTRUCTIONS
Please have your 11-digitcontrol number ready when voting by Internet or Telephone
INTERNET | TELEPHONE | |||||||
Vote Your Proxy on the Internet: | Vote Your Proxy by Phone: | Vote Your Proxy by Mail: | ||||||
Go to www.AALvote.com/BRO | Call 1 (866) 804-9616 | |||||||
Have your proxy card available | Use any touch-tone telephone to | Mark, sign, and date your proxy | ||||||
when you access the above | vote your proxy. Have your proxy | card, then detach it, and return | ||||||
website. Follow the prompts to | card available when you call. | it in the postage-paid envelope | ||||||
vote your shares. | Follow the voting instructions to | provided. | ||||||
vote your shares. |
Attachments
Disclaimer
Brown & Brown Inc. published this content on March 24, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 24, 2025 at 21:18:48.710.
Proxy Statement (Form DEF 14A)
March 21, 2025: Economy Highlights
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News